HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 1453,
"next": "https://mitotox.org/api/compounds/list?format=api&page=12",
"previous": "https://mitotox.org/api/compounds/list?format=api&page=10",
"results": [
{
"compound_ID": "D1026",
"name": "novaluron",
"synonyms": "Novaluron; 116714-46-6; Rimon; Novaluron [ISO]; HSDB 7004; CHEBI:39385; NJPPVKZQTLUDBO-UHFFFAOYSA-N; Benzamide, N-3-chloro-4-(1,1,2-trifluoro)-2-(trifluoromethoxy)ethoxyphenyl-amino-carbonyl-2,6-difluoro-; N-({3-chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl}carbamoyl)-2,6-difluorobenzamide; N-[[3-chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl]carbamoyl]-2,6-difluorobenzamide; Benzamide, N-[[[3-chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl]amino]carbonyl]-2,6-difluoro-; Benzamide, N-(((3-chloro-4-(1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy)phenyl)amino)carbonyl)-2,6-difluoro-; N-[({3-chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl}amino)carbonyl]-2,6-difluorobenzamide; C17H9ClF8N2O4; Pedestal; 1-[3-Chloro-4-(1,1,2-trifluoro-2-trifluoromethoxyethoxy)phenyl]-3-(2,6-difluorobenzoyl)urea; DSSTox_CID_14773; DSSTox_RID_79201; DSSTox_GSID_34773; SCHEMBL26984; CHEMBL1869031; DTXSID5034773; Tox21_300959; s5475; AKOS005063565; CS-3305; NCGC00163902-01; NCGC00163902-02; NCGC00163902-03; NCGC00163902-04; NCGC00254861-01; AS-15773; CC-33085; HY-17519; Q727; AB0017769; LS-182196; CAS-116714-46-6; FT-0631085; Novaluron, PESTANAL(R), analytical standard; C18875; 714N466; C-22890; Q1900206; N-(3-chloro-4-(1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy)phenylcarbamoyl)-2,6-difluorobenzamide; Pesticide3_Novaluron_C17H9ClF8N2O4_N-({3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl}carbamoyl)-2,6-difluorobenzamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H9ClF8N2O4",
"molecular_weight": "492.7",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "93541",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02048",
"RC02669",
"RC03290"
]
},
{
"compound_ID": "D1027",
"name": "n-phenyl-1,4-benzenediamine hydrochloride",
"synonyms": "2198-59-6; N1-Phenylbenzene-1,4-diamine hydrochloride; 4-Aminodiphenylamine hydrochloride; Eucanine Grey B; 1,4-Benzenediamine, N-phenyl-, monohydrochloride; N-Phenyl-p-phenylenediamine hydrochloride; Fourrine Grey B; Durafur Grey BN; C.I. Oxidation Base 2A; Fouramine Grey A; Futramine Grey B; Furro Grey B; Nako Grey GB; Zoba Grey BR; 1,4-Benzenediamine, N-phenyl-, hydrochloride; Fourrine 96; Basf Ursol Grey B; Fouramine Grey AER; N-Phenyl-1,4-benzenediamine hydrochloride; p-Aminodiphenylamine HCl; 56426-15-4; UNII-2TS7135LI6; N-Phenyl-p-phenylenediamine HCl; N-Phenyl-p-phenylenediamine.HCl; p-Phenylenediamine, N-phenyl-, hydrochloride; p-Aminodiphenylamine hydrochloride; 2TS7135LI6; EINECS 218-599-4; CI 76086; N-phenylbenzene-1,4-diamine hydrochloride; N-Phenylbenzene-p-diamine monohydrochloride; 1,4-Benzenediamine, N1-phenyl-, hydrochloride (1:1); (4-aminophenyl)phenylamine, chloride; 4-AMINODIPHENYLAMINEHYDROCHLORIDE; N-(4-Aminophenyl)aniline HCl; EINECS 260-173-5; N-(4-Aminophenyl)aniline hydrochloride; 4-Aminodiphenylamine HCl; DSSTox_CID_1132; DSSTox_RID_75963; DSSTox_GSID_21132; p-Aminodiphenylaminhydrochlorid; SCHEMBL479764; CHEMBL3186715; DTXSID9021132; CTK1A2942; KS-000015RW; Tox21_200117; 1123AB; ANW-52955; SBB003349; AKOS004910389; ACM2198596; LS-7650; NCGC00257671-01; CAS-2198-59-6; AX8094130; DB-045746; N-Phenyl-1,4-phenylenediamine Hydrochloride; TC-141700; FT-0634115; P0189; ST50405720; 4-AMINODIPHENYLAMINE HYDROCHLORIDE 98+%; C-49717; Q27255587;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H13ClN2",
"molecular_weight": "220.7",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "75146",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02049",
"RC02670",
"RC03291"
]
},
{
"compound_ID": "D1028",
"name": "o,p'-ddd",
"synonyms": "mitotane; 53-19-0; Mitotan; Lysodren; o,p'-DDD; Chlodithane; Chloditan; Khlodithan; Chlodithan; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; 2,4'-Ddd; Mitotano; 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene; NCI-C04933; Mitotanum [INN-Latin]; o,p'-TDE; 2,4'-Dichlorodiphenyldichloroethane; o,p-Tde; o,p'-Dichlorodiphenyldichloroethane; Mitotano [INN-Spanish]; 2,4'-Dichlorophenyldichlorethane; Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-; 1-Chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)benzene; CB313; DDD, o,p'-; CB 313; NSC 38721; 1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; 2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane; 2-(o-Chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloroethane; C14H10Cl4; CCRIS 4397; 1,1-Dichloro-2,2-bis(2,4'-dichlorophenyl)ethane; HSDB 3240; NSC38721; 1,1-Dichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane; 2,2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane; EINECS 200-166-6; CB-313; NSC-38721; BRN 2056007; AI3-07575; 1-chloro-4-[2,2-dichloro-1-(2-chlorophenyl)ethyl]benzene; Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-; Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-; Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-; NCGC00015226-07; Khloditan; Mitotanum; Mytotan; (+-)-1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; DSSTox_CID_372; ortho,para-DDD; DSSTox_RID_75548; DSSTox_GSID_20372; o,p-DDD; Opeprim; 2,4 -Dichlorodiphenyldichloroethane; Mitotane (Lsodren); Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-, (+-)-; CAS-53-19-0; Lysodren (TN); Mitotane [USAN:INN:JAN]; SMR000326696; SR-01000075751; (o,p)-DDD; Mitotane (JAN/USP/INN); Prestwick_75; Mitotane(Lysodren); Ethane,1-dichloro-; Mitotane (Lysodren); Mitotane [USAN:USP:INN:BAN:JAN]; (2,4'-Dichlorodiphenyl)dichloroethane; PubChem14974; Spectrum_001959; DDD-o,p'; Spectrum2_000916; Spectrum3_000869; Spectrum4_000709; Spectrum5_002060; C 3010; (o,p')-DDD; SCHEMBL4040; CHEMBL1670; Lopac0_000251; WLN: GYGYR BG&R DG; BSPBio_002517; KBioGR_001237; KBioSS_002513; SPECTRUM330082; MLS001335899; MLS001335900; MLS002152914; MLS002153233; DivK1c_000703; SPBio_000792; CHEBI:6954; GTPL6957; Mitotane, >=98% (HPLC); DTXSID9020372; 2,4'-DDD, analytical standard; CTK8E2992; HMS502D05; KBio1_000703; KBio2_002505; KBio2_005073; KBio2_007641; KBio3_002017; JWBOIMRXGHLCPP-UHFFFAOYSA-N; NINDS_000703; HMS1923K19; HMS2091E07; HMS2232C16; HMS3260D04; HMS3369H10; HMS3655G06; HMS3715H07; Pharmakon1600-00330082; BCP11663; 2,4 inverted exclamation marka-DDD; Tox21_110103; Tox21_302804; Tox21_500251; CCG-40014; LS-185; MFCD00000850; NSC755849; s1732; 1,2-bis(2,4'-dichlorophenyl)ethane; AKOS006028802; Tox21_110103_1; CS-1500; DB00648; LP00251; MCULE-2068358149; NSC-755849; IDI1_000703; 2,4'-DDD 100 microg/mL in Methanol; NCGC00015226-02; NCGC00015226-03; NCGC00015226-04; NCGC00015226-05; NCGC00015226-06; NCGC00015226-08; NCGC00015226-09; NCGC00015226-10; NCGC00015226-11; NCGC00015226-12; NCGC00091374-01; NCGC00091374-02; NCGC00091374-03; NCGC00091374-04; NCGC00091374-05; NCGC00091374-06; NCGC00256452-01; NCGC00260936-01; 2,4'-DDD 10 microg/mL in Cyclohexane; AK546750; AS-11690; HY-13690; NCI60_003688; SC-18530; 2,4'-DDD 100 microg/mL in Cyclohexane; SBI-0050239.P004; AB0010565; TR-018813; EU-0100251; FT-0605518; ST51016017; SW199619-3; EN300-37268; 2,4 inverted exclamation marka-DDD;o,p'-DDD; 2,4'-DDD, PESTANAL(R), analytical standard; D00420; W-5031; AB00052337-09; AB00052337_10; 000M850; Q417465; SR-01000075751-1; SR-01000075751-3; SR-01000075751-6; 2,4'-(2,2-dichloroethane-1,1-diyl)bis(chlorobenzene); Z425389592; 1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane; 1-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-2-chlorobenzene; Ethane,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-; 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene #; Mitotane, United States Pharmacopeia (USP) Reference Standard; Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)- (8CI); 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane, analytical standard; o,p'-DDD|||1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane|||Mitotane; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane for diagnostic uses (cancer investigation), >=98% (HPLC); 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane, for diagnostic uses (cancer investigation), >=98% (HPLC);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H10Cl4",
"molecular_weight": "320",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "4211",
"classification": "L",
"indications": "",
"side_effects": "",
"atc_codes": "L01XX23",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02050",
"RC02671",
"RC03292"
]
},
{
"compound_ID": "D1029",
"name": "o,p'-ddt",
"synonyms": "O,P'-DDT; 789-02-6; 2,4'-DDT; ortho,para'-DDT; NSC 57644; DDT, o,p'-; Benzene, 1-chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]-; NSC 33446; CCRIS 9077; 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; 1-Chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene; 2,2,2,o,p'-Pentachloroethylidenebisbenzene; EINECS 212-332-5; 2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1,1-trichloroethane; 2,2-Bis(o,p-chlorophenyl)-1,1,1-trichloroethane; BRN 1984770; AI3-03983; CHEMBL364900; CHEBI:34027; Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1,1-trichloro-; 1-Chloro-2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)benzene; (-)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane; Benzene, 1-chloro-2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)-; Ethane, 1,1,1-trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-; DSSTox_CID_2345; DSSTox_RID_76554; DSSTox_GSID_22345; WLN: GXGGYR BG&R DG; 2,p-chlorophenyl)-1,1,1-trichloroethane; CAS-789-02-6; o,p-Ddt; Benzene,2,2-trichloro-1-(4-chlorophenyl)ethyl]-; 1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; C14H9Cl5; 2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-trichloroethane; Ethane,1,1-trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-; (-)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-trichloroethane; 2,4'-DDT (1,1,1-Trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane); DDT-o,p'; SCHEMBL708196; DTXSID6022345; CVUGPAFCQJIYDT-UHFFFAOYSA-N; 1,1,1-trichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane; NSC33446; NSC57644; 2,4'-dichlorodiphenyltrichloroethane; Tox21_202239; Tox21_300622; BDBM50410497; NSC-33446; NSC-57644; AKOS015902904; NCGC00091035-01; NCGC00091035-02; NCGC00091035-03; NCGC00091035-04; NCGC00091035-05; NCGC00091035-06; NCGC00254388-01; NCGC00259788-01; 2,4'-DDT 10 microg/mL in Cyclohexane; 2,4'-DDT 1000 microg/mL in Toluene; LS-65249; 2,4'-DDT 100 microg/mL in Cyclohexane; FT-0608457; C14187; C-51970; Q27115760; 2,4'-(2,2,2-trichloroethane-1,1-diyl)bis(chlorobenzene); 1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloro ethane; 1,1,1-trichloro-2-(2-chloro phenyl)-2-(4-chlorophenyl)ethane; 1-Chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene #; (.+/-.)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane; Benzene, 1-chloro-2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)- (9CI); Ethane, 1,1,1-trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)- (8CI); 2,4'-DDT solution, 100 mug/mL in methanol, PESTANAL(R), analytical standard;",
"trade_name": "",
"abbrev_name": "DDT",
"description": "organochlorine insecticide",
"molecular_formula": "C14H9Cl5",
"molecular_weight": "354.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "13089",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02051",
"RC02672",
"RC03293"
]
},
{
"compound_ID": "D1030",
"name": "olvanil",
"synonyms": "OLVANIL; 58493-49-5; N-Vanillyloleamide; N-Vannilyloleoylamide; UNII-4P7KIU7003; NE 19550; NE-19550; TCMDC-124289; CHEMBL76903; Vanillyloleamide; OPZKBPQVWDSATI-KHPPLWFESA-N; 4P7KIU7003; Olvanilum [Latin]; Olvanilo [Spanish]; NCGC00024885-01; (Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide; Olvanil [USAN:INN]; DSSTox_CID_25669; DSSTox_RID_81044; DSSTox_GSID_45669; Olvanilo; Olvanilum; 9-Octadecenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-, (Z)-; CAS-58493-49-5; SR-01000597478; 3-13-00-02192 (Beilstein Handbook Reference); (N-Vanillyl)-9-oleamide; N-((4-Hydroxy-3-methoxyphenyl)methyl)-9-octadecenamide (Z)-; 9-Octadecenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-, (Z)-; Olvanil, powder; Olvanil (USAN); N-Vanillyloleoylamide; Tocris-0934; SCHEMBL94262; GTPL2488; DTXSID1045669; BDBM20460; HMS3262E17; HMS3411J12; HMS3649J03; HMS3675J12; ZINC8036019; Tox21_110935; Tox21_500668; 1967AH; BN0398; MFCD00673962; AKOS024458705; Tox21_110935_1; CCG-221972; LP00668; NCGC00024885-02; NCGC00024885-03; NCGC00261353-01; B6512; D05249; SR-01000597478-1; SR-01000597478-3; Q27088176; (9Z)-N-(4-Hydroxy-3-methoxybenzyl)-9-octadecenamide #; (9Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide; (Z)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]octadec-9-enamide; (Z)-Octadec-9-enoic acid, amide, N-(4-hydroxy-3-methoxyphenyl)-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C26H43NO3",
"molecular_weight": "417.6",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5311093",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02052",
"RC02673",
"RC03294"
]
},
{
"compound_ID": "D1031",
"name": "osalmid",
"synonyms": "osalmid; 526-18-1; 2-Hydroxy-N-(4-hydroxyphenyl)benzamide; Oxaphenamide; Osalmide; Oxaphenamid; Salmidochol; Oksafenamid; Auxobil; Dribazil; Enidran; Saryuurin; Bilene; Driol; Driol-labaz; 4'-Hydroxysalicylanilide; Bilocol; Benzamide, 2-hydroxy-N-(4-hydroxyphenyl)-; PHPS; p'-Hydroxysalicylanilide; Hydroxyphenyl salicylamide; p-Hydroxyphenylsalicylamide; Oxaphenamidum; N-(4-Hydroxyphenyl)salicylamide; N'-Salicyloyl-p-aminophenol; 2-Hydroxy-N-(4-hydroxyphenyl)-Benzamide; N-(p-Hydroxyphenyl)salicylamide; Osalmid [INN:JAN]; Osalmide [INN-French]; Osalmidum [INN-Latin]; Osalmida [INN-Spanish]; SALICYLANILIDE, 4'-HYDROXY-; NSC 93960; L 1718; 2-Hydroxy-N-(4-Hydroxy Phenyl)Benzamide; UNII-89741L759Z; EINECS 208-385-9; BRN 2941480; Oksafenamide; L-1718; NSC-93960; NCGC00160580-01; 89741L759Z; Osalmida; Osalmidum; Jestmin; Kanochol; Yoshicol; Li Dan Feng; Osalmid (JAN/INN); WLN: QR BVMR DQ; DSSTox_CID_22244; DSSTox_RID_79970; DSSTox_GSID_42244; 3-13-00-01137 (Beilstein Handbook Reference); KSC492A4D; MLS006011715; SCHEMBL220088; CHEMBL389507; ZINC1856; DTXSID0042244; CHEBI:31938; CTK3J2041; N-(p-Hydroxyphenyl)salicylanilide; LGCMKPRGGJRYGM-UHFFFAOYSA-N; HY-B2116; KS-00000L4O; NSC93960; Tox21_111914; s3641; AKOS008980445; AC-1737; CS-6242; KS-5271; MCULE-9324768383; VZ24762; AK163677; CAS-526-18-1; SMR004703438; WR 17456; 2-Hydroxy-N-(4-hydroxyphenyl)benzamide #; AB0010550; LS-144200; RT-000184; FT-0603451; ST24040690; D01579; H-7210; M-1849; SR-01000945010; Benzamide, 2-hydroxy-N-(4-hydroxyphenyl)- (9CI); Q-100981; SR-01000945010-1; Q27270017;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H11NO3",
"molecular_weight": "229.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "4602",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02053",
"RC02674",
"RC03295"
]
},
{
"compound_ID": "D1032",
"name": "ouabain",
"synonyms": "ouabain; G-Strophanthin; Ouabaine; Ouabagenin L-rhamnoside; Oubain; Ouabain anhydrous; Acocantherin; Astrobain; Gratibain; Purostrophan; Ouabain octahydrate; 630-60-4; Acocantherine; Ouabagenin-L-rhamnosid; Strophalen; Kombetin; Strodival; Uabaina; Uabanin; Gratus strophanthin; Rectobaina; Solufantina; Strophoperm; Strophosan; G-Strophicor; Quabain; UNII-5ACL011P69; CHEBI:472805; MLS000069786; CHEMBL222863; LPMXVESGRSUGHW-HBYQJFLCSA-N; Ouabain, Octahydrate; 5ACL011P69; Ouabagenin-L-rhamnosid [German]; SMR000058492; Strophanthin-G; DSSTox_CID_23765; DSSTox_RID_80072; DSSTox_GSID_43765; 3-(alpha-L-rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide; Card-20(22)-enolide, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-, (1.beta.,3.beta.,5.beta.,11.alpha.)-; CCRIS 965; OBN; HSDB 3519; EINECS 211-139-3; NSC 25485; NSC-25485; BRN 0101712; 4-[(1S,2R,3R,5S,7S,10R,11S,14R,15R,17R)-3,7,11,17-tetrahydroxy-2-(hydroxymethyl)-15-methyl-5-{[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one; CAS-630-60-4; G-Strophanthin (JAN); SR-01000076047; Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-1,5,11,14,19-pentahydroxy-, (1beta,3beta,5beta,11alpha)-; 11018-89-6; Cardiac glycoside; 1ibg; 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-1,5,11alpha,14,19-pentahydroxycard-20(22)-enolide; 3-(6-Deoxy-alpha-L-mannopyranosyloxy)-1,5,11a,14,19-pentahydroxycard-20(22)-enolide; NCGC00163473-01; 3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; 3a3y; Opera_ID_395; 4-[5-((6S,2R,3R,4R,5R)-3,4,5-trihydroxy-6-methyl(2H-3,4,5,6-tetrahydropyran-2- yloxy))(1S,5S,7S,11S,2R,3R,10R,14R,15R,17R)-3,7,11,17-tetrahydroxy-2-(hydroxym ethyl)-15-methyltetracyclo[8.7.0.0<2,7>.0<; Prestwick0_000471; Prestwick1_000471; Prestwick2_000471; Prestwick3_000471; Epitope ID:161502; O 3125; Lopac0_000943; SCHEMBL15433; BSPBio_000602; 5-18-05-00625 (Beilstein Handbook Reference); SPBio_002541; BPBio1_000664; cid_439501; GTPL4826; DTXSID0043765; REGID_for_CID_439501; 3n23; HMS2089J19; HMS2235A07; HMS3262N08; ZINC8143614; Tox21_110024; Tox21_112057; Tox21_301547; Tox21_500943; BDBM50286739; AKOS024285581; Tox21_112057_1; CCG-205024; CCG-208243; DB01092; LP00943; SMP1_000142; NCGC00013319-01; NCGC00017394-02; NCGC00017394-07; NCGC00017394-11; NCGC00255970-01; NCGC00261628-01; NCGC00263656-01; ST085767; EU-0100943; C01443; D00112; 11,15>]heptadec-14-yl]-5-hydrofuran- 2-one; Q285911; SR-01000721848; SR-01000076047-1; SR-01000076047-5; SR-01000721848-2; SR-01000721848-4; BRD-K35708212-331-03-1; (1alpha,3beta,5beta,11alpha,17alpha)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; (1beta,3beta,5beta,11alpha)-3-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-1,5,11.alpha.,14,19-pentahydroxycard-20(22)-enolide; 4-((1R,3S,5S,8R,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-((1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-((1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-((1R,3S,5S,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-[(1R,3S,5S,10R,11R,13R,14S,17R)-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-[(R)-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-[1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-[1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one(Ouabain); Ouabain4-[1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C29H44O12",
"molecular_weight": "584.7",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "0.6",
"half_life": "",
"absorption": "",
"cid": "439501",
"classification": "C",
"indications": "",
"side_effects": "",
"atc_codes": "C01AC01",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02054",
"RC02675",
"RC03296"
]
},
{
"compound_ID": "D1033",
"name": "oxyphenisatin acetate",
"synonyms": "OXYPHENISATIN ACETATE; Contax; Acetalax; Brocatine; Diphesatin; Diphesatine; Acelax; Bisatin; Isocrin; Acetophenolisatin; Diacetyldiphenolisatin; 115-33-3; Darmoletten; Isaphenin; Izafenin; Promassolax; Puragaceen; Purgaceen; Sanapert; Cirotyl; Eulaxin; Isacen; Isaphen; Laxocol; Lenavac; Lisagal; Prulet; Prulet Liquitab; Laxo-Isatin; Tete-Lax; Diacetyldioxyphenylisatin; Diacetoxydiphenylisatin; Oxyphenisatinacetate; Phenlaxinum; Diacetyldihydroxydiphenylisatin; Oxyphenisatine di(acetate); Diphesatinum; Bisatinum; Diacetyl bis(hydroxyphenyl)isatin; LA 96; 4,4'-Diacetoxydiphenylisatin; Diacetyl bis(p-hydroxyphenyl)isatin; Endophenolphthalein; Isatin, O,O'-diacetyldiphenol-; Purgophen (VAN); 3,3-Bis(p-acetoxyphenyl)oxindole; oxyphenisatine acetate; Isalax; Acetphenolisatin; 3,3-Bis(p-acetoxyphenyl)-2-indolinone; UNII-U0Y1YAL65X; Oxyphenisatin Acetate [USAN]; NSC 117186; 3,3-Bis(p-hydroxyphenyl)-2-indolinone diacetate; Oxindole, 3,3'-bis(p-hydroxyphenyl)-, diacetate; C24H19NO5; 3,3-Bis(p-hydroxyphenyl)-2-indolinone diacetate (ester); EINECS 204-083-6; NSC 59687; U0Y1YAL65X; 2H-Indol-2-one, 3,3-bis(4-(acetyloxy)phenyl)-1,3-dihydro-; 3,3-Bis(4-acetoxyphenyl)oxindole; NSC59687; NSC-59687; NSC117186; (2-Oxoindoline-3,3-diyl)bis(4,1-phenylene) diacetate; NCGC00159420-02; NCGC00159420-03; NCGC00159420-04; [4-[3-(4-acetyloxyphenyl)-2-oxo-1H-indol-3-yl]phenyl] acetate; DSSTox_CID_3411; Isatin,O'-diacetyldiphenol-; DSSTox_RID_77014; DSSTox_GSID_23411; Oxyphenisatin acetate (USAN); Acetfenolisatin; 2-Indolinone, 3,3-bis(p-hydroxyphenyl)-, diacetate (ester); Dioxyphenylisatin; (2-oxo-2,3-dihydro-1H-indole-3,3-diyl)bis(4,1-phenylene) diacetate; (2-oxo-2,3-dihydro-1H-indole-3,3-diyl)dibenzene-4,1-diyl diacetate; 4-{3-[4-(acetyloxy)phenyl]-2-oxo-2,3-dihydro-1H-indol-3-yl}phenyl acetate; CAS-115-33-3; oxyphenisatin diacetate; Oxindole,3'-bis(p-hydroxyphenyl)-, diacetate; 2-Indolinone,3-bis(p-hydroxyphenyl)-, diacetate (ester); 2H-Indol-2-one,3-bis[4-(acetyloxy)phenyl]-1,3-dihydro-; Bydolax; 2H-Indol-2-one, 3,3-bis[4-(acetyloxy)phenyl]-1,3-dihydro-; 4-(3-(4-(Acetyloxy)phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)phenyl acetate; Isocrin (TN); CBDivE_014318; ARONIS27032; SCHEMBL555117; 4, 4'-Diacetoxydiphenylisatin; CHEMBL1402684; DTXSID9023411; SCHEMBL17471461; CHEBI:135638; PHPUXYRXPHEJDF-UHFFFAOYSA-N; 3,3-bis[4-(acetyloxy)phenyl]-1,3-dihydro-2h-indol-2-one; 3, 3-Bis(p-acetoxyphenyl)oxindole; BCP15318; ZINC3831258; Tox21_111651; Tox21_111652; STL257074; AKOS003617803; Tox21_111651_1; CS-6519; DB14627; MB00312; MCULE-5437635554; NSC-117186; KS-000048J1; 3, 3-Bis(p-acetoxyphenyl)-2-indolinone; LS-83762; HY-101714; ST50998014; D05320; 3, 3-Bis(p-hydroxyphenyl)-2-indolinone diacetate; Q27290537; 3, 3-Bis(p-hydroxyphenyl)-2-indolinone diacetate (ester); 4-[3-(4-acetyloxyphenyl)-2-oxoindolin-3-yl]phenyl acetate; [4-[3-(4-acetoxyphenyl)-2-oxo-indolin-3-yl]phenyl] acetate; 2-Indolinone, 3, 3-bis(p-hydroxyphenyl)-, diacetate (ester); 2-Indolinone, 3,3-bis(p-hydroxyphenyl)-, diacetate (ester) (8CI); 2H-Indol-2-one, {3,3-bis[4-(acetyloxy)phenyl]-1,3-dihydro-};",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C24H19NO5",
"molecular_weight": "401.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "8269",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02055",
"RC02676",
"RC03297"
]
},
{
"compound_ID": "D1034",
"name": "p,p'-ddd",
"synonyms": "p,p'-DDD; 72-54-8; Rhothane; Dilene; Tetrachlorodiphenylethane; p,p'-TDE; Dichlorodiphenyldichloroethane; Rothane; 4,4'-DDD; Rhothane d-3; 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethane; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethane; DDD; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethane; TDE; Rcra waste number U060; Benzene, 1,1'-(2,2-dichloroethylidene)bis[4-chloro-; NCI-C00475; p,p'-Dichlorodiphenyldichloroethane; OMS 1078; Caswell No. 307; ENT 4,225; 2,2-Bis(p-chlorophenyl)-1,1-dichloroethane; 1,1-Bis(4-chlorophenyl)-2,2-dichloroethane; DDD, p,p'-; NSC 8941; 1,1-Bis(p-chlorophenyl)-2,2-dichloroethane; CCRIS 573; Dichlorodiphenyl dichloroethane; 1,1'-(2,2-dichloroethane-1,1-diyl)bis(4-chlorobenzene); ME-1700; HSDB 285; UNII-V14159DF29; 1,1'-(2,2-dichloroethylidene)bis[4-chlorobenzene]; Me-700; 4,4-DDD; p,p'-Dichlorodiphenyl-2,2-dichloroethylene; 1,1-Dichloro-2,2-di(4-chlorophenyl)ethane; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethane; 1,1-Dichloro-2,2-bis(parachlorophenyl)ethane; EINECS 200-783-0; Ethane, 1,1-dichloro-2,2-bis(p-chlorophenyl)-; RCRA waste no. U060; EPA Pesticide Chemical Code 029101; BRN 1914072; AI3-04225; CHEMBL196590; 1,1-Dicloro-2,2-bis(4-cloro-fenil)-etano; CHEBI:27841; 1,1-Dichlor-2,2-bis(4-chlor-phenyl)-aethan; 1,1-Dichloor-2,2-bis(4-chloor fenyl)-ethaan; AHJKRLASYNVKDZ-UHFFFAOYSA-N; p,p'-Dichlorodiphenyl dichloroethane; ME1700; p,p'-(Dichlorodiphenyl)dichloroethane; 1,1-Dicloro-2,2-bis(4-cloro-fenil)-etano [Italian]; Benzene, 1,1'-(2,2-dichloroethylidene)bis(4-chloro-; V14159DF29; 1,1-Dichloor-2,2-bis(4-chloor fenyl)-ethaan [Dutch]; 1,1-Dichlor-2,2-bis(4-chlor-phenyl)-aethan [German]; 1,1-Dichloro-2,2-bis(4-chlorophenyl)-ethane [French]; Dichloro-2,2-bis(p-chlorophenyl)ethane; 1-Chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene; DSSTox_CID_373; 2,2-bis-(4-chlorophenyl)-1,1-dichloroethane; DSSTox_RID_75549; DSSTox_GSID_20373; 1,1-DICHLORO-2,2-BIS(PARA-CHLOROPHENYL)ETHANE; CAS-72-54-8; 1,1-bis[p-chlorophenyl]-2,2-dichloroethane; TDE [ISO]; 4,4'-DDD (1,1-Dichloro-2,2-bis(p-chlorophenyl)ethane); Rh othane; p,p[-DDD; DDD(p,p'); ACMC-1BD9D; bmse000845; 1,1-Dichloro-2,2-bis(4-chlorophenyl)-ethane; WLN: GYGYR DG&R DG; MLS002454447; BIDD:ER0614; SCHEMBL819163; (Dichlorodiphenyl)dichloroethane; 1,2-bis(p-chlorophenyl)ethane; 1,2-di(4-chlorophenyl)ethane; DTXSID4020373; 1,2-bis(4-cloro-fenil)-etano; 4,4|A-DDD; CTK6G5642; 1,2-bis(4-chlorophenyl)-ethane; NSC8941; 1,2-bis(4-chloor fenyl)-ethaan; 1,2-bis(4-chlor-phenyl)-aethan; NSC-8941; ZINC1530501; Tox21_201296; Tox21_300191; 6146AF; ANW-36221; BDBM50410537; MFCD00000851; p,p'-Dichlorodip henyl dichloroethane; AKOS015902432; LS-1615; NCGC00091750-01; NCGC00091750-02; NCGC00091750-03; NCGC00091750-04; NCGC00254134-01; NCGC00258848-01; 4,4'-DDD 10 microg/mL in Cyclohexane; 4,4'-DDD 1000 microg/mL in Toluene; p,p'-Dichlorodiphenyldichloroethane (DDD); SMR001253876; 4,4'-DDD 100 microg/mL in Cyclohexane; TR-023689; B0132; Ethane,1-dichloro-2,2-bis(p-chlorophenyl)-; FT-0609171; 4,4'-DDD, PESTANAL(R), analytical standard; C06636; Ethane, 1,1-dichloro-2,2-bis(4-chlorophenyl)-; Q417682; Benzene,1'-(2,2-dichloroethylidene)bis[4-chloro-; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethane (DDD); 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethane, technical grade; 1-Chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene #; Benzene, 1,1'-(2,2-dichloroethylidene)bis(4-chloro- (9CI); 4,4'-DDD solution, certified reference material, 5000 mug/mL in methanol; 4,4'-DDD solution, PESTANAL(R), analytical standard, 100 ng/muL in methanol;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H10Cl4",
"molecular_weight": "320",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "6294",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02056",
"RC02677",
"RC03298"
]
},
{
"compound_ID": "D1035",
"name": "p,p'-dde",
"synonyms": "p,p'-DDE; 72-55-9; 4,4'-DDE; dichlorodiphenyldichloroethylene; DDT dehydrochloride; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethylene; DDE; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethene; NCI-C00555; p,p'-Dichlorodiphenyldichloroethylene; p,p'-Dichlorodiphenyl dichloroethylene; p,p'-(Dichlorodiphenyl)-2,2-dichloroethylene; 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene; Ethylene, 1,1-dichloro-2,2-bis(p-chlorophenyl)-; DDE (VAN); DDE, p,p'-; NSC 1153; para,para'-DDE; 2,2-Bis(p-chlorophenyl)-1,1-dichloroethylene; CCRIS 193; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethylene; Dichlorodiphenyl dichloroethene; UNII-4M7FS82U08; 1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene; HSDB 1625; 4,4-DDE; 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethene; 1,1-Dichloro-2,2-di(p-chlorophenyl)ethylene; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethene; 1,1-Bis(p-chlorophenyl)-2,2-dichloroethylene; EINECS 200-784-6; 1,1'-(Dichloroethenylidene)bis(4-chlorobenzene); Benzene, 1,1'-(dichloroethenylidene)bis[4-chloro-; BRN 1913355; AI3-01715; CHEMBL363207; CHEBI:16598; UCNVFOCBFJOQAL-UHFFFAOYSA-N; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethylene; 4M7FS82U08; 1,1-Dichloro-2,2-bis(para-chlorophenyl) ethylene; 1,1-BIS(CHLOROPHENYL)-2,2-DICHLOROETHYLENE; Benzene, 1,1'-(dichloroethenylidene)bis(4-chloro-; p,p'-Dichlorodiphenoldichloroethylene; 1,1'-(2,2-dichloroethene-1,1-diyl)bis(4-chlorobenzene); DSSTox_CID_374; p,p' -DDE; DSSTox_RID_75550; DSSTox_GSID_20374; p,p'-DDE (p,p'-Dichlorodiphenyldichloroethylene); 68679-99-2; Benzene, 1,1'-(2,2-dichloroethenylidene)bis(chloro-; 1-[2,2-Bis(Chloranyl)-1-(4-Chlorophenyl)ethenyl]-4-Chloranyl-Benzene; CAS-72-55-9; SMR001224518; 1,1'-(Dichloroethenylidene)bis[4-chlorobenzene]; Benzene, 1,1'-(2,2-dichloroethenylidene)bis[chloro-; 4,4'-DDE (1,1-Dichloro-2,2-bis(p-chlorophenyl)ethene); Dichlorodiphenyl Dichloroethylene; p,p-Dde; EINECS 272-060-8; p,p'-DDT mixture; p,2-dichloroethylene; p,p'-:dde; Spectrum_001941; ACMC-209onl; SpecPlus_000582; p,p[-DDE; p,p`-DDE; p,p'-Dichlorodiphenyldichloroethylene (DDE); Spectrum2_001865; Spectrum3_000861; Spectrum4_000701; Spectrum5_002042; 2,2-Bis(chlorophenyl)-1,1-dichloroethylene; DDE(p,p'); 1,1'-Bis(chlorophenyl)-2,2-dichloroethylene; Benzene, 1,1'-(dichloroethenylidene)bis(chloro-; BIDD:PXR0109; BSPBio_002501; KBioGR_001221; KBioSS_002495; SPECTRUM330072; WLN: GYGUYR DG&R DG; MLS001055473; MLS002152918; BIDD:ER0615; DivK1c_006678; SCHEMBL177472; SPBio_001710; 1,2-bis(p-chlorophenyl)ethene; 1,2-di(p-chlorophenyl)ethylene; DTXSID9020374; ETHYLENE, 2,2-BIS(CHLOROPHENYL)-1,1-DICHLORO-; 1,2-bis(p-chlorophenyl)ethylene; CTK8B2236; KBio1_001622; KBio2_002487; KBio2_005055; KBio2_007623; KBio3_002001; 4.4-DDE; NSC1153; HMS2230C07; HMS3369G06; KS-000017LU; NSC-1153; ZINC1530006; Tox21_201260; Tox21_300109; ANW-36223; BDBM50410512; CCG-39403; s5437; AKOS015902433; LS-1616; p,p'-(Dichlorodiphenyl)dichloroethylene; NCGC00090888-01; NCGC00090888-02; NCGC00090888-03; NCGC00090888-04; NCGC00090888-05; NCGC00090888-06; NCGC00090888-07; NCGC00090888-08; NCGC00090888-09; NCGC00090888-10; NCGC00254155-01; NCGC00258812-01; 4,4'-DDE 10 microg/mL in Cyclohexane; 4,4'-DDE 1000 microg/mL in Toluene; LS-68298; 4,4'-DDE 10 microg/mL in Acetonitrile; 4,4'-DDE 100 microg/mL in Cyclohexane; TR-031309; 1,1'-(Dichlorovinylidene)bis(chlorobenzene); 2,2-bis(p-chlorophenyl)-1,1-dichloroethene; B0133; FT-0609172; 4,4'-DDE, PESTANAL(R), analytical standard; A19100; Benzene,1'-(dichloroethenylidene)bis[4-chloro-; C04596; Ethylene,1-dichloro-2,2-bis(p-chlorophenyl)-; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethene 99%; Q409592; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethene, 99%; P,P'-DICHLORODIPHENYLDIC HLOROETHYLENE (DDE); 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethylene (DDE); 1,1-DICHLORO-2,2-BIS(PARA-CHLOROPHENYL)ETYLENE; 1-Chloro-4-[2,2-dichloro-1-(4-chlorophenyl)vinyl]benzene; Benzene, 1,1'-(dichloroethenylidene)bis(4-chloro- (9CI); 1-Chloro-4-[2,2-dichloro-1-(4-chlorophenyl)vinyl]benzene #; 4,4'-DDE solution, 20 mug/mL in methanol, analytical standard; 4,4'-DDE solution, 200 mug/mL in isooctane, analytical standard; 4,4'-DDE solution, certified reference material, 5000 mug/mL in methanol; 6WS;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H8Cl4",
"molecular_weight": "318",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "3035",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02057",
"RC02678",
"RC03299"
]
},
{
"compound_ID": "D1036",
"name": "p,p'-ddt",
"synonyms": "Clofenotane; p,p'-DDT; Chlorophenothane; dichlorodiphenyltrichloroethane; 50-29-3; Dicophane; 4,4'-DDT; Chlorphenothan; Chlorphenotoxum; Parachlorocidum; Pentachlorin; Zerdane; DDT; Arkotine; Benzochloryl; Bovidermol; Estonate; Guesarol; Santobane; Agritan; Anofex; Deoval; Detoxan; Didigam; Didimac; Genitox; Gesafid; Gesarol; Ivoran; Ixodex; Kopsol; Neocid; Pentech; Rukseam; Chlorophenotoxum; Citox; Detox; Dykol; Gyron; Bosan Supra; Chlorophenothan; Penticidum; Dibovin; Mutoxan; Tafidex; Zeidane; Dodat; Hildit; Aavero-extra; PEB1; p,p'-Dichlorodiphenyltrichloroethane; Chlorphenotane; Chlofenotan; Clofenotan; Ppzeidan; Azotox; 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane; Chlorophenothanum; 4,4'-Dichlorodiphenyltrichloroethane; Trichlorobis(4-chlorophenyl)ethane; Clofenotane technique; Dibovan; Gesapon; Gesarex; Geusapon; Guesapon; Mutoxin; Penticide; Dedelo; Havero-extra; Neocidol (solid); OMS 16; Chlorophenothanum technicum; Detox (pesticide); Rcra waste number U061; D.D.T. technique; NCI-C00464; Neocid (VAN); 1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane; 1,1-Bis(4-chlorophenyl)-2,2,2-trichloroethane; Azotox M 33; Caswell No. 308; p'-Zeidane [France]; 2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane; Neocidol, solid; Tech ddt; DDT [BSI:ISO]; 1-Chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene; Clofenotanum [INN-Latin]; Clofenotano [INN-Spanish]; DDT, p,p'-; NSC 8939; OMS 0016 [French]; para,para'-DDT; ENT 1,506; CCRIS 194; DDT 50 WP; DDT and metabolites; Micro ddt 75; UNII-CIW5S16655; HSDB 200; Azotox M-33; Ethane, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-; 1,1'-(2,2,2-trichloroethylidene)bis[4-chlorobenzene]; 1,1,1-Trichloro-2,2-bis(4,4'-dichlorodiphenyl)ethane; Klorfenoton [Swedish Pharmacopoeia]; EINECS 200-024-3; 1,1'-(2,2,2-trichloroethane-1,1-diyl)bis(4-chlorobenzene); 1,1,1-Trichloro-2,2-di(4-chlorophenyl)-ethane; 1,1-Bis-(p-chlorophenyl)-2,2,2-trichloroethane; RCRA waste no. U061; EPA Pesticide Chemical Code 029201; 1,1,1-Trichloro-2,2-bis-(4'-chlorophenyl)ethane; 1,1,1-Trichlorobis(chlorophenyl)ethane; BRN 1882657; Ethane, 1,1,1-trichloro-2,2-bis(4-chlorophenyl)-; AI3-01506; Bis(p-chlorophenyl)-2,2,2-trichloroethane; Benzene, 1,1'-(2,2,2-trichloroethylidene)bis[4-chloro-; alpha,alpha-Bis(p-chlorophenyl)-beta,beta,beta-trichlorethane; CHEBI:16130; YVGGHNCTFXOJCH-UHFFFAOYSA-N; 1,1,1-Tricloro-2,2-bis(4-cloro-fenil)-etano; 2,2,2-Trichloro-1,1-bis(4-chlorophenyl)ethane; CIW5S16655; 1,1,1-Trichlor-2,2-bis(4-chlor-phenyl)-aethan; ENT-1506; Trichlorobis(4'-chlorophenyl)ethane; 1,1,1-Trichloor-2,2-bis(4-chloor fenyl)-ethaan; Clofenotane (INN); Clofenotane [INN]; Dichlorodiphenyltrichloroethane (DDT); 1,1'-(2,2,2-Trichloroethylidene)bis(4-chlorobenzene); 1,1,1-Trichloor-2,2-bis(4-chloor fenyl)-ethaan [Dutch]; 1,1,1-Trichlor-2,2-bis(4-chlor-phenyl)-aethan [German]; 1,1,1-Tricloro-2,2-bis(4-cloro-fenil)-etano [Italian]; 1,1,1-Tricloro-2,2-bis(4-cloro-fenyl)-etano [Italian]; NCGC00091071-01; Clofenotanum; 2,2,2-trichlorobis(4-chlorophenyl)ethane; alpha,alpha-Bis(p-chlorophenyl)-beta,beta,beta-trichloroethane; DSSTox_CID_375; 1,1-Bis(p-chlorophenyl)-2,2,2-trichloroethane; DSSTox_RID_75551; 1,1,1-trichloro-2-2-bis(4-chlorophenyl)ethane; 1,1-bis(p-Chlorophenyl)-2,2,2-trichIoroethane; DSSTox_GSID_20375; R50; 1,1,1-TRICHLORO-2,2-BIS(PARA-CHLOROPHNYL)ETHANE; Benzene, 1,1'-(2,2,2-trichloroethylidene)bis(4-chloro-; Clofenotano; Klorfenoton; 1-Chloranyl-4-[2,2,2-Tris(Chloranyl)-1-(4-Chlorophenyl)ethyl]benzene; p'-Zeidane; CAS-50-29-3; Dicophaner; 4,4'-DDT (1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane); 4-chloro-1-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene; pe ntech; micro ddt 75; 4,4-DDT; Dicophane, BAN; OMS 0016; p,p-DDT; Chlorophenothane [NF]; Spectrum_001927; 4,4'-DDT solution; SpecPlus_000558; p,p'-Dichlorodiphenyltrichloroethane (DDT); Spectrum2_001233; Spectrum3_000859; Spectrum4_000699; Spectrum5_002036; p,p'-DDT, BSI; DDT(p,p'); bmse000634; SCHEMBL7181; 1,1,1-Tricloro-2,2-bis(4-cloro-fenyl)-etano; BIDD:PXR0066; BSPBio_002477; Dichlorojiphinyltrichloroethane; KBioGR_001197; KBioSS_002469; SPECTRUM330070; WLN: GXGGYR DG&R DG; BIDD:ER0496; DivK1c_006654; SPBio_001106; CHEMBL416898; 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane solution; DTXSID4020375; 4,4|A-DDT; KBio1_001598; KBio2_002462; KBio2_005030; KBio2_007598; KBio3_001977; NSC8939; ACM50293; NSC-8939; ZINC1530011; Tox21_111076; Tox21_201495; Tox21_300067; BDBM50410508; CCG-39114; LS-138; MFCD00000802; SBB061567; .alpha.,.beta.,.beta.-trichlorethane; AKOS003235691; Tox21_111076_1; DB13424; MCULE-1446144401; p,p'-DDT 100 microg/mL in Methanol; NCGC00091071-02; NCGC00091071-03; NCGC00091071-04; NCGC00091071-05; NCGC00091071-06; NCGC00091071-07; NCGC00091071-08; NCGC00254176-01; NCGC00259046-01; Trichloro-2,2-bis(p-chlorophenyl)ethane; 4,4'-DDT 10 microg/mL in Cyclohexane; 4,4'-DDT 1000 microg/mL in Toluene; AC-12071; CC-25919; 4,4'-DDT 100 microg/mL in Cyclohexane; 4,4'-DDT 5000 microg/mL in Methanol; 4,4'-DDT, 98%; p,p'-Dichlorodiphenyltrichloromethylmethane; 2,2,2-trichlorobis(4-chloroph enyl)ethane; DB-051751; TR-017982; Bis(p-chlorophenyl)-2,2,2-trichloroetha ne; FT-0603206; ST51047572; T0379; 1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane; 1,1-Trichloro-2,2-di(4-chlorophenyl)ethane; 1,1-Tricloro-2,2-bis(4-cloro-fenil)-etano; 4,4'-DDT solution 100 ng/muL in methanol; 1,1-Trichlor-2,2-bis(4-chlor-phenyl)-aethan; 4,4'-DDT, PESTANAL(R), analytical standard; C04623; D07367; 1,1,1-Trichloro-2,2-di(4-chlorophenyl)ethane; 1,1-Trichloor-2,2-bis(4-chloor fenyl)-ethaan; Ethane,1,1-trichloro-2,2-bis(4-chlorophenyl)-; Ethane,1,1-trichloro-2,2-bis(p-chlorophenyl)-; 1,1,1-trichloro-2,2-bis(4-chlorophenyl)-ethane; 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane; 2,2,2-Trichloro-1,1-bis(p-chlorophenyl)-Ethane; C-20741; Q163648; SR-01000883717; SR-01000883717-1; 1,1-Trichloro-2,2-bis(4,4'-dichlorodiphenyl)ethane; Benzene,1'-(2,2,2-trichloroethylidene)bis[4-chloro-; BRD-K51799616-001-02-2; 1,1'-(2,2,2,-Trichloroethylidene)bis[4-chlorobenzene]; 1,1'-(2,2,2-Trichloroethylidene)bis(4-chloro)-Benzene; 4,4'-DDT, certified reference material, TraceCERT(R); Benzene, 1,1'(2,2,2-trichloroethylidene)bis[4-chloro-; 1,1,1-Trichloro-2,2-bis-(4'-chlorophenyl)ethane (DDT); 4,4'-(2,2,2-Trichloroethane-1,1-diyl)bis(chlorobenzene); 1,1'-(2,2,2-Trichloroethylidene)bis(4-chlorobenzene), 9CI; 1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane chlorophenothane; p,p'-DDT~p,p' -Dichloro-1,1-diphenyl-2,2,2-trichloroethane; p,p'-DDT~p,p'-Dichloro-1,1-diphenyl-2,2,2-trichloroethane; 1-Chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene #; 4,4'-DDT solution, 200 mug/mL in isooctane, analytical standard; .alpha.,.alpha.-Bis(p-chlorophenyl)-.beta.,.beta.,.beta.-trichlorethane; 4,4'-DDT solution, certified reference material, 5000 mug/mL in methanol; 4,4'-DDT solution, 100 ng/muL in methanol, PESTANAL(R), analytical standard; 6WT; InChI=1/C14H9Cl5/c15-11-5-1-9(2-6-11)13(14(17,18)19)10-3-7-12(16)8-4-10/h1-8,13;",
"trade_name": "",
"abbrev_name": "DDT",
"description": "organochlorine insecticide",
"molecular_formula": "C14H9Cl5",
"molecular_weight": "354.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "3036",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108",
"F0701"
],
"references": [
"RC02058",
"RC02679",
"RC03300",
"RC03648"
]
},
{
"compound_ID": "D1037",
"name": "palmatine chloride hydrate",
"synonyms": "Palmatine chloride hydrate; 171869-95-7; Palmatine chloride monohydrate; UNII-ZMR2H7M7PK; ZMR2H7M7PK; CHEMBL2163795; DSSTox_CID_27845; DSSTox_RID_82598; DSSTox_GSID_47869; Palmatine hydrochloride hydrate; C21H22NO4.Cl.H2O; SCHEMBL3321462; PALMATINE CHLORIDE 95%; DTXSID1047869; Palmatine chloride hydrate, 97%; Tox21_200059; 2628AH; AKOS015968461; API0008573; Dibenzo(a,g)quinolizinium, 5,6-dihydro-2,3,9,10-tetramethoxy-, chloride, hydrate (1:1:1); Dibenzo(a,g)quinolizinium, 5,6-dihydro-2,3,9,10-tetramethoxy-, chloride, monohydrate; NCGC00248731-01; NCGC00257613-01; ACM171869957; ST055756; CAS-171869-95-7; Q27295751; 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[3,2-a]isoquinoline, chloride, hy drate;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C21H24ClNO5",
"molecular_weight": "405.9",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16212317",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02059",
"RC02680",
"RC03301"
]
},
{
"compound_ID": "D1038",
"name": "paricalcitol",
"synonyms": "Paricalcitol; Zemplar; 131918-61-1; Compound 49510; 19-Nor-1alpha,25-dihydroxyvitamin D2; 19-Nor-1,25-(OH)2D2; 19-Nor-1-alpha,25-dihydroxyvitamin D2; UNII-6702D36OG5; Compound-49510; HSDB 7360; CHEBI:7931; (7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1alpha,3beta,25-triol; 6702D36OG5; (1R,3R,7E)-17beta-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9,10-secoestra-5,7-diene-1,3-diol; NCGC00182706-01; Paracalcin; (1alpha.3beta,7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol; Paricalcitol [USAN]; 19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol, (1alpha,3beta,7E,22E)-; Zemplar (TN); (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol; Paricalcitol [USAN:USP:INN]; ABT-358; Ab 122358; PubChem18825; SCHEMBL3655; Paricalcitol, 19-nor-(OH)2-vitD2, paracalcin; DSSTox_CID_28566; DSSTox_RID_82838; DSSTox_GSID_48640; BIDD:GT0330; GTPL2791; Paricalcitol (JAN/USAN/INN); CHEMBL1200622; DTXSID4048640; BPKAHTKRCLCHEA-UBFJEZKGSA-N; BDBM233195; ACT07192; 19-Nor-1,25-dihydroxyvitamin D2; Tox21_112987; LMST04030163; ZINC13911941; AKOS005145562; BCP9001050; CS-0705; DB00910; 19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol,(1alpha,3beta,7E,22E); HY-50919; SC-20905; LS-172812; CAS-131918-61-1; C08127; D00930; W-5365; 918P611; Q155746; (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol; (1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol; 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3R,5Z)-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C27H44O3",
"molecular_weight": "416.6",
"state": "solid",
"clearance": "* 1.49 +/- 0.60 L/h [chronic kidney disease Stage 5 with hemodialysis]\n* 1.54 +/- 0.95 L/h [chronic kidney disease Stage 5with peritoneal dialysis]",
"volume_of_distribution": "* 30.8 ± 7.5 L [CKD Stage 5-HD]\n* 34.9 ± 9.5 L [CKD Stage 5-PD]\n* 23.8 L [healthy subjects]",
"route_of_elimination": "Paricalcitol is excreted primarily by hepatobiliary excretion.",
"protein_binding": "99.8% (bound to plasma proteins)",
"half_life": "4 to 6 hours",
"absorption": "Well absorbed",
"cid": "5281104",
"classification": "H",
"indications": "",
"side_effects": "",
"atc_codes": "H05BX02",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02060",
"RC02681",
"RC03302"
]
},
{
"compound_ID": "D1039",
"name": "p-benzoquinone dioxime",
"synonyms": "105-11-3; 1,4-Benzoquinone dioxime; p-Benzoquinonedioxime; P-BENZOQUINONE DIOXIME; p-Quinone dioxime; Quinone dioxime; Benzoquinone dioxime; p-Quinone oxime; Actor Q; 2,5-Cyclohexadiene-1,4-dione, dioxime; Dioxime p-benzoquinone; Dibenzo PQD; para-Quinone oxime; para-Benzoquinone dioxime; Paraquinondioxime; p-Benzoquinone, dioxime; Dioxime 1,4-cyclohexadienedione; NCI-C03850; G-M-F; 1,4-Benzochinondioxim; UNII-MGE6YH92Q2; NSC 4774; NSC 14433; CCRIS 549; Dioxime 2,5-cyclohexadiene-1,4-dione; 1,4-Benzochinondioxim [Czech]; HSDB 2866; EINECS 203-271-5; BRN 2043234; MGE6YH92Q2; AI3-52518; 1,4-cyclohexadienedione dioxime; 2,5-Cyclohexadiene-1,4-dione, 1,4-dioxime; Dioxime 2,4-dione; PQD; QDO; 2,4-dione, dioxime; W-108793; WLN: L6Y DYJ AUNQ DUNQ; N-(4-nitrosophenyl)hydroxylamine; Vulnoc GM; p-Benzoquineone dioxime; dioxime p-benzoquinone; 1,4-benzoquinonedioxime; p-Benzo Quinone Dioxime; p-Nitrosophenylhydroxylamin; DSSTox_CID_1222; ACMC-2098eu; Benzo-1,4-quinone dioxime; DSSTox_RID_76020; DSSTox_GSID_21222; SCHEMBL93568; 4-07-00-02074 (Beilstein Handbook Reference); KSC176A4L; (1E,4E)-benzoquinone dioxime; Benzo-1,4-quinone dioxime #; SCHEMBL8005268; CHEMBL1585396; DTXSID8021222; CHEBI:82404; CTK0H6045; KS-00000VOH; NSC4774; LNHURPJLTHSVMU-CGXWXWIYSA-N; NSC-4774; NSC14433; ZINC3875735; Tox21_200273; [1,4-Phenylenebis(iminooxy)]radical; ANW-15172; MFCD00063636; NSC-14433; AKOS015901106; AKOS015920447; ZINC100301795; 2,5-cyclohexadiene-1,4-dione dioxime; FCH1411688; FCH4121125; MCULE-6082720028; TRA0064919; NCGC00091127-01; NCGC00091127-02; NCGC00248444-01; NCGC00248585-01; NCGC00257827-01; 1,4-di(hydroxyimino)cyclohexa-2,5-diene; AK-47707; AS-19482; BR-47707; CAS-105-11-3; SC-46551; AB0034561; RT-000454; ST2419770; B0090; FT-0606774; ST50988064; X8737; C19345; C-01782; p-Benzoquinone dioxime, technical, >=90% (TLC); p-Benzoquinone dioxime, moistened with ca. 30% water; Q27155923; P-BENZOQUINONE DIOXIME (SEE ALSO: P-BENZOQUINONE MONOOXIME (CAS 637-62-7));",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C6H6N2O2",
"molecular_weight": "138.12",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "7737",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02061",
"RC02682",
"RC03303"
]
},
{
"compound_ID": "D1040",
"name": "penfluridol",
"synonyms": "PENFLURIDOL; 26864-56-2; Semap; 1-(4,4-bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidin-4-ol; TLP-607; McN-JR-16,341; R-16341; 1-[4,4-Bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol; C28H27ClF5NO; Penfluridolum [INN-Latin]; UNII-25TLU22Q8H; R 16341; EINECS 248-074-5; BRN 1558826; CHEMBL47050; 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol; 25TLU22Q8H; MDLAAYDRRZXJIF-UHFFFAOYSA-N; 4-Piperidinol, 1-(4,4-bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)-; 4-Piperidinol, 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-; NCGC00165865-01; AK-73104; DSSTox_CID_28947; DSSTox_RID_83212; DSSTox_GSID_49021; 1-(4,4-Bis(p-fluorophenyl)butyl)-4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-4-piperidinol; W-107147; Penfluridolum; 1-[4,4-Bis(4-fluorophenyl)butyl]-4-[4-chloro-3(trifluoromethyl)phenyl]-4-piperidinol; 4-Piperidinol, 1-(4,4-bis(p-fluorophenyl)butyl)-4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-; 4-Piperidinol, 4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-1-(4,4-bis(p-fluorophenyl)butyl)-; CAS-26864-56-2; Micefal; Penfluridol [USAN:BAN:INN]; Penfluridol [USAN:INN:BAN]; Semap (TN); PubChem15873; Penfluridol (USAN/INN); R16341; SCHEMBL93939; 5-21-02-00409 (Beilstein Handbook Reference); MLS004774011; DTXSID5049021; CHEBI:92278; CTK8E9221; AOB5341; MCN-JR-16341; HMS3264L13; HMS3652G22; Pharmakon1600-01505691; ACT03196; BCP03695; HY-B1077; KS-00000NV3; ZINC4217252; Tox21_113546; BDBM50026066; MFCD00866714; NSC759179; PDSP1_000470; PDSP2_000468; AKOS005065828; Tox21_113546_1; API0003774; BCP9000014; CS-4633; DB13791; KS-5104; NSC-759179; Penfluridol, >=97% (HPLC), powder; VZ21058; NCGC00165865-02; NCGC00165865-03; 4CA-0984; AC-15413; BR-73104; SC-13777; SMR003500704; BCP0726000159; SBI-0206898.P001; AB0011815; AX8009267; DB-017683; LS-116932; ST2408559; TR-012101; FT-0645031; P2076; S4151; SW219540-1; D02630; S-3876; AB01566919_01; 864P562; A818637; L001145; SR-05000001779; Q2149707; R 16,341; SR-05000001779-1; BRD-K15409150-001-01-7; 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloranyl-3-(trifluoromethyl)phenyl]piperidin-4-ol; 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-piperidin-4-ol; 1-[4,4-Bis-(4-fluoro-phenyl)-butyl]-4-(4-chloro-3-trifluoromethyl-phenyl)-piperidin-4-ol; 4-Piperidinol,1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-; 1-[4,4-Bis(p-fluorophenyl)butyl]-4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-4-piperidinol; 1-[4,4-Bis(p-flurophenyl)butyl]-4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-4-piperidinol; 4-Piperidinol, 4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-1-(4,4-bis(p-fluorophenyl)butyl)-; PENFLURIDOL1-[4,4-Bis-(4-fluoro-phenyl)-butyl]-4-(4-chloro-3-trifluoromethyl-phenyl)-piperidin-4-ol;",
"trade_name": "",
"abbrev_name": "Semap, Micefal, Longoperidol",
"description": "a highly potent, first generation diphenylbutylpiperidine antipsychotic",
"molecular_formula": "C28H27ClF5NO",
"molecular_weight": "524",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "33630",
"classification": "N",
"indications": "",
"side_effects": "",
"atc_codes": "N05AG03",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108",
"F030501"
],
"references": [
"RC02062",
"RC02683",
"RC03304",
"RC03739"
]
},
{
"compound_ID": "D1042",
"name": "pentabromophenol",
"synonyms": "PENTABROMOPHENOL; 608-71-9; Phenol, pentabromo-; 2,3,4,5,6-Pentabromophenol; Flammex 5BP; pentabromphenol; Pentabromfenol; Pentabromfenol [Czech]; UNII-V89A88NMMX; CCRIS 4853; HSDB 5500; NSC 5717; EINECS 210-167-3; BRN 1876757; V89A88NMMX; AI3-01561; SVHOVVJFOWGYJO-UHFFFAOYSA-N; Phenol, 2,3,4,5,6-pentabromo-; C6HBr5O; Phenol,2,3,4,5,6-pentabromo-; PubChem13350; 1e4h; Pentabromophenol, 96%; ACMC-1AWHG; DSSTox_CID_2079; DSSTox_RID_76480; DSSTox_GSID_22079; 3-06-00-00766 (Beilstein Handbook Reference); MLS002152927; PENTABROMOHYDROXYBENZENE; SCHEMBL268325; CHEMBL1235157; DTXSID9022079; CTK5B2381; NSC5717; WLN: QR BE CE DE EE FE; 2,3,4,5,6-Pentabromophenol #; NSC-5717; ZINC1687157; Tox21_200339; 2,3,4,5,6-pentakis(bromanyl)phenol; AKOS003672224; AS04485; DB03167; FCH1321427; LS-1448; NCGC00090884-01; NCGC00090884-02; NCGC00257893-01; AS-13066; BC003735; CAS-608-71-9; CC-33524; PBR; SMR001224527; TC-165569; FT-0739390; A832934; C-34165; Q27094104;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C6HBr5O",
"molecular_weight": "488.59",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "11852",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02064",
"RC02685",
"RC03306"
]
},
{
"compound_ID": "D1043",
"name": "pentylparaben",
"synonyms": "Pentyl 4-hydroxybenzoate; 6521-29-5; Amyl 4-hydroxybenzoate; Pentylparaben; Pentyl p-hydroxybenzoate; n-Pentyl 4-hydroxybenzoate; Benzoic acid, 4-hydroxy-, pentyl ester; p-Hydroxybenzoic acid pentyl ester; Amylparaben; NSC 309817; UNII-SJV2E4C7DM; p-Oxybenzoesaurepentylester; Amyl4-Hydroxybenzoate; BENZOIC ACID, p-HYDROXY-, PENTYL ESTER; n-Amyl 4-hydroxybenzoate; p-Oxybenzoesaurepentylester [German]; EINECS 229-408-9; SJV2E4C7DM; BRN 2722438; ZNSSPLQZSUWFJT-UHFFFAOYSA-N; Pentyl Paraben; 4-Hydroxybenzoic Acid Pentyl Ester; MFCD00016479; ACMC-209npt; n-Amyl-4-hydroxybenzoate; n-Pentyl-4-hydroxybenzoate; DSSTox_CID_27863; DSSTox_RID_82616; DSSTox_GSID_47887; SCHEMBL1972693; AMYL-PARA-HYDROXYBENZOATE; CHEMBL3183634; DTXSID9047887; CTK8B2108; 4-Hydroxybenzoic Acid Amyl Ester; ZINC1568931; Tox21_200551; ANW-35007; NSC309817; MCULE-2497088977; NSC-309817; NCGC00248696-01; NCGC00258105-01; AS-18980; LS-37655; CAS-6521-29-5; TC-123752; FT-0673618; ST50407911; X3695; KS-00001620; Benzoic acid, 4-hydroxy-, pentyl ester (9CI); Q10348393; Pentyl 4-hydroxybenzoate, analytical reference material;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H16O3",
"molecular_weight": "208.25",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "23019",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02066",
"RC02687",
"RC03308"
]
},
{
"compound_ID": "D1044",
"name": "perfluorooctanesulfonamide",
"synonyms": "Perfluorooctanesulfonamide; 754-91-6; 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide; Perfluorooctane sulfonamide; Perfluoroctylsulfonamide; PFOSA; Heptadecafluorooctanesulphonamide; Perfluorooctanesulfonic acid amide; UNII-80AM718FML; EINECS 212-046-0; 1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-; 80AM718FML; AI 3-29759; RRRXPPIDPYTNJG-UHFFFAOYSA-N; W-104393; Perfluorooctanesulfonamide, 95%; C8H2F17NO2S; HSDB 8039; perfluorooctane sulphonamide; DSSTox_CID_18939; DSSTox_RID_79421; DSSTox_GSID_38939; SCHEMBL828147; CHEMBL1087375; DTXSID3038939; CTK5E1615; CHEBI:138089; heptadecafluorooctane-1-sulfonamide; ACT01907; ZX-AP000304; Tox21_300412; KM1696; PC6149; ZINC38141476; perfluorooctanesulfonamide, AldrichCPR; AKOS015897505; NCGC00164450-01; NCGC00164450-02; NCGC00254527-01; AK114002; AS-15244; CAS-754-91-6; CC-33587; LS-97930; O614; AX8147268; DB-008667; 4CH-024532; FT-0632897; ST24036587; 754P916; A838431; C-22933; Q7168162; 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-1-octanesulfonamide; 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluoro-octane-1-sulfonamide; 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecakis(fluoranyl)octane-1-sulfonamide; 1-Octanesulfonamide,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C8H2F17NO2S",
"molecular_weight": "499.15",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "69785",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02067",
"RC02688",
"RC03309"
]
},
{
"compound_ID": "D1045",
"name": "phenazopyridine hydrochloride",
"synonyms": "Phenazopyridine hydrochloride; 136-40-3; Phenazopyridine HCl; Pyridium; Urodine; Pyripyridium; Bisteril; Diridone; Mallophene; Phenazodine; Pyrazodine; Pyridacil; Suladyne; Uridinal; Azodyne; Azomine; Sedural; Pirid; Phenylazo tablets; Di-Azo; 3-Phenylazo-2,6-diaminopyridine hydrochloride; Pyridiate; Azosulfisox; Mallofeen; Nefrecil; Pyridivite; Pyrizin; Urazium; Uriplex; Phenyl-idium; Azo-Standard; Phenazopyridinium chloride; Thiosulfil-A forte; Phenazopyridine.HCl; Phenyl-idium 200; pyridene; 3-(phenyldiazenyl)pyridine-2,6-diamine hydrochloride; Dolonil; 2,6-Pyridinediamine, 3-(phenylazo)-, monohydrochloride; Azo-Mandelamine; Thiosulfil-A; NCI-C01672; 2,6-Diamino-3-phenylazopyridine hydrochloride; NC 150; CCRIS 497; Phenylazopyridine hydrochloride; UNII-0EWG668W17; Phenazopyridine (hydrochloride); 3-Phenylazo-2,6-diaminopyridine Monohydrochloride; 2,6-Diamino-3-(phenylazo)pyridine monohydrochloride; NSC 1879; EINECS 205-243-8; Phenylazodiaminopyridine hydrochloride; MFCD00035347; W 1655; AI3-51273; MLS000069507; Pyri-Pyridium; CHEBI:71419; 0EWG668W17; 2,6-Pyridinediamine, 3-(2-phenyldiazenyl)-, hydrochloride (1:1); 3-(Phenylazo)-2,6-pyridinediamine hydrochloride; 3-(Phenylazo)-2,6-pyridinediamine, hydrochloride; component of Sulfid; NSC-1879; component of Azotrex; component of Dolonil; Pyridine, 2,6-diamino-3-(phenylazo)-, hydrochloride; Phenylazo-alpha,alpha'-diaminopyridine monohydrochloride; SMR000058632; component of Azo Gantanol; DSSTox_CID_1118; component of Azo-Mandelamine; DSSTox_RID_75950; DSSTox_GSID_21118; Phenazopyridine M hydrochloride; (E)-3-(phenyldiazenyl)pyridine-2,6-diamine hydrochloride; Pyridine, 2,6-diamino-3-(phenylazo)-, monohydrochloride; 2, 3-(phenylazo)-, monohydrochloride; WLN: T6NJ BZ CNUNR & FZ & GH; 3-[(E)-phenyldiazenyl]pyridine-2,6-diamine hydrochloride; NC-150; NSC227115; 2,6-Diamino-3-(phenylazo)pyridine hydrochloride; 3-(Phenylazo)-2,6-diaminopyridine hydrochloride; Pyridine,6-diamino-3-(phenylazo)-, hydrochloride; NCGC00018130-04; CAS-136-40-3; 3-[phenyldiazenyl]pyridine-2,6-diamine hydrochloride; Pyridine,6-diamino-3-(phenylazo)-, monohydrochloride; 2,6-DIAMINO-3-(PHENYLAZO)-PYRIDINE HYDROCHLORIDE; azodine; azodium; cystopyrin; giracid; phenylazo; pyredal; pyridenal; sulodyne; urofeen; uromide; uropyridin; uropyrine; utostan; vestin; 3-[(E)-phenyldiazenyl]pyridine-2,6-diamine;hydrochloride; Phenylazo-.alpha.,.alpha.'-diaminopyridine monohydrochloride; W-1655; .beta.-Phenylazo-.alpha.,.alpha.'-diaminopyridine hydrochloride; azo gastanol; p yridene; azo-stat; utos tan; azo gantrisin; SR-05000001695; phenazopyridine-hcl; Prestwick_158; cystamine 'mcclung'; Phenazopyridine hydrochloride [USAN]; cystamine 'mcclung '; Phenazopyridine hydrochloride [USAN:USP]; 3-Phenylazo-2,6-diaminopyridine hydrochloride (Phenazopyridine hydrochloride); Opera_ID_1284; ACMC-209c5v; SCHEMBL19357; C11H11N5.HCl; KSC910I7B; MLS001074123; MLS002222176; SPECTRUM1500473; phenazopyridine monohydrochloride; CHEMBL1201022; CHEMBL1606101; DTXSID1021118; CTK8B0470; 3-(2-phenyldiazen-1-yl)pyridine-2,6-diamine hydrochloride; NSC1879; QQBPIHBUCMDKFG-UHFFFAOYSA-N; HMS1570G06; HMS1920F18; Pharmakon1600-01500473; HY-B0985; Phenazopyridine hydrochloride (USP); Phenazopyridine hydrochloride(USAN); Tox21_110829; Tox21_202153; Tox21_302738; ANW-20033; CCG-39935; CP0138; LS-793; NSC757267; s4235; AKOS015919909; AKOS025401514; Tox21_110829_1; AC-2036; CS-4476; KS-1427; MCULE-1193471524; NSC-227115; NSC-757267; RTR-004871; VP13659; KS-000000R2; NCGC00018130-09; NCGC00091334-01; NCGC00091334-03; NCGC00094755-01; NCGC00094755-02; NCGC00094755-03; NCGC00094755-04; NCGC00256528-01; NCGC00259702-01; BR-30240; SC-23554; ST2410390; B0022; FT-0603345; ST50410261; SW196469-3; BIM-0051479.0001; C19290; D05450; S-1578; W 6155; 3-(phenylazo)-2,6-pyridinediamine monohydrochloride; SR-05000001695-2; W-108251; Q27139594; beta-phenylazo-alpha,alpha'-diaminopyridine hydrochloride; phen ylazo-alpha,alpha'-diaminopyridine monohydrochloride; Phenazopyridine hydrochloride, 99%, analytical standard; 3-[(E)-2-phenyldiazen-1-yl]pyridine-2,6-diamine hydrochloride; Phenazopyridine hydrochloride, VETRANAL(TM), analytical standard; Phenazopyridine hydrochloride, United States Pharmacopeia (USP) Reference Standard;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H12ClN5",
"molecular_weight": "249.7",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "8691",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02068",
"RC02689",
"RC03310"
]
},
{
"compound_ID": "D1046",
"name": "phenindione",
"synonyms": "phenindione; 83-12-5; 2-Phenyl-1,3-indandione; 2-Phenyl-1H-indene-1,3(2H)-dione; Dindevan; Phenylindanedione; Phenylindione; Rectadione; Athrombon; Diophindane; Emandione; Fenhydren; Phenhydren; Phenillin; Phenyline; Theradione; Danedion; Fenilin; Pindione; Danilone; Diadilan; Emandion; Eridione; Fenindion; Hemolidione; Phenylen; Phenylin; Tromazal; Bindan; Dineval; Hedulin; Indema; Trombol; Indon; Cronodione; Thrombasal; Indion; 2-Phenylindandione; 2-Phenyl-1,3-diketohydrindene; 1H-Indene-1,3(2H)-dione, 2-phenyl-; Phenindionum; Fenindiona; Phenyllin; 2-Phenyl-1,3-indanedione; Fenindiona [INN-Spanish]; Phenindionum [INN-Latin]; 2-phenylindene-1,3-dione; 1,3-Indandione, 2-phenyl-; 2-phenyl-2,3-dihydro-1H-indene-1,3-dione; PID; 2-phenyl-1,3(2H)-Indenedione; 2-Fenyloindandion-1,3 [Polish]; 2-Phenylindan-1,3-dione; 2-phenylindane-1,3-dione; UNII-5M7Y6274ZE; HSDB 3155; Phenindione(Rectadione); C15H10O2; EINECS 201-454-4; NSC 41693; CHEMBL711; 2-Phenyl-indan-1,3-dione; MLS000069422; CHEBI:8066; NFBAXHOPROOJAW-UHFFFAOYSA-N; 5M7Y6274ZE; NSC-41693; CAS-83-12-5; NCGC00016329-01; SMR000059058; DSSTox_CID_3453; DSSTox_RID_77033; DSSTox_GSID_23453; phenylindandione; 2-Fenyloindandion-1,3; Phenindione [INN:BAN]; Hedulin (TN); Phenindione (INN); SR-01000721861; Phenindione [USP:INN:BAN]; Prestwick_872; Spectrum_000927; Phenindione (Rectadione); Opera_ID_1966; Prestwick0_000538; Prestwick1_000538; Prestwick2_000538; Prestwick3_000538; Spectrum2_000999; Spectrum3_000710; Spectrum4_000476; Spectrum5_001070; P1029; Rectadione;phenylindandione; ACMC-1BM0O; 1H-Indene-1, 2-phenyl-; Oprea1_684242; SCHEMBL33831; BSPBio_000555; BSPBio_002499; KBioGR_000952; KBioSS_001407; MLS001148439; Dindevan,Rectadione;Rectadione; DivK1c_000307; SPECTRUM1500477; SPBio_001097; SPBio_002476; BPBio1_000611; GTPL6838; DTXSID5023453; CTK5F0412; HMS500P09; KBio1_000307; KBio2_001407; KBio2_003975; KBio2_006543; KBio3_001719; KS-00000YJG; NINDS_000307; WLN: L56 BV DV CHJ CR; HMS1569L17; HMS1920F20; HMS2091N22; HMS2096L17; HMS2234N06; HMS3651M04; HMS3713L17; Pharmakon1600-01500477; 2-Phenyl-1,3-indandione, 97%; HY-B0325; NSC41693; 1,3(2H)-Indenedione, 2-phenyl-; Tox21_110375; ANW-13618; BBL011710; BDBM50280157; CCG-40217; NSC757269; s1921; STK395038; AKOS000445019; Tox21_110375_1; ZINC100004862; CS-2366; DB00498; MCULE-1090571544; NE30721; NSC-757269; 1H-Indene-1,3(2H)-dione,2-phenyl-; IDI1_000307; NCGC00016329-02; NCGC00016329-03; NCGC00016329-04; NCGC00016329-05; NCGC00016329-07; NCGC00094756-01; NCGC00094756-02; NCGC00094756-03; NCGC00094756-04; AK129036; LS-81254; Q565; SBI-0051480.P003; AB2000376; TR-025910; AB00052069; ST45021959; SW196997-3; C07584; D08354; AB00052069_13; AB00052069_14; Q1640947; SR-01000721861-2; SR-01000721861-3; 2-phenyl-2-hydrocyclopenta[1,2-a]benzene-1,3-dione; BRD-K70592963-001-21-7; BRD-K70592963-001-26-6; Phenindione, United States Pharmacopeia (USP) Reference Standard; InChI=1/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H10O2",
"molecular_weight": "222.24",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "0.88",
"half_life": "5-10 hours",
"absorption": "Absorbed slowly from the gastrointestinal tract.",
"cid": "4760",
"classification": "B",
"indications": "",
"side_effects": "",
"atc_codes": "B01AA02",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02069",
"RC02690",
"RC03311"
]
},
{
"compound_ID": "D1047",
"name": "phenmedipham",
"synonyms": "Phenmedipham; 13684-63-4; 3-((Methoxycarbonyl)amino)phenyl m-tolylcarbamate; Fenmedifam; BETANAL; Phenmediphame; Kemifam; Spin-aid; Synbetan P; Schering 4072; Schering-38584; [3-(methoxycarbonylamino)phenyl] N-(3-methylphenyl)carbamate; Caswell No. 648B; Morton EP 452; UNII-UJE31KXP78; Phenmediphame [ISO-French]; EP-452; SN 4075; CCRIS 6091; Phenmedipham [ANSI:BSI:ISO]; SN-38584; HSDB 1402; Methyl 3-(3-methylcarbaniloyloxy)carbanilate; Methyl 3-(m-tolylcarbamoyloxy)phenylcarbamate; EINECS 237-199-0; 3-(Carbomethoxyamino)phenyl 3-methylcarbanilate; EPA Pesticide Chemical Code 098701; BRN 2395027; UJE31KXP78; Carbamic acid, (3-methylphenyl)-, 3-[(methoxycarbonyl)amino]phenyl ester; 3-Methoxycarbonylaminophenyl N-3'-methylphenylcarbamate; Methyl-3-m-tolycarbamoloxyphenyl carbamate; m-Hydroxycarbanilic acid methyl ester m-methylcarbanilate; 3-[(Methoxycarbonyl)amino]phenyl (3-methylphenyl)carbamate; CHEMBL1079421; CHEBI:81734; Methyl-3-hydroxycarbanilate-3-methylcarbanilate; 3-Methoxycarbonyl-N-(3'-methylphenyl)-carbamat; Methyl m-hydroxycarbanilate, m-methylcarbanilate; S 4075; 3-(Methylphenyl)carbamic acid 3-((methoxycarbonyl)amino)phenyl ester; 3-Methoxycarbonylaminophenyl 3'-methylcarbanilate; 3-((Methoxycarbonyl)amino)phenyl (3-methylphenyl)carbamate; 3-Methoxycarbonyl-N-(3'-methylphenyl)-carbamat [German]; 3-[(Methoxycarbonyl)amino]phenyl N-(3-methylphenyl)carbamate; AK129706; Carbanilic acid, m-hydroxy-, methyl ester, m-methylcarbanilate; Methyl N-(3-(N-(3-methylphenyl)carbamoyloxy)phenyl)carbamate; Carbanilic acid, m-hydroxy, methyl ester, m-methylcarbanilate (ester); Carbanilic acid, m-hydroxy-, methyl ester, m-methylcarbanilate (ester); DSSTox_CID_4255; Carbamic acid, (3-methylphenyl)-, 3-((methoxycarbonyl)amino)phenyl ester; DSSTox_RID_77343; DSSTox_GSID_24255; 3-((Methoxycarbonyl)amino)phenyl N-(3-methylphenyl)carbamate (Phenmedipham); CAS-13684-63-4; Beetomax; Betosip; Alegro; Beetup; Fender; Methyl N-[3-[N-(3-methylphenyl)carbamoyloxy]phenyl]carbamate; Gusto; Tripart beta; Betanal E; Protrum K; Kemifam FL; Betamix (Salt/Mix); Medipham (Salt/Mix); Synbetan mix (Salt/Mix); Betanal compact (Salt/Mix); SCHEMBL54580; DTXSID1024255; CTK8G8751; KS-00000GWH; IDOWTHOLJBTAFI-UHFFFAOYSA-N; Methyl m-hydroxycarbanilate m-methylcarbanilate (ester) (8CI); ZINC390960; Tox21_201295; Tox21_303044; BDBM50311785; Ethofumesate-phenmedipham (Salt/Mix); LS-799; AKOS015895890; DS-2923; MCULE-2867831626; MP-1928; NCGC00090870-01; NCGC00090870-02; NCGC00257194-01; NCGC00258847-01; CC-33628; O438; SN 38584; ST094978; AX8147450; DB-042361; 4CH-007622; FT-0630409; ST24028260; Methyl m-hydroxycarbanilate m-methylcarbanilate; C18420; 3-methoxycarbonyl-N-(3'-methylphenyl)-carbamate; Phenmedipham, PESTANAL(R), analytical standard; 684P634; A807149; C-18755; 3-(methoxyformamido)phenyl (3-methylphenyl)carbamate; J-006924; Q2085502; 3-methoxycarbonylaminophenyl N-3'methylphenylcarbamate; Methyl m-hydroxycarbanilate m-methylcarbanilate (ester); [3-(methoxycarbonylamino)phenoxy]-N-(3-methylphenyl)carboxamide; Phenmedipham (3-Methoxycarbonylaminophenyl-N-3'-methylphenyl; N-[3-[(3-methylanilino)-oxomethoxy]phenyl]carbamic acid methyl ester; 3-((METHOXYCARBONYL)AMINO) PHENYL N-(3-METHYLPHENYL) CARBAMATE (PHENMEDIPHAM); Carbamic acid, (3-methylphenyl)-, 3-((methoxycarbonyl)amino)phenyl ester (9CI);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H16N2O4",
"molecular_weight": "300.31",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "24744",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02070",
"RC02691",
"RC03312"
]
},
{
"compound_ID": "D1048",
"name": "phenol, 2-(1,1-dimethylethyl)-6-methyl-",
"synonyms": "2-tert-Butyl-6-methylphenol; 2219-82-1; 2-(tert-Butyl)-6-methylphenol; 6-tert-Butyl-o-cresol; Phenol, 2-(1,1-dimethylethyl)-6-methyl-; o-tert-Butyl-o-cresol; 2-Methyl-6-tert-butylphenol; 6-tert-Butyl-2-methylphenol; 2-tert-Butyl-6-methyl-phenol; o-Cresol, 6-tert-butyl-; UNII-LT9E3VZD1C; Phenol, 2-tert-butyl-6-methyl-; EINECS 218-734-7; NSC 78461; LT9E3VZD1C; BRN 1862362; CHEMBL29790; AI3-26294; BKZXZGWHTRCFPX-UHFFFAOYSA-N; W-109762; NSC78461; t-butylhydroxytoluene; 6-t-butyl-o-cresol; ACMC-209fti; 2-methyl-6-t-butylphenol; 2-t-butyl-6-methylphenol; 2-tertbutyl-6-methylphenol; DSSTox_CID_27468; DSSTox_RID_82368; DSSTox_GSID_47468; SCHEMBL56224; 4-06-00-03396 (Beilstein Handbook Reference); KSC490K6R; DTXSID4047468; CTK3J0568; o-Cresol, 6-tert-butyl- (8CI); Phenol,1-dimethylethyl)-6-methyl-; ZINC1718847; Tox21_302562; 1250AB; ANW-24772; BDBM50409548; MFCD00002239; NSC-78461; STL453581; 2-tert-Butyl-6-methyl-phenol, 99%; AKOS015890403; FCH1117845; MCULE-4483448704; RTR-010458; TRA0052400; 2-(1,1-dimethylethyl)-6-methylphenol; NCGC00256916-01; AK-87717; CC-11949; DA-25641; CAS-2219-82-1; AX8019459; LS-104172; TR-010458; B0728; FT-0613422; ST24027669; A816009; C-33408; Q17310083; 2-tert-Butyl-6-methyl-phenol, purum, >=98.0% (GC); InChI=1/C11H16O/c1-8-6-5-7-9(10(8)12)11(2,3)4/h5-7,12H,1-4H;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H16O",
"molecular_weight": "164.24",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16678",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02071",
"RC02692",
"RC03313"
]
},
{
"compound_ID": "D1049",
"name": "phenol, 4,4'-butylidenebis[2-(1,1-dimethylethyl)-5-methyl-",
"synonyms": "85-60-9; Santowhite; SANTOWHITE POWDER; Sumilit bbm; Sumilizer BBM; Anullex PBA 15; 4,4'-Butylidenebis(6-tert-butyl-m-cresol); Yoshinox BB; Sumilizer BBM-S; SWP (antioxidant); Noclizer NS 30; Annulex PBA 15; Antage W300; 4,4'-Butylidenebis(3-methyl-6-tert-butylphenol); 4,4'-(Butane-1,1-diyl)bis(2-(tert-butyl)-5-methylphenol); 6,6'-Di-tert-butyl-4,4'-butylidenedi-m-cresol; 4,4'-Butylidenebis(6-tert-butyl-3-methylphenol); SWP (VAN); UNII-IM86P8WF2S; SWP, antioxidant; NSC 67485; 4,4'-butane-1,1-diylbis(2-tert-butyl-5-methylphenol); CCRIS 4916; 4,4'-Butylidenebis(6-tert-butyl-3-methylphenyl); HSDB 5250; 1,1-Bis(2-methyl-4-hydroxy-5-tert-butylphenyl)butane; C26H38O2; NSC67485; EINECS 201-618-5; BRN 2016567; IM86P8WF2S; BBM; SWP; m-Cresol, 4,4'-butylidenebis(6-tert-butyl-; Phenol, 4,4'-butylidenebis[2-(1,1-dimethylethyl)-5-methyl-; PFANXOISJYKQRP-UHFFFAOYSA-N; 4,4'-Butylidene bis(6-tert-butyl-3-methylphenol); NSC-67485; Phenol, 4,4'-butylidenebis(2-(1,1-dimethylethyl)-5-methyl-; 4,4'-Butylidenebis[6-tert-butyl-m-cresol]; 4,4'-butylidene-bis(3-methyl-6-tert-butylphenol); W-109310; 4,4'-butylidenebis(2-(1,1-dimethylethyl)-5-methyl-phenol); m-Cresol, 4,4'-butylidenebis[6-tert-butyl-; 4,4'-Butylidene bis[6-tert-butyl-3-methylphenol]; Vanox SWP; BBMTBP; 4,4'-butylidenebis(6-t-butyl-m-cresol); DSSTox_CID_9602; ACMC-209q6z; EC 201-618-5; NCIStruc1_001564; NCIStruc2_001580; 2-tert-butyl-4-[1-(5-tert-butyl-4-hydroxy-2-methylphenyl)butyl]-5-methylphenol; DSSTox_RID_78781; DSSTox_GSID_29602; SCHEMBL39107; 4-06-00-06807 (Beilstein Handbook Reference); CHEMBL1337629; DTXSID8029602; CTK5I0347; NCI67485; ZINC1694481; Tox21_200749; 3301AC; ANW-38217; CCG-36974; NCGC00013772; AKOS015839538; MCULE-9750458903; CAS-85-60-9; WLN: 1X&&R BQ D E- 2Y3; NCGC00013772-02; NCGC00013772-03; NCGC00096882-01; NCGC00258303-01; AS-70133; LS-55344; m-Cresol,4'-butylidenebis[6-tert-butyl-; NCI60_026518; 4,4'-Butylidenbis(6-tert-butyl-m-cresol); AX8092059; TR-026739; 4,4'-Butylidene-bis-(6-t-butyl-m-cresol); B0724; 4,4'-butylidene-bis(6-tert-butyl-m-cresol); 4,4\\'-Butylidenebis(6-tert-butyl-3-methylphenol); 4,4'-butylidenebis(3-methyl-6-tertiary-butylphenol); BRD-K82744348-001-01-8; Q27280791; 1,1-Bis(5-tert-butyl-4-hydroxy-2-methylphenyl)-butane; 1,1-bis (5-tert-butyl-4-hydroxy-2-methylphenyl) butane; 4,4'-(Butane-1,1-diyl)bis(2-tert-butyl-5-methylphenol); Phenol,4'-butylidenebis[2-(1,1-dimethylethyl)-5-methyl-; 99346-89-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C26H38O2",
"molecular_weight": "382.6",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "6815",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02072",
"RC02693",
"RC03314"
]
},
{
"compound_ID": "D1050",
"name": "phenol, 4-methyl-, reaction products with dicyclopentadiene and isobutylene",
"synonyms": "EINECS 271-867-2; Phenol, 4-methyl-, reaction products with dicyclopentadiene and isobutylene; C21H28O; Rubber Antioxidant L; EC 271-867-2; SCHEMBL465486; AKOS032949874; O820; LS-181776;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C21H28O",
"molecular_weight": "296.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "162222",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02073",
"RC02694",
"RC03315"
]
},
{
"compound_ID": "D1051",
"name": "phenolphthalein",
"synonyms": "phenolphthalein; 77-09-8; Phthalimetten; Euchessina; Phthalin; Espotabs; Phenolax; Purgophen; Koprol; Laxogen; Trilax; Purga; Lilo; Spulmako-lax; Chocolax; Feen-A-Mint Gum; Purgen; 3,3-Bis(4-hydroxyphenyl)phthalide; Correctol; Alophen; Doxidan; Medilax; Colax; Laxin; FemiLax; Dihydroxyphthalophenone; Phillips Gelcaps; 3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone; Lax-Pills; 1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-; Evac-Q-Kwik; Evac-Q-Tabs; Evac-Q-Kit; Evac-U-Gen; Fenolftalein; Phenolphtaleine; Phenophthalein; Agoral; Fenolftalein [Czech]; 3,3-Bis(p-hydroxyphenyl)phthalide; 3,3-Bis(4-hydroxyphenyl)isobenzofuran-1(3H)-one; NCI-C55798; Feen-A-Mint Laxative Mints; Fenolftaleina [INN-Spanish]; Phenolphtaleine [INN-French]; 3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1(3H)-one; Phenolphthaleinum [INN-Latin]; alpha-Di(p-hydroxyphenyl)phthalide; UNII-6QK969R2IF; NSC 10464; component of Agoral; 3,3-bis(4-hydroxyphenyl)-1,3-dihydro-2-benzofuran-1-one; Phthalide 3,3,-bis(p-hydroxyphenyl)-; CCRIS 6266; HSDB 4161; 3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one; EINECS 201-004-7; MFCD00005913; BRN 0284423; Phenolphthalein, ACS reagent; CHEMBL63857; AI3-09081; MLS000069592; 6QK969R2IF; DTXSID0021125; CHEBI:34914; KJFMBFZCATUALV-UHFFFAOYSA-N; component of Correctol; NCGC00018200-07; SMR000059015; DSSTox_CID_1125; alpha-(p-Hydroxyphenyl)-alpha-(4-oxo-2,5-cyclohexadien-1-ylidene)-o-toluic acid; DSSTox_RID_75956; DSSTox_GSID_21125; Evac-V-Lax; 3,3-bis(4-hydroxyphenyl)-3-hydroisobenzofuran-1-one; component of Feen-A-Mint Pills; Fenolftaleina; Laxettes; Phenolphthaleinum; Phthalide 3,-bis(p-hydroxyphenyl)-; Feen-a-mint; CAS-77-09-8; Phenolphthalein Solution, Alcoholic 1.0%; WLN: T56 BVO DHJ D- D-/R DQ 2; 1(3H)-Isobenzofuranone,3-bis(4-hydroxyphenyl)-; Phenolphthalein, 98.5%, pure, Indicator grade; 3, 3-Bis(p-hydroxyphenyl)-1(3H)-isobenzofuranone; Phenolphthalein [INN:BAN]; phenolphtalein; Figsen; Laxett es; Phenolphthalein [USP:INN:BAN]; FGT; Doxan (Salt/Mix); Phenolphthalein,white; Agoral (Salt/Mix); Modane (TN); Phenolphthalein,(S); Laxcaps (Salt/Mix); Phenolphthalein,yellow; Yellow phenolphthalein; PubChem7084; Phenolphthalein (INN); Spectrum_001077; Opera_ID_1337; Spectrum2_001279; Spectrum3_000888; Spectrum4_000982; Spectrum5_001268; Modane Plus (Salt/Mix); 3,3-bis(4-hydroxyphenyl)isobenzofuran-1-one; EC 201-004-7; Phenolphthalein ACS reagent; cid_4764; SCHEMBL27670; BSPBio_002518; KBioGR_001383; KBioSS_001557; Phenolphthalein, pH indicator; 5-18-04-00188 (Beilstein Handbook Reference); MLS001148397; BIDD:ER0202; DivK1c_000929; SPECTRUM1500480; Phenolphthalein Paper, DAB 6; SPBio_001278; ARONIS002962; BCBcMAP01_000174; HMS502O11; KBio1_000929; KBio2_001557; KBio2_004125; KBio2_006693; KBio3_001776; KS-00000YJD; Phenolphthalein solution, 0.1 N; NINDS_000929; HMS1920H04; HMS2091P06; HMS2236I09; HMS3374P06; LS-47; Pharmakon1600-01500480; component of Correctol (Salt/Mix); HY-D0211; KS-00003W2P; NSC10464; ZINC3831317; Phenolphthalein, p.a., ACS reagent; Tox21_110838; Tox21_202219; Tox21_300282; BBL002030; BDBM50077844; CCG-39112; NSC-10464; NSC215214; NSC757271; s5395; SBB008868; STK029876; AKOS000493033; Tox21_110838_1; CS-8152; DB04824; MCULE-5232154932; NE46883; NSC-215214; NSC-757271; IDI1_000929; SMP1_000235; NCGC00018200-01; NCGC00018200-02; NCGC00018200-03; NCGC00018200-04; NCGC00018200-05; NCGC00018200-06; NCGC00018200-08; NCGC00018200-09; NCGC00018200-10; NCGC00018200-12; NCGC00023694-03; NCGC00023694-04; NCGC00023694-05; NCGC00023694-06; NCGC00023694-07; NCGC00254039-01; NCGC00259768-01; AC-14431; AK130019; BP-30100; SC-74728; ST072636; VS-01000; SBI-0051481.P003; component of Feen-A-Mint Pills (Salt/Mix); TR-037762; 2-[Bis (4-hydroxyphenyl)methyl]benzoic acid; EU-0082600; FT-0659094; P0094; P0700; P0701; P0702; ST24041105; T8172; 3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-on; EN300-92962; Phenolphthalein, SAJ first grade, >=97.0%; .alpha., .alpha.-Di(p-hydroxyphenyl)phthalide; 3,3-bis (4-hydroxyphenyl)-2-benzofuran-1-on; C14286; D05456; Phenolphthalein, JIS special grade, >=98.0%; AB00052070_15; Q187921; SR-01000000112; Q-201555; SR-01000000112-2; TRANSGENIC MODEL EVALUATION (PHENOLPHTHALEIN); 3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1(3H)-one #; 3,3-Bis-(4-hydroxy-phenyl)-3H-isobenzofuran-1-one; BRD-K19227686-001-02-0; BRD-K19227686-001-12-9; Phenolphthalein solution, 1 % (w/v), pH 7.8-10.0; Z57233591; F0921-4309; TRANSGENIC MODEL EVALUATION II (PHENOLPHTHALEIN); Phenolphthalein solution, 0.04 % (w/v), pH 7.8-10.0; Phenolphthalein solution, 0.1 % (w/v), pH 7.8-10.0; Phenolphthalein solution, 0.5 wt. % in ethanol: water (1:1); Phenolphthalein, United States Pharmacopeia (USP) Reference Standard; InChI=1/C20H14O4/c21-15-9-5-13(6-10-15)20(14-7-11-16(22)12-8-14)18-4-2-1-3-17(18)19(23)24-20/h1-12,21-22; Phenolphthalein, ACS reagent, reag. Ph. Eur., indicator, 98-102% (calc. to the dried substance), S. No.: 879; Phenolphthalein, puriss., meets analytical specification of Ph??Eur., BP, 98-101% (calc. to the dried substance);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C20H14O4",
"molecular_weight": "318.3",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "4764",
"classification": "A",
"indications": "",
"side_effects": "",
"atc_codes": "A06AB04",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02074",
"RC02695",
"RC03316"
]
},
{
"compound_ID": "D1052",
"name": "phenoxybenzamine hydrochloride",
"synonyms": "Phenoxybenzamine hydrochloride; 63-92-3; Phenoxybenzamine Hcl; Dibenzyline; N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine hydrochloride; Bensylyt NEN; Dibenzyline hydrochloride; Phenoxybenzamine.HCl; Phenoxybenzamine chloride; NCI-C01661; Dibenzyran; Phenoxybenzamine (hydrochloride); Dibenzyline chloride; MLS000069374; CHEBI:8078; 2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane hydrochloride; benzyl(2-chloroethyl)(1-phenoxypropan-2-yl)amine hydrochloride; NSC 37448; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine hydrochloride; CCRIS 506; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine hydrochloride; CPD000058422; N-2-Phenoxyisopropyl-N-benzyl-chloroethylamine hydrochloride; SMR000058422; Benzyl(2-chloroethyl)(1-methyl-2-phenoxyethyl)amine hydrochloride; EINECS 200-569-7; DSSTox_CID_1127; DSSTox_RID_75958; DSSTox_GSID_21127; AI3-52044; Benzylamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-, hydrochloride; (R)-Phenoxybenzamine Hydrochloride; N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine;hydrochloride; N-Benzyl-N-phenoxyisopropyl-beta-chlorethylamine hydrochloride; N-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine hydrochloride; N-2-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine hydrochloride; Phenoxybenzamine hydrochloride (USP); Benzenemethanamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-, hydrochloride; SR-01000000017; fenoxybenzamin; Dibenzylene; Bensylyte HCl; Dibenzyline (TN); Phenoxybenzamine hydrochloride [USAN]; POB HCl; Opera_ID_300; CAS-63-92-3; Dibenzyline hyd rochloride; C18H23Cl2NO; phenoxybenzamide hydrochloride; phenoxybenzamine-hydrochloride; SCHEMBL50729; MLS002222313; Phenyoxybenzamine hydrochloride; SPECTRUM2300176; CHEMBL1200787; DTXSID0021127; CTK6H8164; HY-B0431A; AOB5790; HMS1570N10; Pharmakon1600-02300176; Phenoxybenzamine Hydrochloride,(S); BCP28467; NSC37448; Tox21_201588; Tox21_302978; WLN: G2N1R&Y1&1OR &GH; ANW-45430; CCG-39614; MFCD00055152; NSC-37448; NSC759572; AKOS015966790; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzylamine Hydrochloride; AC-8077; CS-2537; LP00235; LS-1516; MCULE-2455465785; NC00598; NE47907; NSC-759572; NCGC00089748-02; NCGC00089748-06; NCGC00093699-01; NCGC00093699-02; NCGC00093699-03; NCGC00093699-04; NCGC00256370-01; NCGC00259137-01; AK-64371; AS-16927; H533; SAM002548984; SAM002564244; AB0013102; AB2000604; DB-054579; RT-000645; ST2407428; B-019; D0158; EU-0100235; FT-0603264; N-benzyl-N-(2-chloroethyl)-1-phenoxypropan; S2499; SW197327-3; EN300-52514; C07436; D00507; Phenoxybenzamine hydrochloride, >=97%, powder; 055P152; J-009731; SR-01000000017-2; SR-01000000017-6; Q27107723; N-Phenoxyisopropyl-N-benzyl-2-chloroethylamine Hydrochloride; N-2-phenoxyisopropyl- N-benzyl-chloroethylamine hydrochloride; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine, hydrochloride; Benzenemethanamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-,hydrochloride; Phenoxybenzamine hydrochloride, United States Pharmacopeia (USP) Reference Standard; Phenoxybenzamine HCl pound>>NCI-C01661 pound>> NCI C01661 pound>> NCIC01661 pound>>NSC 37448 pound>>NSC37448 pound>>NSC-37448; Phenoxybenzamine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H23Cl2NO",
"molecular_weight": "340.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5284441",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02075",
"RC02696",
"RC03317"
]
},
{
"compound_ID": "D1053",
"name": "phenyl isothiocyanate",
"synonyms": "Isothiocyanatobenzene; PHENYL ISOTHIOCYANATE; 103-72-0; Phenylisothiocyanate; Benzene, isothiocyanato-; Thiocarbanil; Phenyl mustard oil; PITC; Isothiocyanic acid phenyl ester; Benzene-1-isothiocyanate; Phenylsenfoel; Phenyl thioisocyanate; Isothiocyanato-benzene; Fenylisothiokyanat; USAF M-4; Isothiocyanic acid, phenyl ester; Phenylsenfoel [German]; Fenylisothiokyanat [Czech]; NSC 5583; UNII-0D58F84LSU; CCRIS 3144; CHEBI:85103; EINECS 203-138-1; BRN 0471392; AI3-09310; 0D58F84LSU; QKFJKGMPGYROCL-UHFFFAOYSA-N; AKOS BBS-00004438; Phenyl isothiocyanate, 98%; Ylothane; phenyisothiocyanate; phenylisothiocynate; Isothiocynatobenzene; Phenyl sothocyanate; phenyl isothiocynate; isothiocynato benzene; phenyl-isothiocyanate; MFCD00004798; phenyl isothio cyanate; phenyl isothio-cyanate; benzene, isothiocyanato; 1-Isothiocyanatobenzene; EDMAN'S REAGENT; PubChem18702; ACMC-20ajx2; WLN: SCNR; DSSTox_CID_1129; DSSTox_RID_75960; DSSTox_GSID_21129; SCHEMBL20984; 4-12-00-00867 (Beilstein Handbook Reference); KSC492K1J; CHEMBL309036; DTXSID0021129; CTK3J2514; TIMTEC-BB SBB040940; NSC5583; OTAVA-BB 1055672; ZINC164500; BCP22726; CS-B1640; KS-00000V7I; NSC-5583; Tox21_201128; BBL027476; BDBM50073665; SBB040940; STL281854; AKOS000119287; AM90356; AS04391; FS-4271; LS-7649; MCULE-4369838098; NE10354; RTR-000864; TRA0069149; NCGC00248931-01; NCGC00258680-01; CAS-103-72-0; R522; SC-25756; Phenyl isothiocyanate, reagent grade, 98%; TR-000864; FT-0627519; I0191; ST50214555; EN300-17278; Phenyl isothiocyanate solution, 5% in heptane; 30342-EP2284157A1; 30342-EP2308858A1; 30342-EP2311464A1; 30342-EP2311816A1; 30342-EP2311817A1; 71255-EP2295418A1; 71255-EP2308833A2; A800790; Q422311; J-523934; J-801008; J-802269; Phenyl isothiocyanate, 99%, for protein sequencing; F2121-0322; InChI=1/C7H5NS/c9-6-8-7-4-2-1-3-5-7/h1-5; Phenyl isothiocyanate, for protein sequence analysis, >=99.5% (GC); Phenyl isothiocyanate solution, for protein sequence analysis, ~5% in heptane; Phenyl isothiocyanate, for HPLC derivatization, the detection of alcohols and amines, >=99.0%; Phenyl isothiocyanate, Sigma Grade, 8.36 M, suitable for solid phase protein sequencing analysis, >=99% (GC), liquid;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C7H5NS",
"molecular_weight": "135.19",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "7673",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02076",
"RC02697",
"RC03318"
]
},
{
"compound_ID": "D1054",
"name": "phloretin",
"synonyms": "phloretin; 60-82-2; Dihydronaringenin; 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one; Phloretol; 1-Propanone, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-; NSC 407292; 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone; UNII-S5J5OE47MK; CCRIS 7459; beta-(p-Hydroxyphenyl)phloropropiophenone; 2',4',6'-Trihydroxy-3-(p-hydroxyphenyl)propiophenone; 2',4',6'-Trihydroxy-3-(4-Hydroxyphenyl)propiophenone; C15H14O5; EINECS 200-488-7; MFCD00002288; NSC407292; S5J5OE47MK; beta-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; CHEMBL45068; CHEBI:17276; VGEREEWJJVICBM-UHFFFAOYSA-N; Phloretin, 98%; beta-(4-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; Propiophenone, 2',4',6'-trihydroxy-3-(p-hydroxyphenyl)-; 2',4,4',6'-Tetrahydroxydihydrochalcone; AK162403; .beta.-(p-Hydroxyphenyl)phloropropiophenone; 2',4,4',6'-Tetrahydroxy-Dihydrochalcone; Q-100701; SMR000326783; SR-01000076081; 2uxi; G50; Spectrum_001295; 4,2',4',6'-Tetrahydroxydihydrochalcone; Phloretin, >=99%; ACMC-209mmd; SpecPlus_000333; Spectrum2_000681; Spectrum3_001036; Spectrum4_001172; Spectrum5_001698; Lopac-P-7912; DSSTox_CID_2393; cid_4788; Phloretin(Dihydronaringenin); DSSTox_RID_76569; DSSTox_GSID_22393; Lopac0_001012; Oprea1_824722; REGID_for_CID_4788; SCHEMBL38131; BSPBio_002851; KBioGR_001803; KBioSS_001775; SPECTRUM300554; MLS000728507; MLS000859922; MLS006012024; BIDD:ER0174; DivK1c_006429; SPBio_000801; GTPL4285; DTXSID6022393; BCBcMAP01_000040; BDBM23446; CTK3J2061; KBio1_001373; KBio2_001775; KBio2_004343; KBio2_006911; KBio3_002071; ZINC47553; HMS2224N17; HMS3263K05; HMS3332J03; HMS3656I07; ACN-S003569; BCP28296; HY-N0142; KS-00000C3P; TNP00255; Tox21_202854; Tox21_501012; 2′,4′,6′-Trihydroxy-3-p-hydroxyphenylpropiophenone; ANW-33587; BBL027375; CCG-38573; CP0082; KM0437; LMPK12120525; O1P165; s2342; SBB066137; STL372996; AKOS015856338; AC-7995; ACN-035397; CS-1477; DB07810; LP01012; MCULE-3672992389; NSC-407292; RTR-031371; SDCCGMLS-0066637.P001; TRA0006136; CAS-60-82-2; Phloretin, analytical reference material; SMP1_000238; NCGC00015840-01; NCGC00015840-02; NCGC00015840-03; NCGC00015840-04; NCGC00015840-05; NCGC00015840-06; NCGC00015840-07; NCGC00015840-08; NCGC00015840-09; NCGC00094304-01; NCGC00094304-02; NCGC00094304-03; NCGC00094304-04; NCGC00260400-01; NCGC00261697-01; AS-14100; CC-33738; SC-18405; ST057164; SY017103; AB0016775; AX8147786; DB-053714; LS-187222; LS-188085; TR-031371; EU-0101012; FT-0603256; N1316; P1966; ST24041477; SW219308-1; C00774; P 7912; C-17278; 2',6'-Trihydroxy-3-(p-hydroxyphenyl)propiophenone; Q2268463; SR-01000076081-1; SR-01000076081-7; SR-01000076081-8; .beta.-(p-Hydroxyphenyl)-2,6-trihydroxypropiophenone; BRD-K15563106-001-02-4; BRD-K15563106-001-10-7; Propiophenone,4',6'-trihydroxy-3-(p-hydroxyphenyl)-; .beta.-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; 2',4',6'-Trihydroxy-3-(4-hydroxyphenyl)-propiophenone; 1-(2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)-1-propanone; 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanon; 3-(4-Hydroxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one; Propiophenone, 2',4',6'-trihydroxy-3-(p-hydroxyphenyl)- (8CI); InChI=1/C15H14O5/c16-10-4-1-9(2-5-10)3-6-12(18)15-13(19)7-11(17)8-14(15)20/h1-2,4-5,7-8,16-17,19-20H,3,6H;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H14O5",
"molecular_weight": "274.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "4788",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02077",
"RC02698",
"RC03319"
]
},
{
"compound_ID": "D1055",
"name": "picoxystrobin",
"synonyms": "Picoxystrobin; 117428-22-5; UNII-62DH7GEL1P; (E)-Methyl 3-methoxy-2-(2-(((6-(trifluoromethyl)pyridin-2-yl)oxy)methyl)phenyl)acrylate; 62DH7GEL1P; CHEBI:83197; Methyl (E)-3-methoxy-2-[2-[[6-(trifluoromethyl)pyridin-2-yl]oxymethyl]phenyl]prop-2-enoate; C18H16F3NO4; Picoxystrobin [ISO]; DSSTox_CID_27542; DSSTox_RID_82407; DSSTox_GSID_47542; SCHEMBL18977; CHEMBL522759; DTXSID9047542; IBSNKSODLGJUMQ-SDNWHVSQSA-N; BCP25776; EBD53390; Tox21_300625; 2847AA; ZINC34872909; AKOS016011129; NCGC00248112-01; NCGC00254335-01; AC-26782; AS-31050; AX8148007; CAS-117428-22-5; Pesticide4_Picoxystrobin_C18H16F3NO4_Acanto; 428P225; (E)-methyl 2-[2-(6-trifluoromethylpyrid-2-yloxymethyl)phenyl]-3-methoxyacrylate; (E)-methyl 3-methoxy-2-(2-((6-(trifluoromethyl)pyridin-2-yloxy)methyl)phenyl)acrylate; methyl (2E)-3-methoxy-2-{2-[6-(trifluoromethyl)-2-pyridyloxymethyl]phenyl}acrylate; Methyl (E)-3-methoxy-2-{2-[6-(trifluoromethyl)-2-pyridyloxymethyl]phenyl}acrylate; Benzeneacetic acid, alpha-(methoxymethylene)-2-[[[6-(trifluoromethyl)-2-pyridinyl]oxy]methyl]-, methyl ester, (alphaE)-; methyl (2E)-3-methoxy-2-[2-({[6-(trifluoromethyl)pyridin-2-yl]oxy}methyl)phenyl]prop-2-enoate; methyl (alphaE)-alpha-(methoxymethylene)-2-[[[6-(trifluoromethyl)-2-pyridinyl]oxy]methyl]benzeneacetate;",
"trade_name": "",
"abbrev_name": "",
"description": "fungicide; mitochondrial cytochrome-bc1 complex inhibitor; a methoxyacrylate strobilurin",
"molecular_formula": "C18H16F3NO4",
"molecular_weight": "367.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "11285653",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T004"
],
"function": [
"F0108",
"F020403"
],
"references": [
"RC02078",
"RC02699",
"RC03320",
"RC04950"
]
},
{
"compound_ID": "D1056",
"name": "picropodophyllin",
"synonyms": "Picropodophyllin; Picropodophyllotoxin; 477-47-4; AXL1717; Picropodophyllin (PPP); AXL1717 (Picropodophyllotoxin); NSC 36407; UNII-0F35AOI227; NSC36407; BRN 0099161; (-)PPP; CHEBI:75251; 0F35AOI227; NSC-36407; AXL 1717; 17434-18-3; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-alpha,8a-alpha,9-alpha))-; picropodophyllin-ppp; (5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one; 4354-76-1; Spectrum_001636; Picropodophyllin (8CI); Spectrum2_000520; Spectrum3_001671; Spectrum4_001836; Spectrum5_000631; BSPBio_003481; KBioGR_002538; KBioSS_002116; SCHEMBL159598; SPECTRUM1504410; SPBio_000479; Podophyllotoxin picropodophyllin; CHEMBL283120; GTPL7873; KBio2_002116; KBio2_004684; KBio2_007252; KBio3_002701; DTXSID80197245; YJGVMLPVUAXIQN-HAEOHBJNSA-N; HMS1923O05; AXL-1717; BCP18482; KS-00000TA3; ZINC4098919; CCG-39920; s7668; AKOS015965529; CS-1184; DB12802; SDCCGMLS-0066757.P001; NCGC00161923-01; NCGC00161923-02; NCGC00161923-04; Picropodophyllotoxin;Picropodophyllin;PPP; AC-20289; HY-15494; LS-70860; SC-94922; X1203; Picropodophyllotoxin, >=96% (HPLC), powder; A12195; W-5271; BRD-K81829253-001-02-9; BRD-K81829253-001-03-7; Q27088385; Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer; WLN: T E5 C665 FVO NO PO OHTT&&J DR CO1 DO1 EO1& JQ; (10R,11S,15R,16R)-16-hydroxy-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0?,?.0??,??]hexadeca-1(9),2,7-trien-12-one; (5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one; (5R,5aS,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; (5R,5aS,8aR,9R)-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one; 5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, [5R-(.alpha.-5a.alpha.,8a.alpha.,9.alpha.)]; Furo[3',7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.alpha.,8a.alpha.,9.alpha.)]-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C22H22O8",
"molecular_weight": "414.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "72435",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02079",
"RC02700",
"RC03321"
]
},
{
"compound_ID": "D1057",
"name": "pinacyanol",
"synonyms": "Carbocyanine; Pinacyanol iodide; Pinacyanol; Pinacyanole; Sensitol Red; Eastman kodak 622; EINECS 210-099-4; UNII-94623A1122; NSC 403532; G 1700; 605-91-4; DSSTox_CID_26576; DSSTox_RID_81735; DSSTox_GSID_46576; 94623A1122; 1-Ethyl-2-(3-(1-ethyl-2(1H)-quinolylidene)prop-1-enyl)quinolinium iodide; 1-Ethyl-2-(3-(1-ethyl-2(1H)-quinolylidene)propenyl)quinolinium iodide; Quinolinium, 1-ethyl-2-(3-(1-ethyl-2(1H)-quinolylidene)propenyl)-, iodide; CHEBI:52218; CAS-605-91-4; NCGC00166247-01; SCHEMBL58012; CHEMBL2361697; DTXSID9046576; Tox21_112373; AKOS024302141; Tox21_112373_1; MCULE-6952018083; NCGC00166247-02; LS-142353; EN300-240239; C-45760; Q27123307; 1-ethyl-2-((1E,3Z)-3-(1-ethylquinolin-2(1H)-ylidene)prop-1-en-1-yl)quinolin-1-ium iodide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C25H25IN2",
"molecular_weight": "480.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5709754",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02080",
"RC02701",
"RC03322"
]
},
{
"compound_ID": "D1058",
"name": "pioglitazone hydrochloride",
"synonyms": "pioglitazone hydrochloride; 112529-15-4; Pioglitazone HCl; Pioglitazone (hydrochloride); 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride; U-72107A; Pioditazone hydrochloride; AD 4833; [5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride; Glustin; MFCD04975446; NCGC00095131-01; U-72107E; Actos (TN); (+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride; DSSTox_CID_24203; DSSTox_RID_80116; C19H21ClN2O3S; DSSTox_GSID_44203; U 72107A; Piomed; 5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione HCl; 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride; 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione hydrochloride; 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride; 2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)-; SMR000469167; CAS-112529-15-4; 5-(4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl)thiazolidine-2,4-dione hydrochloride; 5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hcl; 5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hydrochloride; 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride; 5-[4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl]-thiazolidine-2,4-dione hydrochloride; 5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione hydrochloride; Pioglitazone hydrochloride [USAN]; 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione hydrochloride; Pioglitazone hydrochloride [USAN:USP]; pioglitazone, hydrochloride; CHEMBL1715; SCHEMBL21843; C19H20N2O3S.HCl; MLS001306462; MLS001401386; SPECTRUM1504401; pioglitazone-hydrochloride-actos; CHEBI:8229; DTXSID3044203; Pioglitazone Hydrochloride ,(S); CTK8B3228; STR-001; GHUUBYQTCDQWRA-UHFFFAOYSA-N; HMS1922L05; Pioglitazone hydrochloride (Actos); ACT04238; BCP22942; KS-00000IO7; Tox21_111440; Tox21_300584; ANW-42027; CCG-39097; CP0139; s2046; AKOS015844016; Tox21_111440_1; AC-1037; CCG-100931; CS-2235; KS-1186; MCULE-1259842295; NC00181; Pioglitazone hydrochloride (JP17/USP); RTR-001112; SB17324; NCGC00095131-02; NCGC00163128-08; NCGC00254492-01; 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, monohydrochloride; AA-10090; AK-50391; BR-50391; CPD000469167; HY-14601; I868; SAM001246600; SC-19064; BCP0726000151; AB0013914; AB1009260; LS-151328; LS-172192; Pioglitazone hydrochloride, >=98% (HPLC); ST2411660; TR-001112; AM20061770; FT-0082357; FT-0601607; P1901; SW197561-4; A-2403; D00945; J10107; 025P468; A802593; Q-201584; Q27281642; Pioglitazone hydrochloride, European Pharmacopoeia (EP) Reference Standard; [(+-)-5-[[4-[4-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] monohydrochloride; 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, hcl; 5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride; 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, hydrochloride; 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride; 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride; 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione hydrochloride; Pioglitazone for system suitability, European Pharmacopoeia (EP) Reference Standard; Pioglitazone hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Pioglitazone hydrochloride, United States Pharmacopeia (USP) Reference Standard; 2,4-thiazolidinedione,5-((4-(2-(5-ehtyl-2-pyridinyl)ethoxy)phenyl)methyl)-monohydrochloride;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C19H21ClN2O3S",
"molecular_weight": "392.9",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "60560",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02081",
"RC02702",
"RC03323"
]
},
{
"compound_ID": "D1059",
"name": "pirarubicin",
"synonyms": "pirarubicin; 72496-41-4; Theprubicin; THP-doxorubicin; C32H37NO12; NCGC00167982-01; Pirarubicin (JP17/INN); CHEMBL1398373; SCHEMBL15472856; CHEBI:32011; AOB5649; EX-A494; KMSKQZKKOZQFFG-HSUXVGOQSA-N; ZINC3913909; MFCD00869742; AKOS015895621; NCGC00167982-02; K234; D01885; 15207-EP2272827A1; 15207-EP2275420A1; 15207-EP2295055A2; 15207-EP2295416A2; 15207-EP2295426A1; 15207-EP2295427A1; 15207-EP2298748A2; 15207-EP2298764A1; 15207-EP2298765A1; 15207-EP2298768A1; 15207-EP2298778A1; 15207-EP2305642A2; 15207-EP2311453A1; 15207-EP2311808A1; 15207-EP2311829A1; 15207-EP2316832A1; 15207-EP2316833A1; 496P414; Pirarubicin, Antibiotic for Culture Media Use Only; Q-201589; (8S)-10-((2R,4S,5S,6S)-4-amino-6-methyl-5-((S)-tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-6-methyl-5-(((S)-tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C32H37NO12",
"molecular_weight": "627.6",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "636397",
"classification": "L",
"indications": "",
"side_effects": "",
"atc_codes": "L01DB08",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02082",
"RC02703",
"RC03324"
]
},
{
"compound_ID": "D1060",
"name": "pirenoxine sodium",
"synonyms": "Pirenoxine sodium; 51410-30-1; Catalin sodium; Pirenoxine sodium salt; UNII-95JU7URF64; EINECS 257-181-6; 95JU7URF64; Sodium 1-hydroxy-5-oxo-5H-pyrido[3,2-a]phenoxazine-3-carboxylate; 1-Hydroxy-5-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylic acid sodium salt; W-105897; Sodium 1-hydroxy-5-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylate; 5H-Pyrido(3,2-a)phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-, monosodium salt; NCGC00167452-01; Clarvisan (TN); C16H7N2NaO5; DSSTox_CID_26637; DSSTox_RID_81783; DSSTox_GSID_46637; SCHEMBL1650064; CHEMBL2359957; DTXSID1046637; SCHEMBL11579562; BCP12124; Tox21_112456; AKOS015951393; VA11536; ACM51410301; S468; AB1009549; CAS-51410-30-1; LS-133976; D08388; Q27271800; Sodium 1,5-dioxo-1,5-dihydro-4H-pyrido[3,2-a]phenoxazine-3-carboxylate; 1-HYDROXY-5-OXO-5H-PYRIDO[3,2-A]PHENOXAZINE-3-CARBOXYLIC ACID MONOSODIUM SALT; 5H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, sodium salt (1:1);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H7N2NaO5",
"molecular_weight": "330.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "23695982",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02083",
"RC02704",
"RC03325"
]
},
{
"compound_ID": "D1061",
"name": "polyethylene glycol (9z)-9-octadecenyl ether",
"synonyms": "",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "X",
"molecular_weight": "X",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "X",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Others",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02085",
"RC02706",
"RC03327"
]
},
{
"compound_ID": "D1062",
"name": "polyoxyethylene(10)nonylphenyl ether",
"synonyms": "NP-10; NP 10 (Pharmaceutical); 2854-09-3; 1-(2-Hydroxyethyl)-5-nitropyrrole-2-carboxamide; 15960 RP; NP 10; BRN 0479830; Pyrrole-2-carboxamide, 1-(2-hydroxyethyl)-5-nitro-; 1-(2-hydroxyethyl)-5-nitro-1h-pyrrole-2-carboxamide; CTK4G1687; DTXSID80951228; RFQOPUYDLCMQCE-UHFFFAOYSA-N; LS-136820;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C7H9N3O4",
"molecular_weight": "199.16",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "160655",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02086",
"RC02707",
"RC03328"
]
},
{
"compound_ID": "D1063",
"name": "p-phenylazophenol",
"synonyms": "4-HYDROXYAZOBENZENE; 1689-82-3; 4-(phenyldiazenyl)phenol; 4-Phenylazophenol; Solvent Yellow 7; 4-(Phenylazo)phenol; p-Phenylazophenol; p-Hydroxyazobenzene; C.I. Solvent Yellow 7; Organol Yellow AP; Phenol, 4-(phenylazo)-; Pirocard Green 491; Brasilazina Oil Yellow O; Phenol, p-(phenylazo)-; Zlut rozpoustedlova 7; Atul Brilliant Oil Yellow G; p-Benzeneazophenol; CI Solvent Yellow 7; C.I. 11800; (E)-4-Phenylazophenol; Azobenzene, 4-hydroxy-; Phenol, 4-(2-phenyldiazenyl)-; NSC 3177; UNII-VX4306NSH1; p-(Phenylazo)phenol; 4-[(E)-Phenyldiazenyl]phenol; p-(Benzeneazo)phenol; Zlut rozpoustedlova 7 [Czech]; 20714-70-9; HSDB 5527; EINECS 216-880-6; BRN 0957567; CI 11800; AI3-08835; VX4306NSH1; CHEBI:82475; MFCD00002330; Solvent yellow 7 (4-Phenylazophenol); 4-Phenylazophenol, 97%; 4-(2-phenyldiazen-1-yl)phenol; p-(phenylazo)-phenol; Phenol,4-[(1E)-2-phenyldiazenyl]-; (E)-Azobenzene-4-ol; WLN: QR DNUNR; (Z)-4-Hydroxyazobenzene; 4-Phenylazophenol, 98%; DSSTox_CID_2160; ACMC-209dz7; 4-[Phenyldiazenyl]phenol #; DSSTox_RID_76507; DSSTox_GSID_22160; 2-16-00-00038 (Beilstein Handbook Reference); 4-(phenylhydrazinylidene)cyclohexa-2,5-dien-1-one; MLS001174893; CHEMBL79759; SCHEMBL156633; Phenol,4-(phenylazo)-(E)-; (E)-4-(phenyldiazenyl)phenol; Phenol,4-(2-phenyldiazenyl)-; SCHEMBL2868519; CHEMBL1525953; DTXSID3022160; CTK1A4933; CTK3J3041; DTXSID70942923; NSC3177; BEYOBVMPDRKTNR-BUHFOSPRSA-N; BEYOBVMPDRKTNR-UHFFFAOYSA-N; JTSBGMZPPPULTA-UHFFFAOYSA-N; C.I. Solvent Yellow 7 (8CI); HMS2884D14; NSC-3177; Tox21_202968; ANW-22385; GT7915; SBB000372; ZINC12359059; ZINC13130189; AKOS001086525; ZINC100010401; ZINC100010406; MCULE-1307300768; RTR-007363; NCGC00246007-01; NCGC00260514-01; AS-59786; SMR000588379; ST023475; CAS-1689-82-3; AX8099962; LS-105050; TR-007363; FT-0695214; P0149; X5639; C19433; Q9552900; 4-(2-Phenylhydrazinylidene)cyclohexa-2,5-dien-1-one; NSL; SY7;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H10N2O",
"molecular_weight": "198.22",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "15529",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02087",
"RC02708",
"RC03329"
]
},
{
"compound_ID": "D1064",
"name": "prodiamine",
"synonyms": "Prodiamine; 29091-21-2; Barricade; Marathon; Prodiamine solution; Blockade; Endurance; Kusablock; Factor; Rydex; Barricade (herbicide); Endurance (herbicide); Caswell No. 727A; USB-3153; UNII-IJI5J414Q6; Prodiamine [ANSI:BSI:ISO]; CN-11-2936; EINECS 249-421-3; EPA Pesticide Chemical Code 110201; 2,4-Dinitro-N',N'-dipropyl-6-(trifluoromethyl)benzene-1,3-diamine; BRN 2181386; IJI5J414Q6; CHEBI:82032; 1,3-Diamino-N1,N1-dipropyl-2,6-dinitro-4-trifluoromethylbenzene; RSVPPPHXAASNOL-UHFFFAOYSA-N; 1,3-Benzenediamine, 2,6-dinitro-N1,N1-dipropyl-4-(trifluoromethyl)-; N(sup 3),N(sup 3)-Dipropyl-2,4-dinitro-6-trifluoromethyl-m-phenylenediamine; 2,6-Dinitro-N1,N1-dipropyl-4-trifluoromethyl-m-phenylenediamine; 5-Dipropylamino-alpha,alpha,alpha-trifluoro-4,6-dinitro-o-toluidine; N3,N3-Dipropyl-2,4-dinitro-6-trifluoromethyl-1,3-phenylenediamine; 1,3-Benzenediamine, 2,4-dinitro-N3,N3-dipropyl-6-(trifluoromethyl)-; 2,4-Dinitro-N(sup 3),N(sup 3)-dipropyl-6-(trifluoromethyl)-1,3-benzenediamine; m-PHENYLENEDIAMINE, 2,4-DINITRO-N(sup 3),N(sup 3)-DIPROPYL-6-(TRIFLUOROMETHYL)-; Toluene-2,4-diamine, .alpha.,.alpha.,.alpha.-trifluoro-3,5-dinitro-N4,N4-dipropyl-; 2,4-Dinitro-N3,N3-dipropyl-6-(trifluoromethyl)-1,3-benzenediamine; DSSTox_CID_14210; DSSTox_RID_79123; DSSTox_GSID_34210; SCHEMBL55467; CHEMBL1223140; DTXSID1034210; CTK8G2588; ZINC5315724; Tox21_300694; 2,4-dinitro-3-N,3-N-dipropyl-6-(trifluoromethyl)benzene-1,3-diamine; 2,4-Dinitro-N3,N3-dipropyl-6-(trifluoromethyl)-1,3-benzenediamine (9CI); alpha,alpha,alpha-Trifluoro-3,5-dinitro-N4,N4-dipropyltoluene-2,4-diamine; 1,3-Benzenediamine, 2,4-dinitro-N(sup 3),N(sup 3)-dipropyl-6-(trifluoromethyl)- (9CI); ACM29091212; alpha,alpha,alpha-Trifluoro-3,5-dinitro-N4,N4-dipropyltoluene-2,4-diamine (8CI); NCGC00163862-01; NCGC00163862-02; NCGC00163862-03; NCGC00254602-01; Toluene-2,4-diamine, alpha,alpha,alpha-trifluoro-3,5-dinitro-N(sup 4),N(sup 4)-dipropyl- (8CI); CAS-29091-21-2; DB-047522; LS-105859; FT-0602895; C18884; 091P212; J-017385; Q15841049; di-n-propyl-2,4-dinitro-6-trifluoromethyl-1,3-phenylenediamine; 2,4-dinitro-N3,N3-dipropyl-6-(trifluoromethyl)benzene-1,3-diamine; 2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)benzene-1,3-diamine; 2,6-dinitro-N1,N1-dipropyl-4-(trifluoromethyl)benzene-1,3-diamine; N1,N1-dipropyl-2,6-dinitro-4-(trifluoromethyl)-1,3-benzenediamine; 2-methyl-2-(4-(2-methyl-3-piperidin-1-yl-propyl)-phenyl)-propionic acid; 1,3-Benzenediamine, 2,4-dinitro-N(sup 3),N(sup 3)-dipropyl-6-(trifluoromethyl)-; 1,3-Diamino-N(sup1),N(sup1)-dipropyl-2,6-dinitro-4-(trifluoromethyl)benzene; Prodiamine solution, 10 mug/mL in cyclohexane, PESTANAL(R), analytical standard; Toluene-2,4-diamine, alpha,alpha,alpha-trifluoro-3,5-dinitro-N(sup 4),N(sup 4)-dipropyl-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H17F3N4O4",
"molecular_weight": "350.29",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "34469",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02088",
"RC02709",
"RC03330"
]
},
{
"compound_ID": "D1065",
"name": "profenofos",
"synonyms": "PROFENOFOS; Curacron; 41198-08-7; Selecron; Polycron; (+)-Profenofos; (-)-Profenofos; Caswell No. 266AA; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl ester; CGA 15324; Profenofos [ANSI:BSI:ISO]; O-(4-Bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; HSDB 6992; EINECS 255-255-2; EPA Pesticide Chemical Code 111401; BRN 2150258; AI3-29236; CHEBI:38845; O-(4-Bromo-2-chlorophenyl)-O-ethyl-S-propyl phosphorothioate; QYMMJNLHFKGANY-UHFFFAOYSA-N; o-(4-Bromo-2-chlorophenyl) o-ethyl S-propyl thiophosphate; Profenophos; 4-bromo-2-chloro-1-[ethoxy(propylsulfanyl)phosphoryl]oxybenzene; (R)-O-(4-Bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; (S)-O-(4-Bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl)-O-ethyl S-propyl ester; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl ester, (R)-; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl ester, (S)-; 81123-19-5; o-4-bromo-2-chlorophenyl o-ethyl s-propyl phosphorothioate; O-(4-Bromo-2-chlorophenyl)-O-ethyl-S-propylphosphorothioate; C11H15BrClO3PS; CCRIS 9291; EC 255-255-2; DSSTox_CID_12464; DSSTox_RID_78950; DSSTox_GSID_32464; SCHEMBL25281; Profenofos, analytical standard; CHEMBL2138242; DTXSID3032464; CTK3E8251; Tox21_300752; AKOS015899345; Profenofos 100 microg/mL in Methanol; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl ester (9CI); Profenofos 10 microg/mL in Cyclohexane; NCGC00164297-01; NCGC00164297-02; NCGC00164297-03; NCGC00254657-01; Profenofos 100 microg/mL in Cyclohexane; 81116-98-5; CC-33936; I562; CAS-41198-08-7; DB-049725; LS-108416; LS-108417; LS-108418; FT-0630618; Profenofos, PESTANAL(R), analytical standard; C18404; 198P087; C-21206; Q2111894; UNII-7J04O7BS4W component QYMMJNLHFKGANY-QGZVFWFLSA-N; o-(4-Bromo-2-chlorophenyl) o-ethyl S-propyl thiophosphate #; 4-bromo-2-chloro-1-(ethoxy-propylsulfanyl-phosphoryl)oxy-benzene; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl)-O-ethyl-S-propyl ester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H15BrClO3PS",
"molecular_weight": "373.63",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "38779",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02089",
"RC02710",
"RC03331"
]
},
{
"compound_ID": "D1066",
"name": "proflavin hemisulfate",
"synonyms": "Proflavine sulfate; Proflavine hemisulfate; Isoflav; Proflavin sulfate; 3,6-Diaminoacridine sulfate; Pancridine; Sanoflavin; Proflavine sulfate [NF]; Proflavine sulphate; Proflavin hemisulfate; Proflavine (sulfate); 553-30-0; Neutral proflavine sulphate; 3,6-Acridinediamine sulfate; 3,6-Acridinediamine sulphate; UNII-2961Y60ATP; 1811-28-5; 2,8-Diaminoacridinium sulphate; 3,6-Diaminoacridine bisulphate; CCRIS 5162; NSC 1510; EINECS 209-038-4; 3,6-Diaminoacridine sulphate (1:1); 3,6-Diaminoacridinium monohydrogen sulphate; 2961Y60ATP; NSC-1510; 3,6-Diaminoacridine hemisulfate; 3, sulfate (1:1); ACRIDINE, 3,6-DIAMINO-, SULFATE (1:1); Acridine,6-diamino-, sulfate (1:1); 3,6-Acridinediamine, sulfate (1:1); 3,6-Acridinediamine, sulfate; SCHEMBL380278; CHEMBL1964546; CTK1B2377; DTXSID90203821; NSC1510; NSC6095; HMS3264C21; Pharmakon1600-01504305; NSC-6095; NSC689004; NSC759900; ACRIDINE-3,6-DIAMINE SULFATE; CCG-213924; MCULE-7040675519; NSC-689004; NSC-759900; AK546596; LS-14331; FT-0633854; 3,6-Acridinediamine, sulfate (1:1) (9CI); 3,6-DIAMINOACRIDINE HEMISULFATE HEMIHYDRATE; Q27254392; 3237-53-4;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H13N3O4S",
"molecular_weight": "307.33",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "11111",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02090",
"RC02711",
"RC03332"
]
},
{
"compound_ID": "D1067",
"name": "proflavin hydrochloride",
"synonyms": "952-23-8; acridine-3,6-diamine hydrochloride; 3,6-Diaminoacridine hydrochloride; Proflavine hydrochloride; Proflavine monohydrochloride; Proflavin hydrochloride; Proflavine HCl; 3,6-ACRIDINEDIAMINE, MONOHYDROCHLORIDE; 3,6-DIAMINOACRIDINE HCL; 1,7-Diaminoacridine hydrochloride; EINECS 231-239-0; NSC605756; 3,6-Diaminoacridine monohydrochloride; Acridine, 3,6-diamino-, hydrochloride; 3,6-diaminoacridinium chloride; CHEBI:74718; Proflavine.HCl hemihydrate; UNII-51AA3SI0JM; CCRIS 532; 7459-75-8; NCI-C04137; EINECS 213-459-9; Acridine, 3,6-diamino-, monohydrochloride; acridine-3,6-diamine, chloride; 3,6-Diaminoacridine hydrochloride hemihydrate; 2,8-Diaminoacridinium chloride monohydrochloride; 51AA3SI0JM; diacridine-3,6-diamine dihydrochloride hydrate; proflavine.HCl; 3,6-diaminoacridine.HCl; DSSTox_CID_1191; proflavine monohy drochloride; DSSTox_RID_76001; DSSTox_GSID_21191; SCHEMBL664629; CHEMBL606782; DTXSID8021191; PBBGTVBGXBUVLT-UHFFFAOYSA-N; 3,6-Acridinediamine xhydrochloride; 3,6-Acridinediamine, hydrochloride; proflavine hydrochloride hemihydrate; KS-000011NW; Tox21_200513; 3,6-acridinediamine monohydrochloride; CCG-35221; SBB003182; AKOS015894696; CHM0157601; LS-1998; MCULE-9156937078; NSC-605756; NCGC00258067-01; AK163704; CAS-952-23-8; LS-14323; 3,6-Acridinediamine, hydrochloride (8CI); AX8083027; FT-0699261; ST24045906; ST51015092; 3,6-Diaminoacridine hydrochloride, Dye content 95 %; Q27144855;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H12ClN3",
"molecular_weight": "245.71",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "197873",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02091",
"RC02712",
"RC03333"
]
},
{
"compound_ID": "D1068",
"name": "profluralin",
"synonyms": "PROFLURALIN; Profluraline; Pregard; Tolban; 26399-36-0; Caswell No. 271BB; Profluraline [ISO-French]; CGA 10832; SGA 10832; UNII-36W2L722UX; Profluralin [ANSI:BSI:ISO]; HSDB 3923; Benzenamine, N-(cyclopropylmethyl)-2,6-dinitro-N-propyl-4-(trifluoromethyl)-; EINECS 247-656-6; B 4576; ER5461; EPA Pesticide Chemical Code 106601; BRN 2179006; GA-10832; AI3-62694; CHEBI:82191; 36W2L722UX; N-Cyclopropylmethyl-N-n-propyl-4-trifluoromethyl-2,6-dinitroaniline; N-Cyclopropylmethyl-2,6-dinitro-N-propyl-4-trifluoromethylaniline; N-(Cyclopropylmethyl)-2,6-dinitro-n-propyl-4-(trifluoromethyl)aniline; N-(Cyclopropylmethyl)-2,6-dinitro-N-propyl-4-(trifluoromethyl)benzenamine; N-(Cyclopropylmethyl)-alpha,alpha,alpha-trifluoro-2,6-dinitro-N-propyl-p-toluidine; p-Toluidine, N-(cyclopropylmethyl)-.alpha.,.alpha.,.alpha.-trifluoro-2,6-dinitro-N-propyl-; p-Toluidine, N-(cyclopropylmethyl)-alpha,alpha,alpha-trifluoro-2,6-dinitro-N-propyl-; p-Toluidine, N-(cyclopropylmethyl)-2,6-dinitro-N-propyl-alpha,alpha,alpha-trifluoro-; DSSTox_CID_24559; DSSTox_RID_80312; DSSTox_GSID_44559; SCHEMBL54045; CHEMBL1256764; DTXSID2044559; ITVQAKZNYJEWKS-UHFFFAOYSA-N; ZINC5315716; Tox21_301566; ER 5461; NCGC00255881-01; CG-10832; CAS-26399-36-0; LS-154347; C19065; Profluralin, PESTANAL(R), analytical standard; J-016410; Q15632821; N-cyclopropylmethyl-2,6-dinitro -N-propyl-4-(trifluoromethyl)benzenamine;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H16F3N3O4",
"molecular_weight": "347.29",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "33500",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02092",
"RC02713",
"RC03334"
]
},
{
"compound_ID": "D1069",
"name": "propan-2-yl (2r,4s)-4-{acetyl[3,5-bis(trifluoromethyl)benzyl]amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2h)-carboxylate",
"synonyms": "",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "X",
"molecular_weight": "X",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "X",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02093",
"RC02714",
"RC03335"
]
},
{
"compound_ID": "D1070",
"name": "propyl gallate",
"synonyms": "propyl gallate; 121-79-9; Propyl 3,4,5-trihydroxybenzoate; N-Propyl gallate; Tenox PG; Progallin P; Nipagallin P; Gallic acid, propyl ester; Gallic acid propyl ester; NIPA 49; Benzoic acid, 3,4,5-trihydroxy-, propyl ester; 3,4,5-Trihydroxybenzene-1-propylcarboxylate; 3,4,5-Trihydroxybenzoic acid propyl ester; Propylester kyseliny gallove; n-Propyl ester of 3,4,5-trihydroxybenzoic acid; n-Propyl 3,4,5-trihydroxybenzoate; FEMA No. 2947; Pro gallin P; Gallic acid n-propyl ester; NSC 2626; 3,4,5-Trihydroxybenzoic acid, propyl ester; NCI-C505888; 3,4,5-Trihydroxybenzoic acid n-propyl ester; UNII-8D4SNN7V92; CCRIS 541; Nipanox S 1; HSDB 591; Propyl gallate (NF); Propyl gallate [NF]; Propyl gallate, 98%; EINECS 204-498-2; Propylester kyseliny gallove [Czech]; CHEMBL7983; Gallic acid, n-propyl ester; E310; AI3-17136; 8D4SNN7V92; CHEBI:10607; NSC2626; ZTHYODDOHIVTJV-UHFFFAOYSA-N; NSC-2626; MFCD00002196; NCGC00164234-01; AK-94176; DSSTox_CID_1201; DSSTox_RID_76009; DSSTox_GSID_21201; Q-201634; Gallate, Propyl; CAS-121-79-9; n-Propyl-3,4,5-Trihydroxybenzoate; Propylgallate; propyl-gallate; Propyl galiate; n-propyl-gallate; Sustane PG; Propylgallate,(S); Propyl Gallate FCC; Propyl gallate, powder; ACMC-209ahq; Gallic acid-propyl ester; 3,4,5-Trihydroxy-benzoic acid propyl ester; Gallic acid propyl esterZ; Oprea1_580415; SCHEMBL22630; CBDivE_013134; KSC175K3P; BIDD:ER0334; Propyl 3,5-trihydroxybenzoate; WLN: QR BQ CQ EVO3; INS NO.310; DTXSID5021201; CTK0H5537; FEMA 2947; KS-00000GZF; n-Propyl 3,5-trihydroxybenzoate; Propyl gallate, >=98%, FCC; INS-310; NCI-C50588; BCP13340; ZINC1532172; Tox21_113531; Tox21_202286; Tox21_300060; ANW-17868; BDBM50032154; CP0103; LS-655; s5113; SBB060377; AKOS001603853; ANGC-121-79-9; CCG-207932; DB12450; MCULE-2693876364; OR70180; RTR-034741; NCGC00164234-02; NCGC00164234-03; NCGC00164234-04; NCGC00254138-01; NCGC00259835-01; 3,5-Trihydroxybenzene-1-propylcarboxylate; 3,5-Trihydroxybenzoic acid, propyl ester; AC-11365; AS-11986; BI141962; NCI60_002094; Propyl gallate, USP, 98.0-102.0%; SC-19600; AX8149297; DB-003766; TR-034741; Benzoic acid,4,5-trihydroxy-, propyl ester; E-310; EU-0036319; FT-0626599; G0018; ST24031571; ST50307922; n-Propyl ester of 3,5-trihydroxybenzoic acid; A19435; C11155; D02382; J10100; M-5795; Propyl gallate, antioxidant, >=98.0% (HPLC); Q608726; SR-01000944710; Propyl gallate, for microscopy, >=98.0% (HPLC); SR-01000944710-1; EFFF5FFA-651C-4DE3-A25F-D807C65D5537; Propyl gallate, European Pharmacopoeia (EP) Reference Standard; Propyl gallate, United States Pharmacopeia (USP) Reference Standard; Propyl gallate, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C10H12O5/c1-2-3-15-10(14)6-4-7(11)9(13)8(12)5-6/h4-5,11-13H,2-3H2,1H;",
"trade_name": "",
"abbrev_name": "",
"description": "ester formed by the condensation of gallic acid and propanol; antioxidant has been added to foods containing oils and fats to prevent oxidation.",
"molecular_formula": "C10H12O5",
"molecular_weight": "212.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "4947",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F01",
"F0108"
],
"references": [
"RC02094",
"RC02715",
"RC03336",
"RC03972"
]
},
{
"compound_ID": "D1071",
"name": "propylparaben",
"synonyms": "PROPYLPARABEN; Propyl 4-hydroxybenzoate; 94-13-3; Propyl paraben; 4-Hydroxybenzoic acid propyl ester; Propyl p-hydroxybenzoate; Nipasol; Nipazol; Propyl parahydroxybenzoate; Propyl Butex; Betacide P; n-Propyl 4-hydroxybenzoate; Propylparasept; Propagin; Chemacide pk; Chemocide pk; N-Propyl p-hydroxybenzoate; Propyl Parasept; Aseptoform P; Propyl Chemosept; Protaben P; Tegosept P; Propyl aseptoform; Nipagin P; Nipasol P; Solbrol P; Paraben; Paseptol; p-Hydroxypropyl benzoate; Preserval P; Betacine P; Bonomold OP; Nipasol M; p-Hydroxybenzoic acid propyl ester; p-Hydroxybenzoic propyl ester; Parasept; N-Propylparaben; 4-Hydroxybenzoic acid, propyl ester; Propyl-4-hydroxybenzoate; Propyl chemsept; Propyl-paraben; Benzoic acid, 4-hydroxy-, propyl ester; n-propyl paraben; Caswell No. 714; Benzoic acid, p-hydroxy-, propyl ester; FEMA Number 2951; Pulvis conservans (VAN); UNII-Z8IX2SC1OH; Chemoside PK; Lexgard P; Pulvis conservans; p-Hydroxybenzoic acid, propyl ester; FEMA No. 2951; HSDB 203; n-PROPYL-p-HYDROXYBENZOATE; propyl 4-oxidanylbenzoate; p-Oxybenzoesaurepropylester [German]; EINECS 202-307-7; MFCD00002354; NSC 23515; Z8IX2SC1OH; EPA Pesticide Chemical Code 061203; BRN 1103245; AI3-01341; MLS002152934; CHEBI:32063; Propylester kyseliny p-hydroxybenzoove [Czech]; QELSKZZBTMNZEB-UHFFFAOYSA-N; NSC23515; p-Hydroxybenzoic acid n-propyl ester; NCGC00090965-03; NCGC00090965-04; SMR000112070; DSSTox_CID_2527; WLN: QR DVO3; DSSTox_RID_76614; DSSTox_GSID_22527; Propyl 4-hydroxybenzoate, 99+%; Propyl 4-hydroxybenzoate, >=99%; Bayer D 206; CAS-94-13-3; Propylparaben [USAN]; p-Oxybenzoesaurepropylester; Propylparaben [USAN:NF]; 4-Hydroxybenzoic acid propylester; Propylparaben (NF); Propylester kyseliny p-hydroxybenzoove; Propylparaben, USAN; ACMC-209rqc; 85403-59-4; Propylis parahydroxybenzoas; propyl para-hydroxybenzoate; SCHEMBL977; p-Oxybenzoesaeurepropylester; EC 202-307-7; cid_7175; n-propyl-p-hydroxy-benzoate; 4-10-00-00374 (Beilstein Handbook Reference); KSC489Q5P; MLS002222346; MLS006011654; BIDD:ER0229; Propyl-4-Hydroxybenzoate,(S); CHEMBL194014; Propyl parahydroxybenzoate (TN); DTXSID4022527; BDBM70190; CTK3I9857; KS-00000GZK; NSC8511; 4-Hydroxybenzoic acid-propyl ester; HMS2268K21; Propyl 4-hydroxybenzoate, BioXtra; Propyl parahydroxybenzoate (JP17); HY-N2026; NSC-8511; PROPYL PARA HYDROXY BENZOATE; ZINC1586788; Tox21_111048; Tox21_400012; 4-hydroxybenzoic acid n-propyl ester; ANW-40210; BBL023754; NSC-23515; s5405; SBB015060; STL294815; 4-Hydroxybenzoic acid, n-propyl ester; AKOS008948099; component of Heb-Cort MC (Salt/Mix); DB14177; DS-3427; LS-1958; MCULE-6661199693; RTR-029455; TRA0042844; NCGC00090965-01; NCGC00090965-02; NCGC00090965-05; NCGC00090965-06; AK106260; E216; K713; ST075003; TR-029455; CS-0018518; FT-0618698; P1955; ST24049048; T8305; D01422; A844839; Propyl 4-hydroxybenzoate, p.a., 99.0-100.5%; Propyl Parahydroxybenzoate 0.01 mg/ml in Methanol; Propyl Parahydroxybenzoate 1.0 mg/ml in Methanol; Q511627; 4-Arm PEG-OMs, 95%, average M.W. 20,000; Q-201635; Propyl 4-hydroxybenzoate, SAJ first grade, >=98.0%; Propyl 4-hydroxybenzoate, tested according to Ph.Eur.; Propyl 4-hydroxybenzoate, Vetec(TM) reagent grade, 98%; Propylparaben, certified reference material, TraceCERT(R); UNII-AZF98361GV component QELSKZZBTMNZEB-UHFFFAOYSA-N; 4-Hydroxybenzoic acid-propyl ester 100 microg/mL in Acetonitrile; Propylparaben, United States Pharmacopeia (USP) Reference Standard; Propyl parahydroxybenzoate, European Pharmacopoeia (EP) Reference Standard; Propylparaben, Pharmaceutical Secondary Standard; Certified Reference Material; 36M; InChI=1/C10H12O3/c1-2-7-13-10(12)8-3-5-9(11)6-4-8/h3-6,11H,2,7H2,1H;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C10H12O3",
"molecular_weight": "180.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "7175",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [
"T001",
"T002",
"T408"
],
"function": [
"F0108",
"F0201",
"F0303"
],
"references": [
"RC02095",
"RC02716",
"RC03337",
"RC04110",
"RC04234",
"RC04358",
"RC04482",
"RC04606"
]
},
{
"compound_ID": "D1072",
"name": "proscillaridin",
"synonyms": "proscillaridin; Proscillaridin A; 466-06-8; Caradrin; UNII-KC6BL281EN; Proscillaridine; Scillacrist; Cardiovite; Procardin; Sandoscill; Talusin; KC6BL281EN; Proscilardyna; Proscillan; Proslladin; Caradrine; Cardion; Carmazon; Coratol; Procilan; Prostosin; Proszin; Protasin; Solestril; Stellarid; Talucard; Tradenal; Urgilan; Wirnesin; Simeon; Herzo; Herzo proscillan; Purosin-TC; Desgluco-transvaalin; Scillarenin-rhamnose; Transvaalin, degluco-; Proscilardyna [Polish]; Proscillaridina; Proscillaridina [DCIT]; DSSTox_CID_3532; Scillarenin 3beta-rhamnoside; DSSTox_RID_77066; DSSTox_GSID_23532; Proscilaridina [INN-Spanish]; Proscillaridine [INN-French]; Proscillaridinum [INN-Latin]; Scillarenin 3-beta-rhamnoside; Scillarenin-rhamnose [German]; PSC-801; Proscilaridina; Proscillaridinum; A-32686; NSC 7521; Scilla didier; EINECS 207-370-4; Talusin (TN); Proscillaridin [USAN:INN:BAN:JAN]; Scillarenin, 3alpha-L-rhamnopyranoside; (3beta)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide; Scillarenin, 3-alpha-L-rhamnopyranoside; Rhamnopyranoside, scillarenin-3, alpha-L-; Bufa-4,20,22-trienolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3beta)-; Proscillaridin (JAN/USAN/INN); 14-Hydroxy-3-beta-(rhamnosyloxy)bufa-4,20,22-trienolide; 14-Hydroxy-3beta-(rhamnosyloxy)bufa-4,20,22-trienolide; 3-beta,14-beta-Dihydroxybufa-4,20,22-trienolide 3-rhamnoside; 3-beta-Rhamnosido-14-beta-hydroxy-delta(sup 4,20,22)-bufatrienolide; ((6-Deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxybufa-4,20,22-trienolide; Proscillaridine A; 3-beta-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxybufa-4,20,22-trienolide; Bufa-4,20,22-trienolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3-beta)-; Bufa-4,20,22-trienolide, 3-beta-((6-deoxy-alpha-L-mannosyl)oxy)-14-hydroxy-; NCGC00016447-01; CAS-466-06-8; C12816; SCHEMBL123759; CHEMBL600325; DTXSID5023532; CHEBI:32065; MYEJFUXQJGHEQK-ALRJYLEOSA-N; HMS3715E13; HY-N2331; ZINC8214665; Tox21_110442; Tox21_110442_1; API0015855; CCG-220986; DB13307; NCGC00344555-01; CS-0021123; Q7250550;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C30H42O8",
"molecular_weight": "530.6",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5284613",
"classification": "C",
"indications": "",
"side_effects": "",
"atc_codes": "C01AB01; C01AB51",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02096",
"RC02717",
"RC03338"
]
},
{
"compound_ID": "D1073",
"name": "pyraclostrobin",
"synonyms": "Pyraclostrobin; 175013-18-0; Pyraclostrobine; Methyl (2-(((1-(4-chlorophenyl)-1H-pyrazol-3-yl)oxy)methyl)phenyl)(methoxy)carbamate; Headline; Cabrio; UNII-DJW8M9OX1H; Pyraclostrobin [ISO:BSI]; DJW8M9OX1H; CHEBI:78780; Pyrachlostrobin; methyl [2-({[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}methyl)phenyl]methoxycarbamate; methyl N-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-N-methoxycarbamate; HSDB 7497; DSSTox_CID_12638; DSSTox_RID_79017; Methyl N-(2-(1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl)phenyl)-(N-methoxy)carbamate; DSSTox_GSID_32638; SCHEMBL18441; CHEMBL519873; DTXSID7032638; CTK8C1356; HZRSNVGNWUDEFX-UHFFFAOYSA-N; DNDI1724943; ZINC2511853; Tox21_301130; 9060AA; ANW-66330; AKOS015895785; KS-0000016W; methyl N-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-N-methoxy-carbamate; NCGC00163895-01; NCGC00163895-02; NCGC00163895-03; NCGC00163895-04; NCGC00255029-01; AC-27490; ACM175013180; LS-49173; AX8149586; Pyraclostrobin 10 microg/mL in Acetonitrile; RT-015160; 4CH-024111; CAS-175013-18-0; FT-0654374; C18561; 013P180; Pyraclostrobin, PESTANAL(R), analytical standard; J-011054; Q1961265; Carbamic acid, (2-(((1-(4-chlorophenyl)-1H-pyrazol-3-yl)oxy)methyl)phenyl)methoxy-, methyl ester; Carbamic acid, N-[2-[[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]phenyl]-N-methoxy-, methyl ester;",
"trade_name": "",
"abbrev_name": "",
"description": "carbamate ester; fungicide; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic; a methoxycarbanilate strobilurin antifungal agent and a carbanilate fungicide",
"molecular_formula": "C19H18ClN3O4",
"molecular_weight": "387.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "6422843",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T004"
],
"function": [
"F0108",
"F020403"
],
"references": [
"RC02097",
"RC02718",
"RC03339",
"RC04951"
]
},
{
"compound_ID": "D1074",
"name": "pyridate",
"synonyms": "Pyridate; 55512-33-9; Lentagran; Fenpyrate; Pyron; Tough; Caswell No. 716A; Pyridate [BSI:ISO]; UNII-JQH131LU0A; CL 11344; O-(6-Chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate; EINECS 259-686-7; P1 3419; EPA Pesticide Chemical Code 128834; BRN 0759528; JQH131LU0A; O-(6-Chloro-3-phenyl-4-pyridazinyl) S-octyl carbonothioate; Pyridat; CHEBI:81971; CARBONOTHIOIC ACID, O-(6-CHLORO-3-PHENYL-4-PYRIDAZINYL) S-OCTYL ESTER; (6-chloro-3-phenylpyridazin-4-yl) octylsulfanylformate; Carbonothioic acid, O-(6-chloro-3-phenyl-4-pyridizinyl) S-octyl ester; Pyridat, analytical standard; o-(6-Chloro-3-phenyl-4-pyridazinyl) S-octyl thiocarbonate; DSSTox_CID_12639; DSSTox_RID_79018; DSSTox_GSID_32639; SCHEMBL53240; CHEMBL3186929; DTXSID2032639; JTZCTMAVMHRNTR-UHFFFAOYSA-N; ZINC2555391; Tox21_301247; NCGC00255286-01; LS-52224; CAS-55512-33-9; DB-052749; Pyridat, PESTANAL(R), analytical standard; FT-0630683; C18803; 512P339; C-21304; Q1809267; O-6-chloro-3-phenylpyridazin-4-yl S-octyl carbonothioate;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C19H23ClN2O2S",
"molecular_weight": "378.9",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "41463",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02098",
"RC02719",
"RC03340"
]
},
{
"compound_ID": "D1075",
"name": "pyrinuron",
"synonyms": "Pyrinuron; PYRIMINIL; Pyriminyl; Vacor; 53558-25-1; One Time; Pyrinuron [ANSI]; 1-(3-Pyridylmethyl)-3-(4-nitrophenyl)urea; 1-(4-Nitrophenyl)-3-(3-pyridylmethyl)urea; Caswell No. 718B; DLP 787; UNII-Q7BGS137YP; RH-787; N-(4-Nitrophenyl)-N'-(3-pyridinylmethyl)urea; N-3-Pyridylmethyl-N'-p-nitrophenylurea; Urea, N-(4-nitrophenyl)-N'-(3-pyridinylmethyl)-; HSDB 6460; EINECS 258-626-7; EPA Pesticide Chemical Code 104501; BRN 0490322; Q7BGS137YP; Urea, 1-nitrophenyl-3-(3-pyridylmethyl)-; 1-(4-nitrophenyl)-3-(pyridin-3-ylmethyl)urea; 1-(4-Nitrophenyl)-N'-(3-pyridinylmethyl)urea; CLKZWXHKFXZIMA-UHFFFAOYSA-N; DSSTox_CID_22360; DSSTox_RID_80005; DSSTox_GSID_42360; 5-22-09-00313 (Beilstein Handbook Reference); MLS001232711; SCHEMBL146250; CHEMBL1528242; DTXSID1042360; HMS2968P19; ZINC5224211; Tox21_302252; STK494478; AKOS003356375; 3-pyridylmethyl-3-(4-nitrophenyl)urea; MCULE-9179018016; N-3-pyridylmethyl-N'-p-nitrophenyl urea; NCGC00247371-01; NCGC00255836-01; AC-12692; SMR000678267; CAS-53558-25-1; DB-052359; LS-160572; FT-0630661; ST50877271; N-(4-nitrophenyl)-N'-(3-pyridylmethyl)-urea; Q7263605; [(4-nitrophenyl)amino]-N-(3-pyridylmethyl)carboxamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H12N4O3",
"molecular_weight": "272.26",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "40813",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02099",
"RC02720",
"RC03341"
]
},
{
"compound_ID": "D1076",
"name": "pyrvinium pamoate",
"synonyms": "Pyrvinium pamoate; 3546-41-6; Pyrvinium embonate; Viprynium embonate; Vanquin; Pyrvinium pamoate salt hydrate; NSC 223622; Vermitibier; Vanquil; NCGC00017042-01; 4-[(3-carboxylato-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylate;2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine; Vipyrvinium embonate; CAS-3546-41-6; Dipyrivinium Pamoate; Povan (TN); DSSTox_CID_3545; DSSTox_RID_77072; DSSTox_GSID_23545; SCHEMBL62130; Pyrvinium pamoate (JAN/USP); CHEBI:8688; CHEMBL1908377; DTXSID4023545; C75H70N6O6; HY-A0293; Tox21_110753; BDBM50198749; CS-6311; AS-56860; X7305; D00489; SR-01000872694; SR-01000872694-1; (E)-2-(2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)vinyl)-6-(dimethylamino)-1-methylquinolin-1-ium 4,4'-methylenebis(3-hydroxy-2-naphthoate); 4-[(3-carboxylato-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylate; 2-[(E)-2-(2,5-dimethyl-1-phenyl-pyrrol-3-yl)vinyl]-N,N,1-trimethyl-quinolin-1-ium-6-amine; 6-(Dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylate] (2:1)-quinolinium; bis{6-(dimethylamino)-2-[(E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methylquinolinium} 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylate);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C75H70N6O6",
"molecular_weight": "1151.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "54680693",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02100",
"RC02721",
"RC03342"
]
},
{
"compound_ID": "D1077",
"name": "quercetin",
"synonyms": "quercetin; 117-39-5; Sophoretin; Meletin; Xanthaurine; Quercetine; Quercetol; Quercitin; Quertine; 3,3',4',5,7-Pentahydroxyflavone; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; Flavin meletin; 3,5,7,3',4'-Pentahydroxyflavone; Cyanidelonon 1522; T-Gelb bzw. grun 1; C.I. Natural Yellow 10; Quercetin content; Kvercetin; Quertin; C.I. Natural red 1; Kvercetin [Czech]; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; Natural Yellow 10; C.I. 75670; CI Natural Yellow 10; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-; 3',4',5,7-Tetrahydroxyflavan-3-ol; C.I. Natural yellow 10 & 13; NSC 9219; CCRIS 1639; HSDB 3529; Flavone, 3,3',4',5,7-pentahydroxy-; NCI-C60106; UNII-9IKM0I5T1E; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; Cyanidenolon 1522; CHEBI:16243; AI3-26018; NSC9219; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; CHEMBL50; EINECS 204-187-1; BRN 0317313; 9IKM0I5T1E; CI 75670; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; REFJWTPEDVJJIY-UHFFFAOYSA-N; NSC-9219; AK106169; DSSTox_CID_1218; DSSTox_RID_76017; DSSTox_GSID_21218; QUE; Q-200333; BRD9794; BRD-9794; CAS-117-39-5; NSC57655; NSC58588; NSC-57655; SR-01000076098; MixCom3_000183; C.I . natural yellow 10; Ritacetin; Quer; 4dfu; 4mra; Quercetin2H2O; KUC104418N; KUC107684N; 3,3',4,5,7-Pentahydroxyflavone; LIM-5662; LNS-5662; TNP00070; TNP00089; KSC-23-76; Quercetin(Sophoretin); Quercetin_sathishkumar; KSC-10-126; Quercetin (Sophoretin); Quercetin - Sophoretin; Spectrum_000124; Tocris-1125; 3cf8; BiomolKI_000062; Maybridge1_008992; Prestwick0_000507; Prestwick1_000507; Prestwick2_000507; Prestwick3_000507; Spectrum2_000059; Spectrum3_000642; Spectrum4_000807; Spectrum5_001389; Lopac-Q-0125; P0042; C.I. natural yellow 13; BiomolKI2_000068; Enicostemma Littorale Blume; UPCMLD-DP081; Q 0125; NCIOpen2_007628; NCIOpen2_007882; BIDD:PXR0007; Lopac0_000999; SCHEMBL19723; BSPBio_000433; BSPBio_001068; BSPBio_002243; KBioGR_000408; KBioGR_001293; KBioSS_000408; KBioSS_000584; 5-18-05-00494 (Beilstein Handbook Reference); KSC497C4F; MLS006011766; BIDD:ER0315; DivK1c_000485; SCHEMBL219729; SPECTRUM1500672; CU-01000012502-3; SPBio_000217; SPBio_002354; BDBM7460; BPBio1_000477; GTPL5346; MEGxp0_000381; SGCUT00001; 3,4',5,7-Pentahydroxyflavone; DTXSID4021218; NIOSH/LK8760000; UPCMLD-DP081:001; ACon1_000560; CTK3J7142; HMS501I07; KBio1_000485; KBio2_000408; KBio2_000584; KBio2_002976; KBio2_003152; KBio2_005544; KBio2_005720; KBio3_000775; KBio3_000776; KBio3_001463; 3,7,3',4'-Pentahydroxyflavone; NINDS_000485; 3',5,7-Tetrahydroxyflavan-3-ol; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; Bio1_000369; Bio1_000858; Bio1_001347; Bio2_000374; Bio2_000854; HMS1362F09; HMS1792F09; HMS1923O19; HMS1990F09; HMS3263G19; HMS3267M12; HMS3414J21; HMS3649D04; HMS3656C15; HMS3678J19; to_000078; ZINC3869685; 3,5,7,3',4'-Pentahydroxyflavon; Tox21_202308; Tox21_300285; Tox21_500999; ANW-73134; BBL005513; BS0155; CCG-40054; CQ0011; Flavone,3',4',5,7-pentahydroxy-; GP9232; LMPK12110004; LS-589; MFCD00006828; NSC 57655; NSC324608; s2391; SBB012521; STK365650; Quercetin, >=95% (HPLC), solid; 3,4',5,5',7-pentahydroxy-Flavone; AKOS000511724; CS-3981; DB04216; DS-3416; EBD2197934; LP00999; MCULE-2433372790; NUT0000107; RTX-012622; IDI1_000485; IDI1_002129; KS-0000021G; LDN 0052529; LDN-0052529; SMP1_000252; Flavone, 3,4',5,5',7-pentahydroxy-; NCGC00015870-01; NCGC00015870-02; NCGC00015870-03; NCGC00015870-05; NCGC00015870-06; NCGC00015870-07; NCGC00015870-08; NCGC00015870-09; NCGC00015870-10; NCGC00015870-11; NCGC00015870-12; NCGC00015870-13; NCGC00015870-14; NCGC00015870-15; NCGC00015870-16; NCGC00015870-17; NCGC00015870-18; NCGC00015870-19; NCGC00015870-21; NCGC00015870-22; NCGC00015870-23; NCGC00015870-24; NCGC00025016-01; NCGC00025016-02; NCGC00025016-03; NCGC00025016-04; NCGC00025016-05; NCGC00025016-06; NCGC00025016-07; NCGC00025016-08; NCGC00168962-01; NCGC00168962-02; NCGC00168962-03; NCGC00168962-04; NCGC00254218-01; NCGC00259857-01; NCGC00261684-01; 4CN-0923; 74893-81-5; AC-19596; AC-29756; HY-18085; LS-69030; NCI60_042036; S295; SC-25667; SMR000112559; ST024706; ST057237; SY057722; (+)-3,3',4',5,7-Pentahydroxyflavone; Quercetin, Sophoretin, Meletin, Quercetine; AX8030401; EU-0100999; FT-0603318; FT-0655108; LK87600000; N1841; Q0025; ST24039236; SW148203-4; Quercetin; 3,3',4',5,7-Pentahydroxyflavone; 17Q395; A-8821; C00389; K00029; S00057; WLN: T66 BO EVJ CR CQ DQ & DQ GQ IQ; Flavone, 3,3',4',5,7-pentahydroxy-, (+)-; Q409478; SR-01000076098-1; SR-01000076098-3; SR-01000076098-7; SR-01000076098-8; BRD-K97399794-001-02-1; BRD-K97399794-001-07-0; BRD-K97399794-001-09-6; BRD-K97399794-001-11-2; BRD-K97399794-335-03-1; SR-01000076098-11; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromone;hydrate; 49643640-FD4C-4B93-BD28-0D7C2021CC52; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one #; (+)-4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-; 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, zirconium(2+) salt (1:1);",
"trade_name": "",
"abbrev_name": "",
"description": "plant flavonol from the flavonoid group of polyphenols",
"molecular_formula": "C15H10O7",
"molecular_weight": "302.23",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5280343",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [
"T019",
"T205"
],
"function": [
"F0108",
"F02010203",
"F02010204",
"F02010205",
"F02010207",
"F020103",
"F02110301",
"F030802"
],
"references": [
"RC01329",
"RC01330",
"RC01331",
"RC01332",
"RC01333",
"RC01438",
"RC01439",
"RC01440",
"RC01441",
"RC01442",
"RC01443",
"RC01444",
"RC01445",
"RC01446",
"RC01447",
"RC02101",
"RC02722",
"RC03343",
"RC03562",
"RC03756",
"RC03757"
]
},
{
"compound_ID": "D1078",
"name": "quercetin dihydrate",
"synonyms": "Quercetin dihydrate; 6151-25-3; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one dihydrate; Quercetine dihydrate; CCRIS 3304; Quercetin (dihydrate); UNII-53B03V78A6; 3,3',4',5,7-Pentahydroxyflavone dihydrate; MFCD00149487; Quercetin dihydrate (Sophoretin); Flavone, 3,3',4',5,7-pentahydroxy-, dihydrate; 53B03V78A6; NCGC00017056-01; AK101905; CAS-6151-25-3; DSSTox_CID_1219; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; DSSTox_RID_76018; DSSTox_GSID_21219; C15H14O9; Quercetin, Dihydrate; Quercetin,(S); Prestwick_541; PubChem19976; ACMC-20a8z6; 3,3′,4′,5,7-Pentahydroxyflavone; SCHEMBL22103; BMK1-G2; KSC919I6H; Quercetin-dihydrate(Sophoretin); CHEMBL1520590; DTXSID9021219; Quercetin dihydrate - Sophoretin; CTK8B9463; BIK9012; HMS1569F15; HMS2096F15; HMS3403F09; HMS3656A09; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one;dihydrate; BCP07318; HY-N0146; KS-00000Q7H; ZX-AT015955; Tox21_110761; Tox21_201150; ANW-62560; GP1387; s2347; SBB058176; 2-(3,4-dihydroxyphenyl)-3,5,7-; AKOS004910448; Tox21_110761_1; trihydroxy-4H-chromen-4-one dihydrate; CCG-208320; LS-1471; NUT0000108; OR17030; RTR-021187; TRA0050187; NCGC00015870-27; NCGC00258702-01; AS-13663; H655; AB0013168; AX8233444; CS-0007880; FT-0082527; FT-0601606; ST24021688; ST50309238; SW148203-5; J10072; A833274; Q27261093; F0001-1629; QUERCETIN DIHYDRATE (SEE ALSOQUERCETIN (117-39-5)); 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyran-4-one dihydrate; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one, hydrate, hydrate; 2-[3,4-bis(oxidanyl)phenyl]-3,5,7-tris(oxidanyl)chromen-4-one dihydrate; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one, oxamethane, oxamethane; Sophoretin, Meletin, Quercetine, Xanthaurine, Quercetol, Quercitin, 6151-25-3; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Dihydrate (Quercetin Dihydrate); 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 3,3′,4′,5,7-Pentahydroxyflavone dihydrate;",
"trade_name": "",
"abbrev_name": "",
"description": "flavonoid",
"molecular_formula": "C15H14O9",
"molecular_weight": "338.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5284452",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02102",
"RC02723",
"RC03344"
]
},
{
"compound_ID": "D1079",
"name": "rac benidipine hydrochloride",
"synonyms": "benidipine hydrochloride; 91599-74-5; BENIDIPINE HCl; Benidipine (hydrochloride); C28H31N3O6.HCl; (+-)-Benidipine hydrochloride; rac Benidipine hydrochloride; Benidipine (+-)-alpha-form hydrochloride; KW 3049; (-)-alpha-Benidipine hydrochloride; 105979-17-7; KW-3049; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl (3R)-1-(phenylmethyl)-3-piperidinyl ester, monohydrochloride, (4R)-rel-; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 1-(phenylmethyl)-3-piperidinyl ester, monohydrochloride, (R*,R*)-(+-)-; 129262-07-3; NCGC00185768-01; Benidipine hydrochloride [JAN]; Coniel R; Benidipine (+-)-alpha-form HCl; Coniel (TN); DSSTox_CID_28976; DSSTox_RID_83241; DSSTox_GSID_49050; MLS001401418; SCHEMBL349506; CHEMBL2359165; CHEMBL3190257; DTXSID2049050; Benidipine hydrochloride (JP17); CTK8F7953; KS-00000XIL; BCPP000347; (R)-3-((R)-1-Benzylpiperidin-3-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 1-(phenylmethyl)-3-piperidinyl ester, monohydrochloride, (R-(R*,R*))-; HY-B1448; Tox21_113598; s2017; AKOS015895638; BCP9000391; CCG-100952; CCG-221233; CS-5152; NC00202; AS-14293; CPD002529677; K668; SAM001246672; SC-76102; SMR000469192; BCP0726000287; Benidipine hydrochloride, >=98% (HPLC); AB2000423; CAS-91599-74-5; LS-131303; LS-131304; SW197582-2; D02045; 599B745; Q27236529; UNII-0A6746FWDL component KILKDKRQBYMKQX-MIPPOABVSA-N; 1-(BENZYLMETHYL)-3-PIPERIDINYL 1,4-DIHYDRO-2,6-DIM; (+/-)-(r)-3-[(r)-1-benzyl-3-piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride; (3R)-1-Benzyl-3-piperidinyl methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate hydrochloride (1:1); 3-((R)-1-benzylpiperidin-3-yl) 5-methyl (R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride; 5-O-[(3R)-1-benzylpiperidin-3-yl] 3-O-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate,hydrochloride;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C28H32ClN3O6",
"molecular_weight": "542",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "656667",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02103",
"RC02724",
"RC03345"
]
},
{
"compound_ID": "D1080",
"name": "rafoxanide",
"synonyms": "RAFOXANIDE; 22662-39-1; Disalan; Ranide; Flukanide; Bovanide; Duofas; Ranide, veterinary; 3'-Chloro-4'-(4-chlorophenoxy)-3,5-diiodosalicylanilide; MK-990; Rafoxanidum [INN-Latin]; Rafoxanida [INN-Spanish]; UNII-22F4FLA7DH; C19H11Cl2I2NO3; NSC 355278; N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide; 3'-Chloro-4'-(p-chlorophenoxy)-3,5-diiodosalicylanilide; EINECS 245-148-9; BRN 2228187; 22F4FLA7DH; AI3-29020; Salicylanilide, 3'-chloro-4'-(p-chlorophenoxy)-3,5-diiodo-; Benzamide, N-(3-chloro-4-(4-chlorophenoxy)phenyl)-2-hydroxy-3,5-diiodo-; NSC355278; 3'-Chlor-4'-(4-chlorphenoxy)-3,5-diiodsalicylanilid; NCGC00160556-01; DSSTox_CID_26227; DSSTox_RID_81454; DSSTox_GSID_46227; Rafoxanida; Rafoxanidum; Rafoxanid; CAS-22662-39-1; Rafoxanide [USAN:BAN:INN]; Rafoxanide [USAN:INN:BAN]; N-(3-Chloro-4-(4-chlorophenoxy)phenyl)-2-hydroxy-3,5-diiodobenzamide; N-[3-chloro-4-(4-chlorophenoxy)phenyl](2-hydroxy-3,5-diiodophenyl)carboxamide; Rafoxanide Vetranal; MK 990; Rafoxanide (USAN/INN); Salicylanilide,5-diiodo-; MLS001240273; SCHEMBL118031; CHEMBL287542; DTXSID5046227; CTK8D3904; NEMNPWINWMHUMR-UHFFFAOYSA-N; HMS2233M19; BCP15963; N-(3-chloro-4-(4-chlorophenoxy); ZINC4181896; Tox21_111896; BDBM50022832; SBB085183; STK377482; AKOS003631075; N-[3-Chloro-4-(4-chloro-phenoxy)-phenyl]-2-hydroxy-3,5-diiodo-benzamide; N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodo-benzamide; Tox21_111896_1; CS-3979; KS-1309; MCULE-1434675659; NSC-355278; phenyl)-2-hydroxy-3,5-diiodobenzamide; VA11646; WLN: QR BI DI FVMR CG DOR DG; KS-000014F1; NCGC00160556-02; AC-20061; AK546620; CC-34209; HY-17598; I010; SC-14160; SMR000768692; ST011974; DB-045962; LS-144185; TC-064021; FT-0630489; R0108; S5093; Rafoxanide, PESTANAL(R), analytical standard; D05693; 662R391; C-23377; J-014804; Q12048733; 3'-Chloro-4'-(p-chlorophenoxy)-3, 5-diiodosalicylanilide; 3,5-diiodo-3'-chloro-4'-(p-chlorophenoxy)-salicylanilide; 3'-CHLORO-4'-(4-CHLOROPHENOXY)-3,5-DIIODOSALICYLAN; 3-CHLORO-4-(4-CHLOROPHENOXY)-3,5-DIIODOSALICYLANILIDE; Benzamide, {N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,} 5-diiodo-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C19H11Cl2I2NO3",
"molecular_weight": "626",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "31475",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02104",
"RC02725",
"RC03346"
]
},
{
"compound_ID": "D1081",
"name": "raloxifene",
"synonyms": "raloxifene; 84449-90-1; Keoxifene; Raloxifenum [Latin]; Raloxifeno [Spanish]; Raloxifenum; Raloxifeno; Raloxifene [INN:BAN]; LY 139481; LY-139481; UNII-YX9162EO3I; Optruma; CCRIS 7129; HSDB 7460; CHEMBL81; (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone; (6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone; C28H27NO4S; CHEBI:8772; YX9162EO3I; RAL; GZUITABIAKMVPG-UHFFFAOYSA-N; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone; Methanone, [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-; LY-156758; 2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol; Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-; NCGC00015889-05; CAS-82640-04-8; Pharoxifene; Raloxifene, 6; [2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methanone; [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl]{4-[(2-piperidin-1-ylethyl)oxy]phenyl}methanone; Raloxifene (INN); Eviden (TN); Raxeto (TN); Prestwick0_000862; Prestwick1_000862; Prestwick2_000862; Prestwick3_000862; Lopac-R-1402; DSSTox_CID_3550; SCHEMBL6144; DSSTox_RID_77076; DSSTox_GSID_23550; Lopac0_001051; BSPBio_000903; KBioGR_002361; KBioSS_002364; BIDD:ER0216; BIDD:GT0795; SPBio_002824; BPBio1_000995; GTPL2820; DTXSID3023550; BDBM19441; KBio2_002361; KBio2_004929; KBio2_007497; KBio3_002840; cid_11071264; cMAP_000032; HMS2089F06; HMS3742O11; ZINC538275; BCP09772; Tox21_202603; NSC747974; s5781; AKOS015896267; AC-8399; API0003075; CCG-205128; DB00481; MCULE-4598311006; NSC-747974; [6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone; 2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol; MRF-0000684; SMP2_000095; NCGC00015889-01; NCGC00015889-02; NCGC00015889-04; NCGC00015889-06; NCGC00015889-07; NCGC00015889-08; NCGC00015889-10; NCGC00092353-02; NCGC00092353-04; NCGC00260151-01; [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; AS-35086; CC-34210; J22.982B; LY139481; SC-17311; SBI-0051021.P002; AB0073011; CAS-84449-90-1; LS-177821; FT-0630926; VU0155042-3; C07228; D08465; 15189-EP2270008A1; 15189-EP2272825A2; 15189-EP2280012A2; 15189-EP2281815A1; 15189-EP2289892A1; 15189-EP2292615A1; 15189-EP2292617A1; 15189-EP2295426A1; 15189-EP2295427A1; 15189-EP2301928A1; 15189-EP2301933A1; 15189-EP2305640A2; 15189-EP2305671A1; 15189-EP2308855A1; 15189-EP2311808A1; 15189-EP2311825A1; 15189-EP2311827A1; 15189-EP2311829A1; 15189-EP2311840A1; 15189-EP2311842A2; 15189-EP2314581A1; 15189-EP2316832A1; 15189-EP2316833A1; 449R901; C-22734; Q425223; BRD-K63828191-003-11-5; 6-hydroxy-2-(4-hydoxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene; 6-hydroxy-2-(4-hydoxyphenyl)-3[-4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene; 6-Hydroxy-2-(4-Hydroxyphenyl)-3-[4(2-Piperidinoethoxy)benzoyl]benzo[b]thiophene; 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]-thiophene; 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene; 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2piperidinoethoxy)-benzoyl]benzo[b]thiophene; 6-hydroxy-2-(4-hydroxyphenyl)-3[-4-(2-piperidinoethoxy)benzoyl]benzo [b]thiophene; 6-hydroxy-2-(4-hydroxyphenyl)-3[-4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene; 6-hydroxy-2-(4-hydroxyphenyl)-3[-4-(2piperidinoethoxy)benzoyl]benzo[b]thiophene; 6-hydroxy-2-(4-hyroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene; [6-Hydroxy-2-(4-hydroxy-phenyl)-benzo[b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone; [6-hydroxy-2-(4-hydroxyphenyl)benzo-[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1piperidinyl)ethoxy]phenyl]methanone; 6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl methanone;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C28H27NO4S",
"molecular_weight": "473.6",
"state": "solid",
"clearance": "Following intravenous administration, raloxifene was shown to be cleared at a rate approximating hepatic blood flow. The apparent oral clearance is reported to be 44.1 L/kgxhr. The clearance can range from 40 to 60L/kgxhr following chronic dosing. In healthy postmenopausal women receiving multiple oral dose, the mean clearance was 47.4 L/kgxhr. Apparent clearance can be reduced by 56% in patients with hepatic impairment.[label]",
"volume_of_distribution": "Following oral administration of single doses randing from 30 to 150 mg in postmenopausal women, the volume of distribution was about 2348 L/kg. Following oral administration of multiple doses, the value increased to 2853 L/kg. Raloxifene is widely distributed in the tissues. It is not known whether raloxifene is excreted in human milk.[label]",
"route_of_elimination": "Raloxifene predominantly undergoes fecal excretion, with less than 0.2% of the dose being excreted in the urine as unchanged form of the compound and less than 6% of the dose being excreted as glucuronide conjugates. Co-administration with [cholestyramine], a bile acid sequestrant, was shown to reduce the enterohepatic recycling of raloxifene by 60%.[T28]",
"protein_binding": "About 95% of raloxifene and its glucuronide metabolites are bound to plasma proteins.[label] Although this is a relatively high protein binding profile, _in vitro_ studies suggest that raloxifene and its metabolites do not significantly interact with binding of highly protein-bound drugs.[A4977] FDA Label still advises patients to use raloxifene with caution co-administering with other highly protein-bound drugs.[label]",
"half_life": "The average plasma elimination half-life of raloxifene ranges from 27 to 32 hours.[A4977,T28] The prolonged half-life has been attributed to the drug's reversible systemic metabolism and significant enterohepatic cycling.[A4977]",
"absorption": "Raloxifene is well absorbed from the gastrointestinal tract, with approximately 60% fo the drug being absorbed following oral administration.[T28] Due to the extensive first-pass hepatic metabolism that involves glucuronide conjugation, the absolute oral bioavailability of raloxifene is about 2%.[T28] Following oral ingestion of a single dose or multiple dose of raloxifen in healthy postmenopausal women, the mean peak plasma concentrations (Cmax) were 0.50 and 1.36 ng/mL, respectively, and the AUC values were 27.2 and 24.2 ngxhr/mL, respectively. The time to reach Cmax following a single or multiple oral doses were 27.7 and 32.5 hours, respectively.[label] Although not clinically significant, oral ingestion of raloxifene with high-fat meals is thought to increase the systemic bioavailability of the drug[A4977] by increasnig the peak plasma concentrations (Cmax) and AUC by 28% and 16%, respectively.[label]",
"cid": "5035",
"classification": "G",
"indications": "",
"side_effects": "",
"atc_codes": "G03XC01",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02105",
"RC02726",
"RC03347"
]
},
{
"compound_ID": "D1082",
"name": "raloxifene hydrochloride",
"synonyms": "RALOXIFENE HYDROCHLORIDE; 82640-04-8; Raloxifene Hcl; Evista; Keoxifene hydrochloride; Keoxifene; (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride; LY 156758; Raloxifene (hydrochloride); UNII-4F86W47BR6; C28H27NO4S.HCl; LY156758; CHEBI:50740; Evista (Raloxifene Hydrochloride); 4F86W47BR6; Optruma; LY-156758; 6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride; C28H28ClNO4S; DSSTox_CID_14181; DSSTox_RID_79119; DSSTox_GSID_34181; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride; 2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol hydrochloride; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride; Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride; SMR000058508; NCGC00015889-05; CAS-82640-04-8; Loxifen; SR-01000076102; Keoxifene HCl; CDT-Raloxifene; Raloxifene hydrochloride [USAN]; Evista (TN); Prestwick_1035; Raloxifene hydrochloride [USAN:USP]; Methanone, hydrochloride; LY156758 hydrochloride; Study Drug, raloxifene HCI; CHEMBL1116; SCHEMBL19077; MLS000859902; MLS001332533; MLS001332534; MLS002222293; Raloxifene hydrochloride, solid; Evista, Raloxifene hydrochloride; DTXSID1034181; LY156758 (Keoxifene) HCl; CTK7J9865; KS-00000JPS; LY-139481 HCl; BKXVVCILCIUCLG-UHFFFAOYSA-N; HMS1570N05; Pharmakon1600-01505622; BCP05713; Raloxifene hydrochloride (JAN/USP); Tox21_110255; Tox21_302369; Tox21_501051; ANW-54600; HY-13738A; MFCD01938233; NSC706725; NSC759285; s1227; AKOS008131940; Tox21_110255_1; AC-8390; CCG-213497; CS-1775; DS-2162; KS-1102; LP01051; MCULE-7336063262; NC00665; NSC-706725; NSC-759285; VA11647; NCGC00015889-03; NCGC00015889-11; NCGC00092353-01; NCGC00092353-03; NCGC00094334-01; NCGC00094334-02; NCGC00255153-01; NCGC00261736-01; 2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol hydrochloride; 4CA-1076; AK-54611; CPD000058508; LS-91271; SAM002548975; SC-20043; AB0020647; TC-063566; EU-0101051; FT-0630912; R0109; ST24020666; SW197106-5; V1611; EN300-52517; D02217; J90021; M-8965; R 1402; 68523-EP2270008A1; 68523-EP2292617A1; 68523-EP2298768A1; 68523-EP2308855A1; 640R048; Q-201656; SR-01000076102-2; SR-01000076102-9; Q27122215; Raloxifene hydrochloride, European Pharmacopoeia (EP) Reference Standard; Raloxifene Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Raloxifene hydrochloride, United States Pharmacopeia (USP) Reference Standard; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride; [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(piperidin-1-yl)ethoxy]phenyl}methanone--hydrogen chloride (1/1); [6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride; [6-Hydroxy-2-(4-hydroxyphenyl)benzo [b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone Hydrochloride; [6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride; [6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride; [6-hydroxy-2[4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride; 1-[2-(4-{[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]carbonyl}phenoxy)ethyl]piperidinium chloride; 6-hydroxy-2-(4-hydroxyphenyl)-3-[ 4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene, hydrochloride; 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]-thiophene hydrochloride; 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]thiophene hydrochloride; 6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl methanone hydrochloride; 6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl ketone hydrochloride; Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl) (4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride; Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-,hydrochloride (1:1); Raloxifene hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C28H28ClNO4S",
"molecular_weight": "510",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "54900",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02106",
"RC02727",
"RC03348"
]
},
{
"compound_ID": "D1083",
"name": "riboflavin",
"synonyms": "riboflavin; vitamin B2; Lactoflavin; Riboflavine; 83-88-5; Vitamin G; Lactoflavine; (-)-riboflavin; Beflavin; Beflavine; Flavaxin; Ribocrisina; Riboflavina; Vitaflavine; Flaxain; Lactobene; Ribipca; Riboderm; Ribosyn; Ribotone; Ribovel; Vitamin Bi; Flavin BB; Vitasan B2; Riboflavinum; HYRE; Russupteridine Yellow III; 7,8-Dimethyl-10-ribitylisoalloxazine; 6,7-Dimethyl-9-D-ribitylisoalloxazine; E101; Riboflavinequinone; Riboflavine [INN-French]; Riboflavinum [INN-Latin]; Riboflavina [INN-Spanish]; Dermadram; Fiboflavin; Hyflavin; HSDB 817; Aqua-Flave; UNII-TLM2976OFR; CCRIS 1904; CHEBI:17015; 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine; C17H20N4O6; 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione; EINECS 201-507-1; NSC 33298; Riboflavin (Vitamin B2); TLM2976OFR; AI3-14697; Isoalloxazine, 7,8-dimethyl-10-D-ribityl-; AUNGANRZJHBGPY-SCRDCRAPSA-N; 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol; D-Ribitol, 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo(g)pteridin-10(2H)-yl)-; MFCD00005022; DSSTox_CID_1777; Isoalloxazine, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-; 1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol; DSSTox_RID_76321; DSSTox_GSID_21777; 1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol; 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione; 7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione; Riboflavin (Vit B2); Benzo(g)pteridine-2,4(3H,10H)-dione, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-; Riboflavin [USP:INN:BAN]; Riboflavin [USAN:INN:JAN]; NSC-33298; 1kyv; 2ccb; 2vxa; ()-Riboflavin; San Yellow B; CAS-83-88-5; NCGC00017291-05; Bisulase (TN); 13123-37-0; Food Yellow 15; Prestwick_442; Riboflavin-Vitamin-B2; Vitamin B2;E101; 2fl5; 2vx9; 4d1y; Prestwick3_000634; Epitope ID:161730; SCHEMBL7706; CHEMBL1534; BSPBio_000628; MLS001066391; BPBio1_000692; GTPL6578; Riboflavin (JP17/USP/INN); RIBOFLAVINE; VITAMIN B2; DTXSID8021777; BIR0613; INS NO. 101(I); ZX-AFC000568; (-)-Riboflavin, 97-103%; HMS2096P10; Benzo[g]pteridine riboflavin deriv.; HY-B0456; Riboflavin(B2);7,8-Dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione; ZINC2036848; Tox21_110813; Tox21_111714; Tox21_201633; Tox21_302980; 6,7-Dimethyl-9-ribitylisoalloxazine; BDBM50362895; s2540; Riboflavin (B2), analytical standard; Tox21_111714_1; CS-2567; DB00140; LS-2192; NCI-0033298; NCGC00091288-01; NCGC00091288-02; NCGC00091288-03; NCGC00091288-05; NCGC00179498-01; NCGC00256408-01; NCGC00259182-01; AS-15936; R437; SMR000112236; AB0008077; AB2000637; ST2413784; R0020; (-)-Riboflavin, tested according to Ph.Eur.; C00255; D00050; Y-9791; (-)-Riboflavin, meets USP testing specifications; A840676; Q130365; (-)-Riboflavin, from Eremothecium ashbyii, >=98%; (-)-Riboflavin, acrylamide photopolymerization tested; Riboflavin, European Pharmacopoeia (EP) Reference Standard; Riboflavin, United States Pharmacopeia (USP) Reference Standard; Riboflavin, Pharmaceutical Secondary Standard; Certified Reference Material; 5-deoxy-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol; 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzo[g]pteridine-2,4(3H,10H)-dione; Riboflavin for peak identification, European Pharmacopoeia (EP) Reference Standard; (-)-Riboflavin (Vitamin B2) solution, 100 mug/mL (Methanol:0.1% Ammonium acetate in Water (1:1)), ampule of 1 mL, analytical standard; (-)-Riboflavin, 100 mug/mL (1% ammonium acetate in 50:50 methanol:water), certified reference material, ampule of 1 mL; (-)-Riboflavin, BioReagent, suitable for cell culture, suitable for insect cell culture, >=98%; (-)-Riboflavin-13C4,15N2 (Vitamin B2-13C4,15N2) solution, 100 mug/mL (1% ammonium acetate in 50:50 methanol:water), certified reference material, ampule of 1 mL; 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione; 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrakis(oxidanyl)pentyl]benzo[g]pteridine-2,4-dione; InChI=1/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H20N4O6",
"molecular_weight": "376.4",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "0.6",
"half_life": "66-84 minutes",
"absorption": "Vitamin B2 is readily absorbed from the upper gastrointestinal tract.",
"cid": "493570",
"classification": "S; A",
"indications": "",
"side_effects": "",
"atc_codes": "S01XA26; A11HA04",
"group": "Drug",
"drug_type": "",
"target": [
"T001",
"T002",
"T408"
],
"function": [
"F0108",
"F0201",
"F0303"
],
"references": [
"RC02109",
"RC02730",
"RC03351",
"RC04115",
"RC04239",
"RC04363",
"RC04487",
"RC04611"
]
},
{
"compound_ID": "D1084",
"name": "rifampicin",
"synonyms": "Rifampicin; rifampin; Rifadin; Rimactane; Rimactan; Rifamycin AMP; 13292-46-1; Rifaldazine; Rifaprodin; Riforal; Tubocin; Rifa; Rifampicinum; Archidyn; Rifoldin; Rifoldine; Rimactizid; Rifagen; Rimazid; Rifampicin SV; R/AMP; Arficin; Benemicin; Doloresum; Eremfat; Fenampicin; Rifadine; Rifaldazin; Rifaldin; Rifamor; Rifinah; Rifobac; Rimactazid; Sinerdol; Arzide; Rifcin; Rifam; L-5103 Lepetit; Dione 21-acetate; Rifampicine [French]; Rifampicina; Abrifam; Rifampicinum [INN-Latin]; Ba 41166/E; Rifampicina [INN-Spanish]; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; CCRIS 551; Rifadin I.V.; Rifater; HSDB 3181; UNII-VJT6J7R4TR; BA-41166E; NSC113926; VJT6J7R4TR; NSC-113926; Rifampicine; Rifampicin [INN:BAN:JAN]; Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-; RFP; CHEBI:28077; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; L-5103; C43H58N4O12; EINECS 236-312-0; NSC 113926; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-; Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-; DSSTox_CID_1244; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; DSSTox_RID_76035; DSSTox_GSID_21244; RIF; Benemycin; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate; CAS-13292-46-1; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; rifamcin; [1,11,13]trienimino)naphto[2,1-b]furan-21-yl acetate; Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-; JQXXHWHPUNPDRT-WLSIYKJHSA-N; Rifamsolin; Dipicin; Rimycin; Famcin; Rifamicin AMP; Rifadin I.V; Rimactane (TN); NCGC00094777-01; AZT + Rifampin; Rifampin (USP); (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acet; (2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; [pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate; Rifampicin & EEP; Rifampin [USAN]; Prestwick_833; R-Cin; Rifadin (TN); Piperine & Rifampicin; Rifampicin & Propolis; Reserpine & Rifampicin; Rifampin [USAN:USP]; Prestwick2_000525; Prestwick3_000525; Spectrum5_002018; Rifampicin (JP17/INN); SCHEMBL23490; BSPBio_000509; L-5103-LEPETIT; 8CI); BPBio1_000561; CHEMBL374478; DTXSID6021244; HMS1569J11; HMS2089F12; HMS2096J11; HMS3713J11; DRG-0109; Rifampicin, >=97.0% (HPLC); Rifampicin, powder, gamma-irradiated; Tox21_111329; Tox21_201385; Tox21_300550; Ba 41166; BDBM50370232; GR-306; MFCD00151389; NIH-10782; AKOS015951372; Rifampicin, >=97% (HPLC), powder; Tox21_111329_1; BA-411661E; CCG-208267; DB01045; LS-7689; NCGC00022678-03; NCGC00022678-04; NCGC00022678-05; NCGC00022678-06; NCGC00179536-02; NCGC00254537-01; NCGC00258936-01; M880; ST057531; AB1009526; C06688; D00211; J10110; Rifampicin, VETRANAL(TM), analytical standard; AB00383022_07; 292R461; SR-05000002118; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; SR-05000002118-3; WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; Rifampicin, European Pharmacopoeia (EP) Reference Standard; Rifampin, United States Pharmacopeia (USP) Reference Standard; Rifampin, Pharmaceutical Secondary Standard; Certified Reference Material; 4,7>.0<5,28>]triaconta-1(28),2,4,9,1 9,21,25(29),26-octaen-13-yl acetate; Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline; yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl ac; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11- methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino] methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1 (28),2,4,9,19,21,25(29),26-octaen-13-yl acetate; 2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate; 2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth; 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate; 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (; 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (8CI); 26-[(1E)-2-(4-methylpiperazinyl)-2-azavinyl](7S,11S,13S,17S,18S,12R,14R,15R,16 R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-d ioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate; 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate; RMP; Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C43H58N4O12",
"molecular_weight": "822.9",
"state": "solid",
"clearance": "* 0.19 +/- 0.06 L/hr/kg [300 mg IV]\n* 0.14 +/- 0.03 L/hr/kg [600 mg IV]",
"volume_of_distribution": "",
"route_of_elimination": "Less than 30% of the dose is excreted in the urine as rifampin or metabolites.",
"protein_binding": "0.89",
"half_life": "3.35 (+/- 0.66) hours",
"absorption": "Well absorbed from gastrointestinal tract.",
"cid": "135398735",
"classification": "J",
"indications": "",
"side_effects": "",
"atc_codes": "J04AM07; J04AB02; J04AM05; J04AM02; J04AM06",
"group": "Drug",
"drug_type": "",
"target": [
"T001",
"T002",
"T408"
],
"function": [
"F0108",
"F0201",
"F0303"
],
"references": [
"RC02110",
"RC02731",
"RC03352",
"RC04116",
"RC04240",
"RC04364",
"RC04488",
"RC04612"
]
},
{
"compound_ID": "D1085",
"name": "rifapentine",
"synonyms": "RIFAPENTINE; Priftin; 61379-65-5; Cyclopentylrifampicin; Rifapentin; Priftin (TN); Rifamycin AF/ACPP; CHEBI:45304; MDL 473; MDL-473; 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin; DL 473; KTC 1; UNII-XJM390A33U; XJM390A33U; Cyclopentyl rifampin; DL-473; R-773; R 77-3; Rifapentina; Rifapentinum [Latin]; Rifapentina [Spanish]; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; Antibiotic DL 473IT; DL 473;Cyclopentylrifampicin; MDL473; 3-(N-(4-Cyclopentyl-1-piperazinyl)formimidoyl)rifamycin; 3-[N-(4-Cyclopentyl-1-piperazinyl)formimidoyl]rifamycin; Rifapentinum; C47H64N4O12; DRG-0283; EINECS 262-743-9; NCGC00167431-01; Rifapentine (USAN/INN); 3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV; CHEMBL1660; DSSTox_CID_21115; DSSTox_RID_79627; KTC-1; DSSTox_GSID_41115; SCHEMBL41590; ANTIBIOTIC DL-473IT; Rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-; Rifapentine [USAN:INN:BAN]; DTXSID8041115; DL473; HMS3713M16; Tox21_112435; BDBM50248298; AKOS024255723; CCG-220467; DB01201; KS-1409; CAS-61379-65-5; C08059; D00879; J90035; R-77-3; AB01209744-01; AB01209744-03; AB01209744_04; 379R655; M000473; Rifapentine, Antibiotic for Culture Media Use Only; W-105162; (2R,16S,17R,18R,19R,20S,21S,22S,23S)-8-{[(4-CYCLOPENTYLPIPERAZIN-1-YL)IMINO]METHYL}-5,6,9,17,19-PENTAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA[1,11,13]TRIENOIMINO)NAPHTHO[2,1-B]FURAN-21-YL ACETATE; 3-(((4-CYCLOPENTYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate; [[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl] acetate; 1279038-35-5; RPE;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C47H64N4O12",
"molecular_weight": "877",
"state": "solid",
"clearance": "* Apparent Oral cl=2.51 +/- 0.14 L/h [Male tuberculosis patients who received 600 mg rifapentine in combination with isoniazid, pyrazinamide and ethambutol]\n* Apparent Oral cl=1.69 +/- 0.41 L/h [Female tuberculosis patients who received 600 mg rifapentine in combination with isoniazid, pyrazinamide and ethambutol]",
"volume_of_distribution": "* 70.2 ± 9.1 L",
"route_of_elimination": "Following a single 600 mg oral dose of radiolabeled rifapentine to healthy volunteers (n=4), 87% of the total 14C rifapentine was recovered in the urine (17%) and feces (70%).",
"protein_binding": "97.7% (bound to plasma proteins)",
"half_life": "",
"absorption": "Rapidly and well absorbed from the gastrointestinal tract.",
"cid": "135403821",
"classification": "J",
"indications": "",
"side_effects": "",
"atc_codes": "J04AB05",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02111",
"RC02732",
"RC03353"
]
},
{
"compound_ID": "D1086",
"name": "rimonabant",
"synonyms": "Rimonabant; 168273-06-1; Acomplia; 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide; Zimulti; SR141716; SR 141716; SR141716A; UNII-RML78EN3XE; A 281; SR-141716A; RML78EN3XE; CHEMBL111; Rimonabant (SR141716); SR-141716; Rimoslim; CHEBI:34967; JZCPYUJPEARBJL-UHFFFAOYSA-N; 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide; NCGC00164572-01; [3H]SR141716A; [3H]RIMONABANT; 5-(p-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide; DSSTox_CID_26453; DSSTox_RID_81627; DSSTox_GSID_46453; 5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID PIPERIDIN-1-YLAMIDE; Rimonabant [USAN:INN]; Acomplia (TN); N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide; SMR003500713; CAS-168273-06-1; Rimonabant (JAN/USAN/INN); Rimonabant [USAN:INN:JAN]; 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide; SR141,716A; rimonabant-sr141716; Rimonabant - from sample; Rimonabant(SR141716); SCHEMBL38637; GTPL743; MLS004774043; MLS006011772; PYR405; DTXSID3046453; BDBM21278; CTK8E8269; KS-00000NTG; EX-A688; HMS3604M05; HMS3657O15; BCP07803; ZINC1540228; Tox21_112200; AC-731; BBL030198; GP8358; s3021; STK642500; AKOS005266728; Tox21_112200_1; AM84578; API0004077; CS-0645; DB06155; MCULE-7311256045; RTR-007307; SB19549; 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(1-piperidyl)pyrazole-3-carboxamide; 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-n-piperidinopyrazole-3-carboxamide; NCGC00164572-02; AK-61012; AS-37280; BR-61012; CC-34263; HY-14136; SR-14171; AB0056959; AC-163720; DB-011649; LS-128155; ST2418566; TR-007307; 4CH-015711; B1429; FT-0631194; SW220167-1; 81R131; A11547; C14319; D05731; S-3507; AB01566860_01; 143881-EP2287165A2; 143881-EP2287166A2; 143881-EP2292620A2; A810956; C-22624; L000572; Q412529; SR-01000884001; J-010440; SR-01000884001-1; 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(1-piperidinyl)-3-pyrazolecarboxamide; 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-pyrazole-3-carboxamide; 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidino-1H-pyrazole-3-carboxamide; N-piperidino-5-(4-chlorophenyl)-1(2,4-dichlorophenyl)-4-methyl-pyrazole-3-carboxamide; N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazolecarboxamide; 1H-Pyrazole-3-carboxamide,5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-; 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide; AY6;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C22H21Cl3N4O",
"molecular_weight": "463.8",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "Almost 100%",
"half_life": "6 to 9 days with normal BMI and 16 days if BMI is greater than 30",
"absorption": "Undetermined",
"cid": "104850",
"classification": "A",
"indications": "",
"side_effects": "",
"atc_codes": "A08AX01",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108",
"F02010203"
],
"references": [
"RC01291",
"RC01305",
"RC02112",
"RC02733",
"RC03354"
]
},
{
"compound_ID": "D1087",
"name": "rolicyclidine",
"synonyms": "ROLICYCLIDINE; PCPy; 1-(1-Phenylcyclohexyl)pyrrolidine; 2201-39-0; Roliciclidina; Rolicyclidinum; Pyrrolidine, 1-(1-phenylcyclohexyl)-; UNII-183O9O9JE3; CHEBI:60805; 183O9O9JE3; NCGC00160464-01; Rolicyclidinum [INN-Latin]; Roliciclidina [INN-Spanish]; DEA No. 7458; Pyrrolidine analog of phencyclidine; Rolicyclidine [INN]; PCP pyrrolidine analog; DSSTox_CID_26167; DSSTox_RID_81398; DSSTox_GSID_46167; SCHEMBL517928; CHEMBL1719398; DTXSID8046167; HSDB 7636; FYOWWXMGDATDQY-UHFFFAOYSA-N; 1-(1-phenylcyclohexyl)-pyrrolidine; ZINC1481918; Tox21_111832; Pyrrolidine, 1-(1-phenylcyclohexyl); DB01549; CAS-2201-39-0; ZINC000001481918; 1-(1-phenylcyclohexyl)pyrrolidine (Rolicyclidine); Q570183;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H23N",
"molecular_weight": "229.36",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "62436",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02113",
"RC02734",
"RC03355"
]
},
{
"compound_ID": "D1088",
"name": "salicylanilide",
"synonyms": "SALICYLANILIDE; 87-17-2; 2-Hydroxy-N-phenylbenzamide; N-Phenylsalicylamide; Salinide; Salicylanilid; Salifebrin; Salinidol; Ansadol; Salicylic acid anilide; Salnide; Benzamide, 2-hydroxy-N-phenyl-; Aseptolan; Hyanilid; Shirlan; o-Hydroxybenzanilide; Shirlan Extra; Sherstat SLN; Shirlan AG; 2-Hydroxybenzanilide; 2-N-Phenylcarboxamidophenol; Shirlan (VAN); Caswell No. 730; Anilid kyseliny salicylove; UNII-LHP8NEY345; NSC 14881; 2-Hydroxy-N-phenyl-benzamide; WR 10019; Anilid kyseliny salicylove [Czech]; EINECS 201-727-8; EPA Pesticide Chemical Code 077407; BRN 1108135; LHP8NEY345; AI3-08114; ASK; CHEBI:239133; WKEDVNSFRWHDNR-UHFFFAOYSA-N; MFCD00002212; (2-hydroxyphenyl)-N-benzamide; Salicylanilide [NF]; Salicylanilide [NF XIII]; Salicylanilide, 98%; PubChem22916; ACMC-209qib; SpecPlus_000935; WLN: QR BVMR; Spectrum5_000937; CBMicro_016731; DSSTox_CID_1784; 2-Phenylaminocarbonylphenol; Cambridge id 5305868; DSSTox_RID_76325; DSSTox_GSID_21784; Oprea1_853375; 4-12-00-00906 (Beilstein Handbook Reference); KSC490G4P; MLS000105638; CHEMBL82970; DivK1c_007031; SCHEMBL152221; ZINC2057; DTXSID7021784; SCHEMBL14051034; CTK3J0347; KBio1_001975; 2-Hydroxy-N-phenylbenzamide (1); BDBM234300; HMS2091A21; HMS2401B23; HMS3652N07; Pharmakon1600-00300618; CCG-5616; HY-B1408; NSC14881; Tox21_301301; ANW-38625; NSC-14881; NSC755836; s4187; SBB056703; STL477629; AKOS000119673; CS-7965; MCULE-5347120160; NE10154; NSC-755836; RTR-031112; TRA0061215; WR10019; CAS-87-17-2; KS-0000172L; NCGC00076924-01; NCGC00257535-01; AK112784; S359; SMR000102616; BIM-0016643.P001; SBI-0016643.P004; LS-144182; TR-031112; FT-0690167; FT-0690183; S0007; ST24022263; ST50308512; SW219188-1; C18915; AB00053159_10; AB00053159_11; Q3469751; W-104040; BRD-K83036479-001-04-3; Z68084595; InChI=1/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9,15H,(H,14,16; SLI;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H11NO2",
"molecular_weight": "213.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "6872",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02115",
"RC02736",
"RC03357"
]
},
{
"compound_ID": "D1089",
"name": "selenious acid",
"synonyms": "SELENIOUS ACID; Selenous acid; 7783-00-8; Selenious acid (H2SeO3); Monohydrated selenium dioxide; UNII-F6A27P4Q4R; Selenium dioxide, monohydrated; CCRIS 5530; HSDB 6065; Selenious acid [USP]; EINECS 231-974-7; F6A27P4Q4R; CHEBI:26642; Selenious acid (USP); Selenious acid, 98%; Selenium, Reference Standard Solution; selenige Saeure; Selenite ion(2-); dihydroxidooxidoselenium; Selenous acid, 98%; Selenite (SeO32-); DSSTox_CID_4300; Selenite ion (SeO32-); EC 231-974-7; NCIMech_000026; Selenous acid, Puratronic?; DSSTox_RID_77360; DSSTox_GSID_24300; [SeO(OH)2]; CHEMBL2009089; DTXSID9024300; CTK2H8628; selenious acid,selenous acid,monohydrated selenium dioxide; MCAHWIHFGHIESP-UHFFFAOYSA-N; Selenous acid, p.a., 95.0%; Tox21_200407; CCG-35433; MFCD00011331; AKOS015960374; DB11127; UN-3283; VZ36877; KS-0000193L; NCGC00248596-01; NCGC00257961-01; NCI60_003085; CAS-7783-00-8; LS-144800; TR-024855; Selenous acid, 99.999% trace metals basis; D05814; Selenious acid, 99.999%, (trace metal basis); Q413722;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "H2O3Se",
"molecular_weight": "128.99",
"state": "solid",
"clearance": "",
"volume_of_distribution": "Following oral intake and absorption, selenium from sodium selenite is found in the highest concentrations in the liver and kidneys of humans and animals [L1924].\n\nIn one study, tissue samples taken at autopsy from 46 healthy individuals killed in accidents and from 75 corpses of victims of various diseases to analyze selenium levels and distribution [A32296]. The per-weight-unit basis of selenium levels ng/gm in wet in tissues decreased in the following order: kidney (469) > liver > spleen > pancreas > heart > brain > lung > bone > skeletal muscle. The highest proportion of body selenium was found in skeletal muscles (27.5%) [A32296], [L1985]. Significantly less selenium was measured in bones (16%) and blood (10%). In the tissues of cancer corpses, the selenium levels were lower than levels in the control group. The lowest selenium concentrations were measured in alcoholic livers [A32296].",
"route_of_elimination": "Selenium is eliminated mainly in the urine. However, significant endogenous losses through the feces can also occur [L1984]. The rate of excretion varies with the chemical form of selenium used in supplementation and the route of administration. Other minor routes of elimination are lungs and skin [L1922].\n\nAnalysis of 72-hour urine sampling from a study of 48 Norwegian women given a 200 μg supplement of selenium in the form of selenite indicated approximately 50% absorption of selenite [L1924].",
"protein_binding": "",
"half_life": "30 days in beagle dogs [L1910].",
"absorption": "The absorption of selenite following oral administration approximately 40-70% of an oral dose, based on studies done in humans [L1924].\n\nSelenoprotein P, the plasma form of selenium, contains at least 40% of the total selenium in plasma [L1987]. Deletion of the gene for selenoprotein P in mouse models alters the distribution of selenium in body tissues suggesting that selenoprotein P is necessary for selenium transport [A32296].",
"cid": "1091",
"classification": "A",
"indications": "",
"side_effects": "",
"atc_codes": "A12CE02",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02116",
"RC02737",
"RC03358"
]
},
{
"compound_ID": "D1090",
"name": "siduron",
"synonyms": "SIDURON; 1-(2-Methylcyclohexyl)-3-phenylurea; Tupersan; Trey; 1982-49-6; Du Pont herbicide 1,318; Du Pont 1318; Urea, N-(2-methylcyclohexyl)-N'-phenyl-; Caswell No. 733A; N-Phenyl-N'-(2-methylcyclohexyl)urea; DuPont 1318; Urea, 1-(2-methylcyclohexyl)-3-phenyl-; 1-(2-Methylcycohexyl)-3-phenylurea; Siduron [ANSI:BSI:ISO]; H 1318; NSC 131951; HSDB 1764; EINECS 217-844-2; EPA Pesticide Chemical Code 035509; N-(2-Methylcyclohexyl)-N'-phenylurea; CHEBI:81744; DSSTox_CID_12474; DSSTox_RID_78952; DSSTox_GSID_32474; SCHEMBL66323; WLN: L6TJ AMVMR& B1; CHEMBL1902120; DTXSID7032474; CTK8E3001; JXVIIQLNUPXOII-UHFFFAOYSA-N; Tox21_301425; MFCD00072453; NSC131951; AKOS001192124; NSC-131951; NCGC00163937-01; NCGC00163937-02; NCGC00255363-01; N-(2-Methylcyclohexyl)-N'-phenylurea #; CAS-1982-49-6; LS-160460; Siduron, PESTANAL(R), analytical standard; TR-009206; ST51026952; C18435; N-(2-methylcyclohexyl)(phenylamino)carboxamide; UREA,N-(2-METHYLCYCLOHEXYL)-N'-PHENYL-; Urea, N-(2-methylcyclohexyl)-N'-phenyl- (9CI); Q27155591;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H20N2O",
"molecular_weight": "232.32",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16116",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02117",
"RC02738",
"RC03359"
]
},
{
"compound_ID": "D1091",
"name": "silwet l77",
"synonyms": "Silwet L77; DSSTox_CID_20611; DSSTox_RID_79511; DSSTox_GSID_40611; CHEMBL3186439; Tox21_301769; NCGC00255664-01; CAS-27306-78-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C19H46O4Si3",
"molecular_weight": "422.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "60196421",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02118",
"RC02739",
"RC03360"
]
},
{
"compound_ID": "D1093",
"name": "sodium (4-fluoro-2-{[(1s)-1-phenylpropyl]carbamoyl}phenyl)(quinolin-8-ylsulfonyl)azanide",
"synonyms": "",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "X",
"molecular_weight": "X",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "X",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Others",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02120",
"RC02741",
"RC03362"
]
},
{
"compound_ID": "D1094",
"name": "sodium 2-phenylphenate tetrahydrate",
"synonyms": "6152-33-6; Sodium 2-phenylphenate tetrahydrate; NCGC00164321-01; DSSTox_CID_20794; DSSTox_RID_79602; DSSTox_GSID_40794; CAS-6152-33-6; 2-Phenylphenol sodium salt tetrahydrate; 2-Hydroxybiphenyl sodium salt tetrahydrate; Sodium, (2-biphenylyloxy)-, tetrahydrate; CHEMBL1903906; DTXSID1040794; Tox21_112097; Tox21_301387; Tox21_112097_1; LS40587; NCGC00091595-07; NCGC00255652-01; E232; Sodium [1,1'-biphenyl]-2-olate tetrahydrate; 2-HYDROXYBIPHENYL SODIUM SALTTETRAHYDRATE; 2-Phenylphenol sodium salt tetrahydrate, technical;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H17NaO5",
"molecular_weight": "264.25",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "517383",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02121",
"RC02742",
"RC03363"
]
},
{
"compound_ID": "D1095",
"name": "sodium bithionolate",
"synonyms": "bithionolate sodium; Sodium bithionolate; 6385-58-6; Vancide BN; Natrii bithionolas; 2,2'-Thiobis(4,6-dichlorophenol) disodium salt; Caswell No. 408; Bithionol, sodium salt; Sodium bitionolate; Bithionolate Sodium [USAN]; Natrii bitionolas [INN-Latin]; UNII-66V0139H9A; Bitionolato sodico [INN-Spanish]; Bitionolate de sodium [INN-French]; EPA Pesticide Chemical Code 064203; Phenol, 2,2'-thiobis(4,6-dichloro-, disodium salt; Thiobis(4,6-dichlorophenol sodium salt); AI3-26653; Disodium 2,2'-thiobis(4,6-dichlorophenate); Sodium 6,6'-thiobis(2,4-dichlorophenolate); Disodium 2,2'-thiobis(4,6-dichlorophenoxide); 66V0139H9A; Bithionate sodium; Sodium, (2,2'-thiobis(4,6-dichloro-o-phenylene)oxy)di-; Sodium bithonolate disodium 2,2'-thiobis(4,6-dichlorophenoxide); Sodium bitionolate (INN); Sodium bitionolate [INN]; 2,2'-thiobis(4,6-dichlorophenol)disodium salt; disodium 2,2'-thiobis(4,6-dichlorophenolate); Bithionolate sodium (USAN); Natrii bitionolas; Bitionolato sodico; Bitionolate de sodium; Bithionol Disodium Salt; DSSTox_CID_1270; DSSTox_RID_76049; DSSTox_GSID_21270; SCHEMBL636173; SPECTRUM1500148; CHEMBL1447476; DTXSID8021270; HMS1920I03; HMS2091O05; Tox21_202791; CCG-39711; LS-7700; NCGC00094603-01; NCGC00094603-02; NCGC00260337-01; CAS-6385-58-6; FT-0708482; D03135; disodium 2,2'-thiobis(4,6-dichlorobenzenolate); Q27264025; Bis(3,5-dichloro-2-hydroxyphenyl) Sulfide Disodium Salt; 2,2'-Thiobis(4,6-dichlorophenol) disodium salt, AldrichCPR; disodium;2,4-dichloro-6-(3,5-dichloro-2-oxidophenyl)sulfanylphenolate;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H4Cl4Na2O2S",
"molecular_weight": "400",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "22882",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02122",
"RC02743",
"RC03364"
]
},
{
"compound_ID": "D1096",
"name": "sodium warfarin",
"synonyms": "Warfarin sodium; 129-06-6; Sodium warfarin; Jantoven; Marevan; Athrombin; Sodium coumadin; Aldocumar; Coumadine; Dicusat; Marevam; Orfarin; Tintorane; Varfine; Warcoumin; Warfilone; Simarc; Coumadin sodium; UniWarfin; Ratsul soluble; Coumadan Sodico; Coumafene sodium; Warfarin sodium salt; Waran; Warfarin, sodium salt; Zoocoumarin sodium salt; Caswell No. 903A; (+-)-Warfarin sodium; Warfarin sodium [USP]; EINECS 204-929-4; EPA Pesticide Chemical Code 086003; C19H15NaO4; 3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin sodium salt; Sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-2H-chromen-4-olate; 5543-79-3; 3-(3-Oxo-1-phenylbutyl)-4-sodiooxy-2H-1-benzopyran-2-one; Warfarin sodium (USP); Sodium, ((3-(alpha-acetonylbenzyl)-2-oxo-2H-1-benzopyran-4-yl)oxy)-; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt; Coumarin, 3-(alpha-acetonylbenzyl)-4-hydroxy-, sodium salt; warfarin-sodium; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt (1:1); CPD000058849; Warfarin, sodium deriv.; Warfarin sodium [USAN]; Coumadin (TN); Jantoven (TN); EINECS 226-909-4; Warfarin, sodium deriv; Warfarin sodium clathrate; SCHEMBL7826; DSSTox_CID_15010; DSSTox_RID_79236; DSSTox_GSID_35010; MLS001074341; C19H15O4.Na; CHEMBL1200879; DTXSID7035010; CTK5A3600; KYITYFHKDODNCQ-UHFFFAOYSA-M; HMS2233P10; HMS3259G13; HMS3369M10; BCP20702; Tox21_301545; BDBM50248297; AKOS015951251; AKOS015955387; AC-8078; API0004610; CS-W019743; MCULE-2794487450; NC00490; NCGC00255556-01; AC-19972; CAS-129-06-6; CC-35635; H742; LS-55086; SAM002548943; SAM002554882; SMR000058849; AB0013224; AB1009293; AX8156592; ST24031985; W0005; Warfarin sodium (contains Isopropyl Alcohol); D00564; J10262; A805899; C-20012; J-005647; Sodium warfarin;WARF42 sodium; Athrombine-K sodium; Q27263296; 3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin Sodiuim Salt; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin Sodium Salt; sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-1-benzopyran-4-olate; sodium 2-oxidanylidene-3-(3-oxidanylidene-1-phenyl-butyl)chromen-4-olate; 2H-1-Benzopyran-2-one,4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-, sodium salt (9CI); 67430-45-9; Coumadin sodium|||4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-Benzopyran-2-one, sodium salt (1:1);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C19H15NaO4",
"molecular_weight": "330.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16204922",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02123",
"RC02744",
"RC03365"
]
},
{
"compound_ID": "D1097",
"name": "sofalcone",
"synonyms": "sofalcone; 64506-49-6; Solon; Isoprenyl chalcone; Sofalconum [Latin]; Sofalcona [Spanish]; Sofalcone [INN:JAN]; SU-88; UNII-2B668TJX8E; Sofalcone (JAN); C27H30O6; BRN 2191482; 2B668TJX8E; Sofalcone [JAN]; NCGC00159481-02; 2'-Carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone; DSSTox_CID_3586; DSSTox_RID_77093; DSSTox_GSID_23586; Sofalconum; Sofalcona; (5-((3-Methyl-2-butenyl)oxy)-2-(p-((3-methyl-2-butenyl)oxy)cinnamoyl)phenoxy)acetic acid; Acetic acid, (5((3-methyl-2-butenyl)oxy)-2-(3-(4-((3-methyl-2-butenyl)oxy)phenyl)-1-oxo-2-propenyl)phenoxy)-; CAS-64506-49-6; Solon (TN); Sofaclone; {5-[(3-Methyl-2-butenyl)oxy]-2-{p-[(3-methyl-2-butenyl)oxy]cinnamoyl}phenoxy}acetic acid; Sofalcone [MI]; Sofalcone [INN]; Sofalcone [MART.]; Sofalcone [WHO-DD]; SCHEMBL24786; CHEMBL1441961; DTXSID5023586; CHEBI:135732; SU 88; BCP12009; EBD45865; HY-B2184; ZINC3831462; Tox21_111705; s5450; AKOS015895236; Tox21_111705_1; CS-7893; DB05197; KS-1141; NCGC00159481-03; AC-22578; LS-12474; SC-13787; D01956; 506S496; A834791; Q15410187; 2-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone; 2'-carboxymethoxy-4,4'-bis(3-methylbut-2-enyloxy)chalcone sofalcone; ({5-[(3-methylbut-2-en-1-yl)oxy]-2-[(2E)-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}prop-2-enoyl]phenyl}oxy)acetic acid; (E)-2-(5-(3-methylbut-2-enyloxy)-2-(3-(4-(3-methylbut-2-enyloxy)phenyl)acryloyl)phenoxy)acetic acid; 153175-87-2; 2-[5-(3-methylbut-2-enoxy)-2-[(E)-3-[4-(3-methylbut-2-enoxy)phenyl]-1-oxoprop-2-enyl]phenoxy]acetic acid; 2-[5-(3-methylbut-2-enoxy)-2-[(E)-3-[4-(3-methylbut-2-enoxy)phenyl]prop-2-enoyl]phenoxy]ethanoic acid; 2-{5-[(3-methylbut-2-en-1-yl)oxy]-2-(3-{4-[(3-methylbut-2-en-1- yl)oxy]phenyl}prop-2-enoyl)phenoxy}acetic acid; 2-{5-[(3-methylbut-2-en-1-yl)oxy]-2-[(2E)-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}prop-2-enoyl]phenoxy}acetic acid; Acetic acid, 2-(5-((3-methyl-2-buten-1-yl)oxy)-2-((2E)-3-(4-((3-methyl-2-buten-1-yl)oxy)phenyl)-1-oxo-2-propen-1-yl)phenoxy)-; Acetic acid,[5-[(3-methyl-2-butenyl)oxy]-2-[3-[4-[(3-methyl-2-butenyl)oxy]phenyl]-1-oxo-2-propenyl]phenoxy]-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C27H30O6",
"molecular_weight": "450.5",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5282219",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02124",
"RC02745",
"RC03366"
]
},
{
"compound_ID": "D1098",
"name": "sorafenib",
"synonyms": "Sorafenib; 284461-73-0; Nexavar; BAY 43-9006; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; UNII-9ZOQ3TZI87; 4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 9ZOQ3TZI87; CHEMBL1336; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; DTXSID7041128; CHEBI:50924; BAY-43-9006; Sorafenib (Nexavar); Sorafenib [INN]; 2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; sorafenibum; 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-; NSC-724772; BAY-54-9085; NCGC00167488-01; Sorafinib; Sorafenib [USAN:INN:BAN]; SR-00000000529; Sorafenib-d3; HSDB 8173; 1uwh; 3gcs; 3heg; 4asd; Hit compound, 8; Sorafenib, 4; BAY 439006; BAY43-9006; Kinome_766; SORAFENIB BASE; Sorafenib (USAN/INN); Nexavar (TN) (Bayer); EC 608-209-4; SCHEMBL8218; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; BAY 43-9006; Sorafenib; cid_216239; GTPL5711; QCR-65; BDBM16673; Nexavar|||BAY 43-9006; SYN1082; MLDQJTXFUGDVEO-UHFFFAOYSA-N; BCPP000064; HMS2043A18; HMS3244A15; HMS3244A16; HMS3244B15; HMS3656N20; K00597a; ACT06732; AOB87782; BCP01767; EX-A2894; ZINC1493878; BAY439006; CS0056; MFCD06411450; NSC747971; s7397; STK627350; AKOS005560229; AC-1674; ACN-032355; CS-1590; DB00398; MCULE-6112506696; NSC-747971; PB14443; SB19942; SF-0529; BAY-43-0006; KS-0000009E; Sorafenib free base (BAY-43-9006); NCGC00167488-02; NCGC00167488-03; NCGC00167488-04; NCGC00167488-05; NCGC00167488-07; NCGC00167488-14; 100012-18-8; 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; AK163019; EN002709; HY-10201; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; SC-19355; AB0019677; AB1004622; LS-186067; LS-187021; LS-187788; AM20090614; FT-0650736; SW202562-4; D08524; J10391; 15216-EP2272827A1; 15216-EP2298778A1; 15216-EP2311840A1; 15216-EP2316832A1; 15216-EP2316833A1; AB00933189-05; AB00933189-06; AB00933189_08; 461S730; Q421136; Q-201728; SR-00000000529-1; BRD-K23984367-001-01-8; Z89277543; BAY 439006; BAY439006; BAY-439006; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido) phenoxy)-N-methylpicolinamide; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido)phenoxy)-N-methylpicolinamide; N-(3-trifluoromethyl-4-chlorophenyl)-N'-(4-(2-methylcarbamoyl pyridin-4-yl)oxyphenyl)urea; 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)- N-methylpyridine-2-carboxamide; 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide;tosylic acid; 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide; 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methyl-pyridine-2-carboxamide; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl) urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C21H16ClF3N4O3",
"molecular_weight": "464.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "216239",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T001",
"T002",
"T408"
],
"function": [
"F0108",
"F0201",
"F0303"
],
"references": [
"RC02125",
"RC02746",
"RC03367",
"RC04123",
"RC04247",
"RC04371",
"RC04495",
"RC04619"
]
},
{
"compound_ID": "D1099",
"name": "sp600125",
"synonyms": "129-56-6; 1,9-Pyrazoloanthrone; SP600125; Pyrazolanthrone; Dibenzo[cd,g]indazol-6(2H)-one; Pyrazoleanthrone; SP 600125; Anthra[1,9-cd]pyrazol-6(2H)-one; SP-600125; Anthra-1,9-pyrazol-6-none; JNK Inhibitor II; 2H-Dibenzo[cd,g]indazol-6-one; C.I. 70300; NSC 75890; ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE; 1pmv; UNII-1TW30Y2766; NSC75890; EINECS 204-955-6; BRN 0746890; CHEMBL7064; MLS002693964; CHEBI:90695; ACPOUJIDANTYHO-UHFFFAOYSA-N; 1TW30Y2766; NCGC00015958-03; SAPK Inhibitor II; SMR000015440; SR-01000075840; 2zmd; InSolution™ JNK Inhibitor II; NSC-75890; Kinome_3844; Tocris-1496; BiomolKI_000068; Lopac-S-5567; BiomolKI2_000072; cid_8515; DSSTox_CID_20525; DSSTox_RID_79502; CBiol_002049; DSSTox_GSID_40525; Lopac0_000473; BMK1-G8; BSPBio_001066; ChemBiol10705 Compound 4; KBioGR_000406; KBioSS_000406; JMC517015 Compound 2; KSC516G2D; MLS002153267; MLS006011577; SCHEMBL170980; anthra[1,9-cd]pyrazol-6-one; GTPL5273; CHEMBL1725279; DTXSID2040525; SCHEMBL15583517; BCBcMAP01_000053; BDBM16018; CTK4B6321; dibenz[cd,g]indazol-6(2h)-one; KBio2_000406; KBio2_002974; KBio2_005542; KBio3_000771; KBio3_000772; Bio1_000335; Bio1_000824; Bio1_001313; Bio2_000373; Bio2_000853; HMS1362F07; HMS1667K13; HMS1792F07; HMS1990F07; HMS2250C03; HMS3229I16; HMS3261O08; HMS3267P06; HMS3403F07; HMS3412F05; HMS3654P10; HMS3676F05; HMS3747M19; ALBB-024051; Anthra[1,9cd]pyrazol-6(2H)-one; BCP05457; EX-A1998; Tox21_110267; Tox21_500473; Anthra[1-9-cd]pyrazol-6(2H)-one; ANW-68872; BDBM50024294; BDBM50433916; CCG-47500; Dibenzo[cd,g]indazol-6(2H)-one #; HSCI1_000136; s1460; SBB000595; ZINC96298875; AKOS000115584; Anthrapyrazolone; 1,9-Pyrazoloanthrone; CCG-100672; CS-0196; DB01782; LP00473; MCULE-7820194475; VA10299; 1,6-dihydrodibenzo[cd,g]indazol-6-one; 2,6-dihydrodibenzo[cd,g]indazol-6-one; IDI1_002128; QTL1_000077; SMP2_000240; NCGC00015958-01; NCGC00015958-02; NCGC00015958-04; NCGC00015958-05; NCGC00015958-06; NCGC00015958-07; NCGC00015958-08; NCGC00025186-01; NCGC00025186-02; NCGC00025186-03; NCGC00025186-04; NCGC00025186-05; NCGC00261158-01; WLN: T C6665 1A P IV OMNJ; 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one; AK-57219; AS-14374; CAS-129-56-6; HY-12041; K914; LS-20607; SC-62298; SMR002530644; ST018684; DB-041928; TC-157617; EU-0100473; FT-0607068; ST24046474; SW218106-2; EN300-02083; Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100; K00068; S 5567; SP600125, >=98% (HPLC); AB00075935-01; SP 600125 & Z-100; 129S566; Q4545713; SR-01000075840-1; SR-01000075840-2; SR-01000075840-4; SR-01000075840-6; SR-01000637108-1; W-108360; BRD-K01567962-001-04-0; BRD-K01567962-001-06-5; BRD-K01567962-001-08-1; BRD-K01567962-001-22-2; Z56785477; F1414-1245; SP600125, 129-56-6; 14,15-diazatetracyclo[7.6.1.0(2),.0(1)(3),(1)]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one; 14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H8N2O",
"molecular_weight": "220.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "8515",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02126",
"RC02747",
"RC03368"
]
},
{
"compound_ID": "D1100",
"name": "spiclomazine hydrochloride",
"synonyms": "Clospirazine hydrochloride; Spiclomazine hydrochloride; Diceplon; Disepron; UNII-N6B142V0U0; APY-606; 27007-85-8; NSC 290956; N6B142V0U0; 8-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-thia-4,8-diazaspiro(4.5)decan-3-one hydrochloride; Clospirazine HCl; 1-Thia-4,8-diazaspiro(4.5)decan-3-one, 8-(3-(2-chlorophenothiazin-10-yl)propyl)-, hydrochloride; NSC290956; NSC-290956; DSSTox_CID_3593; DSSTox_RID_77099; C22H24ClN3OS2.HCl; DSSTox_GSID_23593; 8-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-thia-4,8-diazaspiro[4.5]decan-3-one hydrochloride; SCHEMBL3501689; CHEMBL1967529; DTXSID4023593; CHEBI:31423; Spiclomazine hydrochloride (JAN); APY 606; Tox21_110055; NCGC00014648-01; CAS-27007-85-8; LS-150121; D01487; Q27284615; 1-Thia-4, 8-[3-(2-chlorophenothiazin-10-yl)propyl]-, monohydrochloride; 1-Thia-4, 8-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-, monohydrochloride; 1-Thia-4,8-diazaspiro(4.5)decan-3-one, 8-(3-(2-chlorophenothiazin-10-yl)propyl)-, monohydrochloride; 1-Thia-4,8-diazaspiro(4.5)decan-3-one, 8-(3-(2-chlorophenothiazin-10-yl)propyl)-, monohydrochloride (8CI); 1-Thia-4,8-diazaspiro(4.5)decan-3-one, 8-(3-(2-chlorophenothiazin-10-yl)propyl)-,hydrochloride;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C22H25Cl2N3OS2",
"molecular_weight": "482.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "122820",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02127",
"RC02748",
"RC03369"
]
},
{
"compound_ID": "D1101",
"name": "spiperone",
"synonyms": "spiperone; Spiroperidol; Spiropitan; 749-02-0; Espiperona; Spiperonum; [3H]spiperone; [3H]-spiperone; R 5147; Spiperonum [INN-Latin]; Espiperona [INN-Spanish]; E 525; UNII-4X6E73CJ0Q; NSC 170983; 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; MLS000028615; Spiperone [USAN:INN:BAN:JAN]; 8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one; 8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane; EINECS 212-024-0; BRN 0632204; SMR000058674; 1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-; 4X6E73CJ0Q; CHEBI:9233; CHEMBL267930; C23H26FN3O2; DKGZKTPJOSAWFA-UHFFFAOYSA-N; Butyrophenone, 4'-fluoro-4-(4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decan-8-yl)-; NSC170983; NCGC00015964-09; CAS-749-02-0; 1,3,8-Triazaspiro(4.5)decan-4-one, 8-(3-(p-fluorobenzoyl)propyl)-1-phenyl-; 8-[3-(p-Fluorobenzoyl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; R-5147; DSSTox_CID_25205; DSSTox_RID_80749; DSSTox_GSID_45205; Spiroperidone; Spiroperone; 1,3,8-Triazaspiro[4.5]decan-4-one, 8-[3-(p-fluorobenzoyl)propyl]-1-phenyl-; 1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-; SR-01000000261; Spiperone, solid; Spiropitan (TN); Prestwick_624; [3H]-Spiroperidol; Spectrum_001143; Tocris-0995; Spiperone (JAN/USAN); regid855701; Opera_ID_1551; Prestwick0_000288; Prestwick1_000288; Prestwick2_000288; Prestwick3_000288; Spectrum2_001426; Spectrum3_001460; Spectrum4_000451; Spectrum5_000987; Lopac-S-7395; GTPL99; 4-Phenyl-8-[3-(4-fluorobenzoyl)propyl]-1-oxo-2,4,8-triazaspiro[4,5]decane; cid_5265; Lopac0_001069; REGID_for_CID_5265; BSPBio_000196; BSPBio_002959; KBioGR_000862; KBioSS_001623; MLS001076321; DivK1c_000566; SCHEMBL116031; SPECTRUM1501152; SPBio_001532; SPBio_002415; BPBio1_000216; GTPL3300; DTXSID5045205; BDBM21397; HMS501M08; KBio1_000566; KBio2_001623; KBio2_004191; KBio2_006759; KBio3_002459; NINDS_000566; HMS1568J18; HMS1921L09; HMS2089E16; HMS2092H17; HMS2095J18; HMS2235E11; HMS3371L01; HMS3712J18; Pharmakon1600-01501152; ZINC643233; Tox21_110269; BN0500; CCG-38975; MFCD00055099; NSC757864; AKOS024282958; Tox21_110269_1; API0004229; MCULE-7534168791; NSC-170983; NSC-757864; 8-[4-(4-fluorophenyl)-4-oxobutyl]-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one; IDI1_000566; NCGC00015964-01; NCGC00015964-02; NCGC00015964-03; NCGC00015964-04; NCGC00015964-05; NCGC00015964-06; NCGC00015964-07; NCGC00015964-08; NCGC00015964-10; NCGC00015964-11; NCGC00015964-12; NCGC00015964-13; NCGC00015964-17; NCGC00016536-01; NCGC00022260-02; NCGC00022260-04; NCGC00022260-05; NCGC00022260-06; NCGC00022260-07; ST059306; SBI-0051039.P003; LS-154780; AB00052224; FT-0674639; D01051; 36693-EP2272537A2; 36693-EP2311801A1; 36693-EP2311802A1; 36693-EP2311803A1; 36693-EP2371814A1; AB00052224-15; AB00052224_16; L000569; Q3077150; SR-01000000261-5; SR-01000000261-8; BRD-K55468218-001-05-5; BRD-K55468218-003-01-0; WLN: T6N DXTJ A3VR DF& D-& CT5MVXN EHJ DR; 8-[3-(p-Fluorobenzoyl)propyl]-1-phenyl-1,8-triazaspiro[4.5]decan-4-one; 1,8-Triazaspiro[4.5]decan-4-one, 8-[3-(p-fluorobenzoyl)propyl]-1-phenyl-; 1,8-Triazaspiro[4.5]decan-4-one, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-; 8-[4-(4-fluorophenyl)-4-keto-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; 8-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; 8-[4-(4-fluorophenyl)-4-oxo-butyl]-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one; 1-(4-Fluorophenyl)-4-(4-hydroxy-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-8-yl)-1-butanone #;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C23H26FN3O2",
"molecular_weight": "395.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5265",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02128",
"RC02749",
"RC03370"
]
},
{
"compound_ID": "D1102",
"name": "su-5416",
"synonyms": "Semaxanib; Semaxinib; SU5416; SU 5416; 204005-46-9; 194413-58-6; Semoxind; Semaxanib (SU5416); SU-5416; TSU 16; UNII-71IA9S35AJ; VEGF Receptor 2 Kinase Inhibitor III; (Z)-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one; NSC-696819; (Z)-SU 5416; VEGFR2 Kinase Inhibitor III; 71IA9S35AJ; CHEMBL276711; Z-Semaxanib; (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; 3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole; 3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone; H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-; Semaxnib; 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; (3Z)-3-[(3,5-DIMETHYL-1H-PYRROL-2-YL)METHYLIDENE]-2,3-DIHYDRO-1H-INDOL-2-ONE; 3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one; SMR000568416; TSU-16; SR-01000076044; Semaxanib (USAN/INN); Semaxanib [USAN:INN]; Sugen 5416; methylene]-2H-indol-2-one; NCGC00094381-03; AK174866; AK174898; semaxanib-su5416; NSC 696819; 2x2m; Semaxanib; SU5416; 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one; S 8442; SCHEMBL8190; Lopac0_001110; SCHEMBL19571; 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl); MLS001074896; MLS001332519; MLS001332520; BDBM4810; GTPL5056; QCR-86; 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one; InSolution™ VEGF Receptor 2 Kinase Inhibitor III; CHEBI:91083; cid_5329098; AOB6828; SIBNPBQTUXWRMZ-ZSOIEALJSA-N; WUWDLXZGHZSWQZ-WQLSENKSSA-N; HMS2234L12; HMS3229O13; HMS3263M22; HMS3268J13; HMS3413H10; HMS3648O12; HMS3677H10; BCP06068; EX-A2158; Tox21 111271; Tox21_501110; 2033AH; 2712AH; BS0306; HSCI1_000303; MFCD01940922; NSC696819; s2845; SU5146; ZINC12410091; 3-[(3,5-dimethyl-1h-pyrrol-2-yl)methylene]-1,3-dihydro-2h-indol-2-one; AKOS015994557; CCG-205186; CS-1225; DB06436; ES-0010; LP01110; NCGC00094381-01; NCGC00094381-02; NCGC00094381-04; NCGC00094381-05; NCGC00261795-01; HY-10374; LS-83886; QC-11357; SC-96714; SU005416; AB0094985; LS-193151; RT-016226; EU-0101110; SW219791-1; A12437; D05819; W-5403; 2H-Indol-2-one,5-dimethyl-2-pyrrolyl)methylene]-; J-013281; Q7449140; SR-01000076044-2; SR-01000076044-8; BRD-K63504947-001-05-5; 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone; 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-indolin-2-one; Semaxanib, Semoxind, TSU-16, NSC-696819, SU-5416; 3-[(3,5-Dimethyl-2H-pyrrol-2-ylidene)methyl]-1H-indol-2-ol; 3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro- 2H-indol-2-one; 2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (3Z)-; 2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (Z)-; 2H-Indol-2-one, 3-(3,5-dimethyl-1H-pyrrol-2-yl)methylene)- 1,3-dihydro-, (Z)-; 3-[1-(3,5-dimethyl-1h-pyrrol-2-yl)-meth-(z)-ylidene]-2-oxo-2,3-dihydro-indole;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H14N2O",
"molecular_weight": "238.28",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5329098",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02129",
"RC02750",
"RC03371"
]
},
{
"compound_ID": "D1103",
"name": "sulfanitran",
"synonyms": "sulfanitran; 122-16-7; APNPS; UNII-QT35T5T35Q; N-[4-[(4-nitrophenyl)sulfamoyl]phenyl]acetamide; component of Novastat; component of Polystat; NSC 77120; NSC 217299; N(sup4)-Acetyl-4'-nitrosulfanilanilide; 4'-((p-Nitrophenyl)sulfamoyl)acetanilide; QT35T5T35Q; NSC77120; N(sup4)-Acetyl-N(sup1)-(p-nitrophenyl)sulfanilamide; NSC217299; N(sup4)-Acetyl-N(sup1)-(4-nitrophenyl)sulfanilamide; NCGC00095045-01; DSSTox_CID_25898; DSSTox_RID_81210; DSSTox_GSID_45898; Acetamide, N-(4-(((4-nitrophenyl)amino)sulfonyl)phenyl)-; Sulfanitrano; Sulfanitranum; 4'-[(p-Nitrophenyl)sulfamoyl]acetanilide; CAS-122-16-7; Acetanilide, 4'-((p-nitrophenyl)sulfamoyl)-; Acetanilide, 4'-[(p-nitrophenyl)sulfamoyl]-; N-{4-[(4-nitrophenyl)sulfamoyl]phenyl}acetamide; SR-05000001857; Sulfanitranum [INN-Latin]; Sulfanitrano [INN-Spanish]; Acetamide, N-[4-[[(4-nitrophenyl)amino]sulfonyl]phenyl]-; Sulfanitran [USAN:INN:BAN]; Sulfanitran, ~85%; Spectrum_001693; Spectrum3_001755; Spectrum4_000858; Spectrum5_001477; Sulfanitran (USAN/INN); Oprea1_470804; SCHEMBL93837; BSPBio_003490; KBioGR_001495; KBioSS_002173; MLS004774076; DivK1c_000830; SPECTRUM1503339; CHEMBL493636; DTXSID4045898; CTK8G3259; HMS502J12; KBio1_000830; KBio2_002173; KBio2_004741; KBio2_007309; KBio3_002710; CHEBI:114204; GWBPFRGXNGPPMF-UHFFFAOYSA-N; NINDS_000830; HMS1922A20; HMS2093E09; Pharmakon1600-01503339; HY-B0947; KS-00001F9J; ZINC3873374; Tox21_111401; BDBM50248248; MFCD00024598; NSC-77120; NSC758458; STL139243; N(4)-Acetyl-4'-nitrosulfanilanilide; AKOS003980372; Tox21_111401_1; API0010063; CCG-213164; CS-4420; DB11463; MCULE-3335430158; NSC-217299; NSC-758458; Sulfanitran 100 microg/mL in Methanol; IDI1_000830; NCGC00095045-02; NCGC00095045-03; NCGC00095045-05; SMR003500745; SBI-0052913.P002; DB-041653; N4-Acetyl-N1-(4-nitrophenyl)sulfanilamide; FT-0631698; N4-Acetyl-N1-(4-nitrophenyl)-sulfanilamide; D05951; AB00052349_02; N(4)-Acetyl-N(1)-(p-nitrophenyl)sulfanilamide; Sulfanitran, VETRANAL(TM), analytical standard; J-004768; N-(4-(N-(4-nitrophenyl)sulfamoyl)phenyl)acetamide; N-(4-[(4-Nitroanilino)sulfonyl]phenyl)acetamide #; SR-05000001857-1; SR-05000001857-3; Acetanilide, 4'-((p-nitrophenyl)sulfamoyl)- (8CI); BRD-K76845197-001-01-3; Q27195401; Acetamide, N-[4-[[ (4-nitrophenyl)amino]sulfonyl]phenyl]-; N4-ACETYL-N1-(4-NITROPHENYL)-SULFANILAMIDE, TECH.; Acetamide, N-?[4-?[[(4-?nitrophenyl)?amino]?sulfonyl]?phenyl]?-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H13N3O5S",
"molecular_weight": "335.34",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5334",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02130",
"RC02751",
"RC03372"
]
},
{
"compound_ID": "D1104",
"name": "surinabant",
"synonyms": "Surinabant; 288104-79-0; SR-147778; UNII-SF8R9VCB0X; SR147778; SR 147778; SF8R9VCB0X; CHEMBL189676; Surinabant [INN]; DSSTox_CID_27357; DSSTox_RID_82293; DSSTox_GSID_47357; SCHEMBL675894; GTPL9233; DTXSID2047357; CHEBI:125484; ZINC1549068; Tox21_300239; BDBM50171290; DB13070; NCGC00247959-01; NCGC00254070-01; 5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide; DA-38649; ZINC000001549068; LS-193786; CAS-288104-79-0; FT-0766481; Q7646304; BRD-K09557221-001-01-6; 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-piperidin-1-ylpyrazole-3-carboxamide; 1H-Pyrazole-3-carboxamide, 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-1-piperidinyl-; 5-(4-Bromo-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C23H23BrCl2N4O",
"molecular_weight": "522.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "9849616",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02131",
"RC02752",
"RC03373"
]
},
{
"compound_ID": "D1105",
"name": "talniflumate",
"synonyms": "Talniflumate; 66898-62-2; Somalgen; Lomucin; Talniflumato; Talniflumate [USAN:INN]; Talniflumatum [INN-Latin]; BA 7602-06; Talniflumato [INN-Spanish]; C21H13F3N2O4; Phthalidyl 2-(3-trifluoromethylanilino)nicotinate; BRN 0503261; Ba-7602-06; ANMLJLFWUCQGKZ-UHFFFAOYSA-N; 3-Phthalidyl ester of 2-((3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylic acid; NCGC00167754-01; Phthalidyl 2-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinate; 2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid phthalidyl ester; 3-Ftalidilico del acido 2-((3-(trifluormetil)fenil)amino)-3-piridincarboxilico; 3-Ftalidilico del acido 2-((3-(trifluormetil)fenil)amino)-3-piridincarboxilico [Spanish]; DSSTox_CID_26740; DSSTox_RID_81869; DSSTox_GSID_46740; Talniflumatum; Phthalidyl 2-(alpha,alpha,alpha,-trifluoro-m-toluidino)nicotinate; 2-[3-(trifluoromethyl)anilino]-3-pyridinecarboxylic acid (3-oxo-1H-isobenzofuran-1-yl) ester; NICOTINIC ACID, 2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)-, PHTHALIDYL ESTER; 3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 1,3-dihydro-3-oxo-1-isobenzofuranyl ester; CAS-66898-62-2; Somalgen (TN); 3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 1,3-dihydro-3-oxo-1-isobenzofuranyl ester; Talniflumate (USAN/INN); SCHEMBL23691; CHEMBL1081506; DTXSID3046740; CHEBI:91991; CTK8G3296; HMS3269M13; HMS3413D19; HMS3677D19; MSI-1995; Tox21_112584; s6439; AKOS015895754; Tox21_112584_1; API0004315; DB09295; KS-5130; (3-oxo-1H-2-benzofuran-1-yl) 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate; KS-000017U3; NCGC00167754-02; AC-14144; CC-34632; LS-96640; M935; ZINC000000601275; AB0015459; DB-054972; FT-0630769; D02701; 898T622; A835581; C-21964; BRD-A98378129-001-01-4; Q22075910; phthalidyl 2-(3'-trifluormethylanilino)-pyridin-3-carboxylate; phthalidyl 2-(3-trifluoromethylanilino)-3-pyridinecarboxylate; Phthalidyl 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)nicotinate; [(1R)-3-oxo-1H-2-benzofuran-1-yl] 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate; 2-(.alpha.,.alpha.,.alpha.-Trifluoro-m-toluidino)nicotinic acid phthalidyl ester; 3-oxo-1,3-dihydroisobenzofuran-1-yl 2-(3-(trifluoromethyl)phenylamino)nicotinate; Nicotinic acid, 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)-, phthalidyl ester; (3-oxidanylidene-1H-2-benzofuran-1-yl) 2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylate; 2-[[3-(Trifluoromethyl)phenyl]amino]-1,3-dihydro-3-oxo-1-isobenzofuranyl 3-pyridinecarboxylic acid ester; 2-[[3-(Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid 1,3-dihydro-3-oxo-1-isobenzofuranyl ester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C21H13F3N2O4",
"molecular_weight": "414.3",
"state": "solid",
"clearance": "This drug undergoes extensive first pass effect.",
"volume_of_distribution": "In 12 subjects after a single oral administration, total plasma clearance of the main metabolite, niflumic acid, averaged 45 ml/min giving a distribution volume of 0.12 l/kg on average [A31964].",
"route_of_elimination": "",
"protein_binding": "Niflumic acid, the active form of Talniflumate, is weak acid that is strongly bound to plasma proteins. Bioavailability was 100% in a study of 12 volunteers. It is a weak acid, strongly bound to plasma proteins [A31964].\n",
"half_life": "Approximately 2h in 12 subjects [A31964]",
"absorption": "",
"cid": "48229",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02132",
"RC02753",
"RC03374"
]
},
{
"compound_ID": "D1106",
"name": "tamibarotene",
"synonyms": "Tamibarotene; 94497-51-5; Am 80; retinobenzoic acid; Am80; 4-((5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbamoyl)benzoic acid; AM-80; Amnolake; Tamibaro; Amnoid; 4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid; NSC 608000; UNII-08V52GZ3H9; 4-[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbamoyl]benzoic acid; NSC-608000; CHEMBL25202; CHEBI:32181; 08V52GZ3H9; NSC608000; 4-((5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl)benzoic acid; NCGC00181111-01; AK-72889; Benzoic acid, 4-(((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino)carbonyl)-; DSSTox_CID_26853; DSSTox_RID_81962; DSSTox_GSID_46853; N-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)terephthalamic acid; SMR002530320; CAS-94497-51-5; Tamibarotene [INN]; Amnoleuk; 2cbr; Amnoid (TN); Tamibarotene(Am-80); Tamibarotene (JAN/INN); SCHEMBL36207; TOS-80T; MLS003899239; MLS004774034; MLS006011150; EBD989; GTPL2648; INNO-507; TOS-80; DTXSID5046853; CTK8E9821; Tamibarotene, >=98% (HPLC); MUTNCGKQJGXKEM-UHFFFAOYSA-N; 4-[(1,1,4,4-tetramethyltetralin-6-yl)carbamoyl]benzoic acid; HMS3652H04; HMS3743C03; ZINC538415; BCP07492; OMS-0728; Tox21_112725; BDBM50061625; MFCD00866188; s4260; TM-411; AKOS015902693; N-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl)-2-naphthyl)terephthalamic acid; Tox21_112725_1; AC-7049; API0005327; CS-0654; DB04942; 4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino]carbonyl]benzoic acid; NCGC00181111-02; 121GE003; AS-14083; BR-72889; CC-34634; HY-14652; LS-38350; NCI60_004716; ZINC000000538415; AB0009956; AX8113755; TR-029540; 4CH-007027; AM20060757; FT-0080835; FT-0601534; ST24028715; SW219913-1; Z-208; C12864; D01418; J90051; S-7407; 497T515; C-20659; Q7681221; 4-(((5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)amino)carbonyl)benzoic acid; 4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ylcarbamoyl)benzoic acid; Terephthalic acid mono-5,5,8,8-tetramethyl- 5,6,7, 8-tetrahydro-2-naphthylamide; Terephthalic acid mono-5,8,8-tetramethyl- 5,6,7,8-tetrahydro-2-naphthylamide; A80;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C22H25NO3",
"molecular_weight": "351.4",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "Over 99%, predominantly to serum albumin.",
"half_life": "",
"absorption": "",
"cid": "108143",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02133",
"RC02754",
"RC03375"
]
},
{
"compound_ID": "D1107",
"name": "tamsulosin hydrochloride",
"synonyms": "TAMSULOSIN HYDROCHLORIDE; 106463-17-6; Tamsulosin HCl; Flomax; Omnic; Pradif; Urolosin; Secotex; Josir; Alna; Omic; Omix; Amsulosin hydrochloride; Expros; Harnal; LY253351; Tamsulosin (hydrochloride); (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride; YM 617; UNII-11SV1951MR; R-(-)-YM-12617; YM617; CHEBI:9399; YM-12617-1; 11SV1951MR; YM-617; R-(-)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride; (-)-(R)-5-(2-((2-(o-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride; LY-253351; Flomax (TN); 5-[(R)-2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamide Hydrochloride; DSSTox_CID_26628; DSSTox_RID_81777; DSSTox_GSID_46628; Q-201777; (R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide hydrochloride; 5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride; Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, monohydrochloride, (R)-; CAS-106463-17-6; NCGC00167442-01; tamsulosin.HCl; Harnalidge OCAS; Flomax MR; AlnaOCAS; 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide hydrochloride; AK124398; Flomax hydrochloride; Harnal (TN); MFCD00922997; Tamsulosin hydrochloride [USAN:JAN]; Amsulosin Hydrochloride;Tamsulosin hydrochloride; PubChem18241; Tamsulosin-hydrochloride; Tamsulosin hydrochloride [USAN:USP:JAN]; tamsulosine hydrochloride; Tamsulosina hydrochloride; Tamsulosinum hydrochloride; (-)-LY 253352; C20H29ClN2O5S; SCHEMBL23428; C20H28N2O5S.HCl; Tamsulosin Hydrochloride,(S); MLS003899197; CHEMBL1200914; DTXSID2046628; HY-B0661A; 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride; ZZIZZTHXZRDOFM-XFULWGLBSA-N; KS-00000H3T; Tox21_112446; BG0475; EU-617; s4729; AKOS015895342; AKOS015995287; Tox21_112446_1; API0001417; BS-1019; CS-2897; MP-0769; RTX-011084; Tamsulosin hydrochloride (JP17/USAN); (-)-ly253352; NCGC00167442-03; CC-34638; H991; LS-31577; SC-17028; SMR002543366; BCP0726000042; Tamsulosin hydrochloride, >=98% (HPLC); AB0013408; FT-0631038; FT-0674803; ST24026438; Y-617; A14936; D01024; 463T176; (R)-(-)-YM12617;LY253351; (R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2; Q27108379; Tamsulosin hydrochloride, British Pharmacopoeia (BP) Reference Standard; Tamsulosin hydrochloride, European Pharmacopoeia (EP) Reference Standard; (R)-5-(2-((2-(2-ETHOXYPHENOXY)ETHYL)AMINO)PROPYL)-2-METHOXYBENZENESULFONAMIDE HCL; 5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-benzenesulfonamide hydrochloride; Tamsulosin hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Tamsulosin hydrochloride, United States Pharmacopeia (USP) Reference Standard; (R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride; 2-methoxy-5-[3,3,3-trideuterio-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]benzenesulfonamidehydrochloride; 5-[(2R)-2-{[2-(2-Ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzene-1-sulfonamide--hydrogen chloride (1/1); Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-,monohydrochloride, (R)-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C20H29ClN2O5S",
"molecular_weight": "445",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5362376",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02134",
"RC02755",
"RC03376"
]
},
{
"compound_ID": "D1108",
"name": "tau-fluvalinate",
"synonyms": "Tau-fluvalinate; 102851-06-9; FLUVALINATE; CHEBI:39367; Fluvarol; Fluwarol; cyano(3-phenoxyphenyl)methyl (2-chloro-4-(trifluoromethyl)phenyl)-D-valinate; Mavrik EW; cyano(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate; N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valine cyano(3-phenoxyphenyl)methyl ester; Tau-fluvalinate [ISO]; (a-RS,2R)-Fluvalinate; (RS)-alpha-Cyano-3-phenoxybenzyl N-(2-chloro-alpha,alpha,alpha-trifluoro-p-tolyl)-D-valinate; [cyano-(3-phenoxyphenyl)methyl] (2R)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate; Fluvalinate (tau-); Tau-fluvalinate (I); D-Valine, N-(2-chloro-4-(trifluoromethyl)phenyl)-, cyano(3-phenoxyphenyl)methyl ester; DSSTox_CID_17555; DSSTox_RID_79336; DSSTox_GSID_37555; SCHEMBL27925; CHEMBL1895592; DTXSID7037555; EX-A1444; tau-Fluvalinate, analytical standard; Tox21_300722; AKOS015896164; NCGC00163840-01; NCGC00163840-02; NCGC00254628-01; [cyano-(3-phenoxyphenyl)methyl] (2R)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methyl-butanoate; SC-79497; 545-EP2274983A1; 545-EP2275422A1; 545-EP2308857A1; CAS-102851-06-9; FT-0604861; tau-Fluvalinate 10 microg/mL in Cyclohexane; tau-Fluvalinate 100 microg/mL in Cyclohexane; C18790; Tau-fluvaliante 100 microg/mL in Acetonitrile; 851T069; A800631; tau-Fluvalinate, PESTANAL(R), analytical standard; Q27119834; (rs)-cyano-(3-phenoxyphenyl)methyl N-(2-chloro-4-trifluoromethylphenyl)-d-valinate; D-Valine, N-[2-chloro-4-(trifluoromethyl)phenyl]-,cyano(3-phenoxyphenyl)methyl ester; (2R)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoic acid [cyano-(3-phenoxyphenyl)methyl] ester; [cyano-(3-phenoxyphenyl)methyl] (2R)-2-[[2-chloranyl-4-(trifluoromethyl)phenyl]amino]-3-methyl-butanoate;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C26H22ClF3N2O3",
"molecular_weight": "502.9",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "91768",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02135",
"RC02756",
"RC03377"
]
},
{
"compound_ID": "D1109",
"name": "tenonitrozole",
"synonyms": "TENONITROZOLE; 3810-35-3; Moniflagon; Thenitrazol; Atricam; Tricosept; Neo-trichocid; N-(5-nitro-1,3-thiazol-2-yl)thiophene-2-carboxamide; Atrican 109; Tenonitrozole [INN]; UNII-PBQ7WLE1WP; Tenonitrozol [INN-Spanish]; Tenonitrozolum [INN-Latin]; PBQ7WLE1WP; EINECS 223-282-9; TC 109; BRN 0247925; alpha-Thenoylamino-2-nitro-5-thiazole [French]; N-(5-Nitro-2-thiazolyl)-2-thiophenecarboxamide; N-(5-Nitrothiazol-2-yl)thiophene-2-carboxamide; 2-Thiophenecarboxamide, N-(5-nitro-2-thiazolyl)-; Tenonitrozole (INN); NCGC00160655-01; Tenonitrozol; 2-(alpha-Thenoylamino)-2-nitro-5-thiazole; DSSTox_CID_26277; DSSTox_RID_81504; DSSTox_GSID_46277; Tenonitrozolum; CAS-3810-35-3; SR-01000213288; C8H5N3O3S2; Atrican (TN); alpha-Thenoylamino-2-nitro-5-thiazole; MLS001240199; SCHEMBL150446; REGID_for_CID_19646; CHEMBL1082354; DTXSID5046277; KS-00001YKI; Thiophene-2-carboxylic acid (5-nitro-thiazol-2-yl)-amide; CHEBI:135042; HMS2233B18; HMS3370N03; ZINC4217523; Tox21_111962; STK071581; TC-109; AKOS003277664; Tox21_111962_1; DB13659; MCULE-6457622214; NCGC00160655-02; NCGC00160655-03; SMR000674575; LS-152967; ST50236207; 6N-021; D07360; Q7700556; SR-01000213288-1; SR-01000213288-5; BRD-K93862950-001-07-1; N-(5-nitro(1,3-thiazol-2-yl))-2-thienylcarboxamide; N-(5-nitro-1,3-thiazol-2-yl)-2-thiophenecarboxamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C8H5N3O3S2",
"molecular_weight": "255.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "19646",
"classification": "P",
"indications": "",
"side_effects": "",
"atc_codes": "P01AX08",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02137",
"RC02758",
"RC03379"
]
},
{
"compound_ID": "D1110",
"name": "tenovin-1",
"synonyms": "Tenovin-1; 380315-80-0; Tenovin 1; UNII-BIQ6AID2B7; BIQ6AID2B7; N-[(4-acetamidophenyl)carbamothioyl]-4-tert-butylbenzamide; N-(4-acetamidophenylcarbamothioyl)-4-tert-butylbenzamide; NCGC00181351-01; AK175787; C20H23N3O2S; N-((4-acetamidophenyl)carbamothioyl)-4-(tert-butyl)benzamide; N-[(4-acetamidoanilino)-sulfanylidenemethyl]-4-tert-butylbenzamide; DSSTox_CID_26920; DSSTox_RID_82016; DSSTox_GSID_46920; Oprea1_317255; cc-649; SCHEMBL907582; ARONIS003419; CHEMBL1436543; DTXSID1046920; CHEBI:94482; CTK8E7058; AOB3695; EX-A146; QCR-245; WOWJIWFCOPZFGV-UHFFFAOYSA-N; HMS3648C12; HMS3653D17; ZINC674444; BCP06745; KS-00000T6Q; KS-00003WF7; Tox21_112809; s8000; STK077754; AKOS000492892; API0014025; CCG-208685; CS-1512; MCULE-2127700307; SB19404; NCGC00181351-05; AS-16764; HY-13423; SC-96762; AB0095644; BB0280547; RT-015907; CAS-380315-80-0; SW133688-2; Y0471; A11943; S-7743; AB00109204-01; SR-01000946350; J-524320; SR-01000946350-1; BRD-K05977823-001-01-2; Q27166342; N-{[4-(acetylamino)phenyl]carbamothioyl}-4-tert-butylbenzamide; N-({[4-(acetylamino)phenyl]amino}carbonothioyl)-4-tert-butylbenzamide; N-[4-({[(4-tert-butylphenyl)formamido]methanethioyl}amino)phenyl]acetamide; Benzamide, N-(((4-(acetylamino)phenyl)amino)thioxomethyl)-4-(1,1-dimethylethyl)-; N-[[[4-(Acetylamino)phenyl]amino]thioxomethyl-4-(1,1-dimethylethyl)]benzamide; n-[[[4-(acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)benzamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C20H23N3O2S",
"molecular_weight": "369.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1013376",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02138",
"RC02759",
"RC03380"
]
},
{
"compound_ID": "D1111",
"name": "tenoxicam",
"synonyms": "tenoxicam; 59804-37-4; Mobiflex; Tilcotil; Tenoxicamum; Liman; Tenoxicamum [INN-Latin]; Ro 12-0068; Tenoxicam(Mobiflex); UNII-Z1R9N0A399; CCRIS 5264; Ro 12-0068/000; BRN 0572193; 4-Hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide; MLS000069830; CHEBI:32192; C13H11N3O4S2; LZNWYQJJBLGYLT-UHFFFAOYSA-N; Z1R9N0A399; MFCD00083502; 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide; 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide; NCGC00016889-01; SMR000058865; CAS-59804-37-4; 2H-Thieno(2,3-e)-1,2-thiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; DSSTox_CID_25486; DSSTox_RID_80909; DSSTox_GSID_45486; 4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-THIENO[2,3-E]-1,2-THIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE; Q63395752; Alganex; Octiveran; Rexalgan; 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide; Tilcotil (TN); Tenoxicam [USAN:BAN:INN:JAN]; SR-01000721894; Ro-12-0068; Tenoxikam; Tenoxicam (JAN/USAN/INN); (4-hydroxy-2-methyl-1,1-dioxothiopheno[2,3-e]1,2-thiazin-3-yl)-N-(2-pyridyl)ca rboxamide; Tenoxicam [USAN:INN:BAN:JAN]; Tenoxicam, NSAID; 2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; Mobiflex, Tenoxicam; Prestwick_849; Ro-120068; Spectrum_001430; Opera_ID_1757; Prestwick0_000527; Prestwick1_000527; Prestwick2_000527; Prestwick3_000527; Spectrum2_001080; Spectrum3_001563; Spectrum4_000731; Spectrum5_001615; (3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; SCHEMBL25343; SCHEMBL25344; BSPBio_000513; BSPBio_003066; KBioGR_001022; KBioSS_001910; MLS001074071; MLS006011432; BIDD:GT0650; DivK1c_000252; SPECTRUM1503142; SPBio_001100; SPBio_002434; BPBio1_000565; CHEMBL302795; CHEMBL3188633; DTXSID8045486; SCHEMBL13448847; BCBcMAP01_000251; BDBM92332; CTK7I2701; HMS500M14; KBio1_000252; KBio2_001910; KBio2_004478; KBio2_007046; KBio3_002566; NINDS_000252; HMS1569J15; HMS1923I15; HMS2090P19; HMS2092L20; HMS2096J15; HMS2232K23; HMS3370L01; HMS3656O10; HMS3713J15; Pharmakon1600-01503142; BCP03624; HY-B0440; KS-000010UB; ZX-AT018824; Tox21_110666; BBL028173; BG0331; CCG-40126; NSC758397; s2512; SBB056362; STK637103; ZINC12503102; ZINC40884328; AKOS000282084; AKOS026750148; Tox21_110666_1; ZINC100006429; AC-4526; CS-2546; DB00469; KS-1313; MCULE-4636246417; NSC-758397; IDI1_000252; SMP1_000040; NCGC00016889-02; NCGC00016889-03; NCGC00016889-05; NCGC00016889-06; NCGC00095260-01; NCGC00095260-02; AK481350; SC-13535; BCP0726000170; SBI-0051780.P002; AB0012300; AB2000615; LS-152556; Ro-120068000; FT-0659572; ST50950119; SW219788-1; D01767; Q45050; AB00052322-11; AB00052322_12; AB00052322_13; 804T374; A832479; C-20248; SR-01000721894-2; SR-01000721894-4; Tenoxicam, British Pharmacopoeia (BP) Reference Standard; Tenoxicam, European Pharmacopoeia (EP) Reference Standard; N-(2-pyridyl)-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide; (3Z)-2-methyl-1,1-bis(oxidanylidene)-3-[oxidanyl-(pyridin-2-ylamino)methylidene]thieno[2,3-e][1,2]thiazin-4-one; (3Z)-3-[hydroxy-(2-pyridinylamino)methylidene]-2-methyl-1,1-dioxo-4-thieno[2,3-e]thiazinone; (Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2,3-dihydro-4H-thieno[2,3-e][1,2]thiazin-4-one 1,1-dioxide; 2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-2,3-dihydro-4H-thieno[2,3-e][1,2]thiazin-4-one 1,1-dioxide; 4-Hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-1,2-dihydro-1lambda~6~-thieno[2,3-e][1,2]thiazine-3-carboxamide; 4-Hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno-[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide; 4-hydroxy-2-methyl-n-pyridin-2-yl-2h-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide; 4-Hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide (Tenoxicam);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H11N3O4S2",
"molecular_weight": "337.4",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "0.99",
"half_life": "72 hours (range 59 to 74 hours)",
"absorption": "Oral absorption of tenoxicam is rapid and complete (absolute bioavailability 100%).",
"cid": "54677971",
"classification": "M",
"indications": "",
"side_effects": "",
"atc_codes": "M01AC02",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02139",
"RC02760",
"RC03381"
]
},
{
"compound_ID": "D1112",
"name": "tert-butyl 4-hydroxybenzoate",
"synonyms": "tert-Butyl 4-hydroxybenzoate; 25804-49-3; Tert-butyl-4-hydroxybenzoate; UNII-B8SS68TDWJ; B8SS68TDWJ; 4-hydroxy-benzoic acid tert-butyl ester; Benzoic acid, 4-hydroxy-, 1,1-dimethylethyl ester; 4-hydroxybenzoic acid 1,1-dimethylethyl ester; EINECS 247-272-9; DSSTox_CID_24895; DSSTox_RID_80566; DSSTox_GSID_44895; SCHEMBL38810; CHEMBL3185248; DTXSID7044895; CTK4F6484; WHWMOMRHHQLBQQ-UHFFFAOYSA-N; KS-00000H4P; ZINC5353709; 1,1-dimethylethyl 4-hydroxybenzoate; Tox21_301248; AB3413; AKOS013211449; 2-Methyl-2-propanyl 4-hydroxybenzoate; 4-Hydroxybenzoic acid tert butyl ester; 4-Hydroxybenzoic acid tert-butyl ester; CM12803; CS-W023012; NCGC00256248-01; AK156203; AS-19931; DA-07612; SC-66362; AB0043865; CAS-25804-49-3; FT-0769943; Z1825; X-3132; (4-Hydroxyphenyl)-carboxylic acid-tert-butyl ester; Benzoic acid,4-hydroxy-, 1,1-dimethylethyl ester; Q27274512;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H14O3",
"molecular_weight": "194.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "117640",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02140",
"RC02761",
"RC03382"
]
},
{
"compound_ID": "D1113",
"name": "tetra-aminopyrimidine sulfate",
"synonyms": "2,4,5,6-Tetraaminopyrimidine sulfate; 5392-28-9; Pyrimidinetetramine sulfate; Pyrimidine-2,4,5,6-tetraamine sulfate; tetraaminopyrimidine sulfate; 49647-58-7; Pyrimidinetetramine, sulfate (1:1); pyrimidine-2,4,5,6-tetramine; sulfuric acid; Pyrimidinetetramine, sulfate; UNII-53QQY0I99M; 2,4,5,6-TETRAAMINIOPYRIMIDINE SULFATE; 53QQY0I99M; 2,4,5,6-Pyrimidinetetramine, sulfate (1:?); 2,4,5,6-Pyrimidinetetramine, sulfate (1:1); 2,4,5,6-tetraminopyrimidine sulfate; MFCD00012786; Pyrimidine-2,4,5,6-tetraamine xsulfate; pyrimidine-2,4,5,6-tetramine;sulfuric acid; Tetraaminopyrimidine sulphate; 2,4,5,6-Tetraaminopyrimidine sulfate hydrate, 98%; Pyrimidinetetramine sulphate; Pyrimidinetetrayltetraamine sulphate; NSC 3277; EINECS 226-393-0; EINECS 256-407-0; Pyrimidine, tetraamino-, sulfate (1:1); ACMC-1AOOB; AI3-17130; tetraminopyrimidine sulfate; DSSTox_CID_17023; DSSTox_RID_79296; tetra-Aminopyrimidine sulfate; DSSTox_GSID_37023; Pyrimidine, sulfate (1:1); SCHEMBL121743; C4H10N6O4S; CHEMBL3185354; DTXSID0037023; NIOSH/UV9738000; CTK1D7276; KS-00000NYK; Pyrimidine, tetraamino-, sulfate; NSC3277; MQEFDQWUCTUJCP-UHFFFAOYSA-N; 2,5,6-Tetraaminopyrimidine sulfate; ACT01401; NSC-3277; Tox21_202843; ANW-31879; NSC227862; SBB070638; AKOS009157219; AC-2771; CS-W018518; MCULE-4325131370; NSC-227862; Pyrimidine-2,4,5,6-tetraaminexsulfate; NCGC00260389-01; AK-47316; AS-11871; BP-12573; BR-47316; SC-17592; SY002869; CAS-5392-28-9; 2,4,5,6-Tetraaminopyrimidine sulfate salt; LS-135528; Pyrimidine, 2,4,5,6-tetraamino-, sulfate; TC-120624; AM20100326; FT-0609777; FT-0698475; ST24032266; UV97380000; 2,4,5,6-Pyrimidinetetramine sulfate (1:1); 2,4,5,6-TETRAAMINO PYRIMIDINE SULFATE; 92T289; M-6364; 2,4,5,6-Tetraaminopyrimidine sulfate salt, 97%; A800214; Q-200172; Q-200173; Q27261126; Z940713454;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C4H10N6O4S",
"molecular_weight": "238.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "79358",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02141",
"RC02762",
"RC03383"
]
},
{
"compound_ID": "D1114",
"name": "tetrabromophenolphthalein ethyl ester",
"synonyms": "Tetrabromophenolphthalein ethyl ester; 1176-74-5; Ethyl tetrabromophenolphthalein; UNII-6D91NS781O; 3',3'',5',5''-Tetrabromophenolphthalein ethyl ester; 6D91NS781O; Ethyl 2-((3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)benzoate; ethyl 2-((3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxocyclohexa-2,5-dien-1-ylidene)methyl)benzoate; Ethyl 2-[(3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]benzoate; Benzoic acid, 2-((3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-, ethyl ester; Benzoic acid, 2-[(3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-, ethyl ester; Tetrabromophenolphthalein ethyl ester, pure; Chromoionophore VIII; Bromophthalein Magenta E; Brom Phthalein Magenta E; Bromophthalein Margenta E; HSDB 7731; EINECS 214-645-2; NSC 16214; DSSTox_CID_24520; DSSTox_RID_80287; DSSTox_GSID_44520; SCHEMBL143877; CHEMBL3187347; DTXSID5044520; CTK8D9212; SQFXATUXPUCFFO-UHFFFAOYSA-N; KS-000001WV; NSC16214; ZINC4261803; Tox21_301921; NSC-16214; TD8094; Tetrabromophenolphthalein, ethyl ester; AKOS015904012; MCULE-6887334761; Chromoionophore VIII, Selectophore(TM); NCGC00255775-01; 3 inverted exclamation marka,3 inverted exclamation marka,5 inverted exclamation marka,5 inverted exclamation marka-Tetrabromophenolphthalein ethyl ester; AK160926; Benzoic acid,2-[(3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-,ethyl ester; CAS-1176-74-5; AX8293951; 4CH-023416; ST24050114; ST50997498; T-1942; 3',3,5',5-Tetrabromophenolphthalein ethyl ester; 3',5',5''-Tetrabromophenolphthalein ethyl ester; 3',5',5''-Tetrabromophenolphthalein, ethyl ester; 3',5',5''-Tetrabromophenylphthalein, ethyl ester; J-003651; Q27264570; 3,3\",5,5\"-Tetrabromophenolphthalein ethyl ester for microscopy; 3',3\",5',5\"-Tetrabromophenolphthalein ethyl ester, for microscopy; Benzoic acid,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-, ethyl ester; ethyl 2-[(3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxocyclohexa-2,5-dienylid ene)methyl]benzoate; o-Toluic acid,5-dibromo-4-hydroxyphenyl)-.alpha.-(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)-, ethyl ester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C22H14Br4O4",
"molecular_weight": "662",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "92873",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02142",
"RC02763",
"RC03384"
]
},
{
"compound_ID": "D1115",
"name": "tetrabutylphosphonium chloride",
"synonyms": "Tetrabutylphosphonium chloride; 2304-30-5; Tetra-N-butylphosphonium chloride; Phosphonium, tetrabutyl-, chloride; Tetrabutyl phosphonium chloride; UNII-5977P51M7G; Phosphonium, tetrabutyl-, chloride (1:1); EINECS 218-964-8; 5977P51M7G; DSSTox_CID_24616; DSSTox_RID_80351; DSSTox_GSID_44616; CAS-2304-30-5; Tetrabutylphosphoniumchloride; C16H36ClP; ACMC-1CN22; tetrabutylphosphanium,chloride; SCHEMBL124627; CHEMBL3186347; DTXSID4044616; CTK3J1516; KS-00000VKU; IBWGNZVCJVLSHB-UHFFFAOYSA-M; tetra n-butyl phosphonium chloride; Tox21_200765; Tox21_303484; ANW-42042; AKOS015907850; RTR-010768; TRA-0183921; NCGC00257245-01; NCGC00258319-01; R518; LS-106937; Tetrabutylphosphonium chloride 80% solution; TR-010768; FT-0657244; T1649; tetrabutylphosphonium chloride (80% in water); W-107439; Q27261673;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H36ClP",
"molecular_weight": "294.9",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "75311",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02143",
"RC02764",
"RC03385"
]
},
{
"compound_ID": "D1116",
"name": "tetrabutyltin",
"synonyms": "Tetrabutylstannane; TETRABUTYLTIN; 1461-25-2; Tetra-n-butyltin; Stannane, tetrabutyl-; Tin, tetrabutyl-; Tetra-N-butylcin; Tetra-n-butylcin [Czech]; UNII-QJ7Y5V377V; CCRIS 6322; Tetra-Normal-Butyltin; HSDB 6074; EINECS 215-960-8; NSC 22330; NSC 28131; NSC 65524; BRN 3648237; QJ7Y5V377V; AFCAKJKUYFLYFK-UHFFFAOYSA-N; Tetra-n-butyltin, 96%; EN300-93667; WLN: 4-SN-4&4&4; Tetra-N-butylcin [Czech]; C16H36Sn; tetrabutyl tin; Tin, tetrabutyl; Tetrabutyl tin ion; Tin tetra-n-butyl; Bu4Sn; MFCD00009422; DSSTox_CID_2153; EC 215-960-8; ACMC-1C25D; DSSTox_RID_76505; NCIOpen2_008184; DSSTox_GSID_22153; KSC179S7H; (C4H9)4Sn; DTXSID4022153; CTK0H9973; NSC22330; NSC28131; NSC65524; Tox21_302893; 7236AA; ANW-20987; NSC-22330; NSC-28131; NSC-65524; Tetrabutyltin, technical grade, 93%; AKOS016010486; ZINC169743017; RTR-005780; NCGC00164231-01; NCGC00256589-01; Terbutyltin 1000 microg/mL in Methanol; Tetrabutyltin 100 microg/mL in Methanol; CAS-1461-25-2; Tetrabutyltin 10 microg/mL in Cyclohexane; LS-146607; TR-005780; ST24031874; Q425214;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H36Sn",
"molecular_weight": "347.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "15098",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02144",
"RC02765",
"RC03386"
]
},
{
"compound_ID": "D1117",
"name": "tetradecylpyridinium bromide",
"synonyms": "1-tetradecylpyridin-1-ium bromide; 1155-74-4; Myristylpyridinium bromide; 1-Tetradecylpyridinium bromide; TETRADECYLPYRIDINIUM BROMIDE; Fixanol VR; Morpan TPB; Fylomac 90; UNII-V2WIJ52V0W; N-Tetradecylpyridinium bromide; V2WIJ52V0W; Pyridinium, 1-tetradecyl-, bromide (1:1); Pyridinium,1-tetradecyl-, bromide (1:1); tetradecylpyridine, bromide; Pyridinium, 1-tetradecyl-, bromide; EINECS 214-586-2; NSC 148339; DSSTox_CID_22459; DSSTox_RID_80030; DSSTox_GSID_42459; SCHEMBL177665; CHEMBL3181920; DTXSID5042459; CTK4A9386; Tox21_301239; 2528AA; NSC148339; SBB060436; AKOS015891724; MCULE-5833815773; NSC-148339; VZ33815; NCGC00255864-01; CAS-1155-74-4; AX8166949; ST51046612; A803456; Q27291460;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C19H34BrN",
"molecular_weight": "356.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "62379",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02145",
"RC02766",
"RC03387"
]
},
{
"compound_ID": "D1118",
"name": "tetradifon",
"synonyms": "TETRADIFON; 116-29-0; Tetradichlone; Duphar; Akaritox; Polacaritox; Roztoczol; Roztozol; Tetradiphon; Tetrafidon; Aredion; Mition; Tedion; Roztoczol extra; 2,4,5,4'-Tetrachlorodiphenyl sulfone; 1,2,4-Trichloro-5-((4-chlorophenyl)sulfonyl)benzene; Aracnol K; Childion; Dorvert; Tedane; Tedion V-18; Tedane Combi; Turbair Acaricide; 2,4,4',5-Tetrachlorodiphenyl sulfone; Caswell No. 836; 4-Chlorophenyl 2,4,5-trichlorophenyl sulfone; UNII-TIP8EA8VTS; FMC 5488; NIA 5488; 1,2,4-Trichloro-5-[(4-chlorophenyl)sulfonyl]benzene; p-Chlorophenyl 2,4,5-trichlorophenyl sulfone; 2,4,5,4'-Tetrachlorodiphenylsulphone; ENT 23,737; Tetradifon [ANSI:BSI:ISO]; CCRIS 4026; Sulfone, 2,4,4',5-tetrachlorodiphenyl; 1,2,4-trichloro-5-(4-chlorophenyl)sulfonylbenzene; V-18; HSDB 1773; TIP8EA8VTS; Benzene, 1,2,4-trichloro-5-[(4-chlorophenyl)sulfonyl]-; p-Chlorophenyl 2,4,5-trichlorophenyl sulphone; Sulfone, p-chlorophenyl 2,4,5-trichlorophenyl; EINECS 204-134-2; 3,4,6,4'-Tetrachlor-diphenylsulfon; 2,4,4',5-Tetrachloor-difenyl-sulfon; 2,4,4',5-Tetrachlor-diphenyl-sulfon; 2,4,4',5-Tetracloro-difenil-solfone; EPA Pesticide Chemical Code 079202; 2,4,4',5-Tetrachlorodiphenyl sulphone; BRN 2292528; AI3-23737; CHEBI:39330; p-Chlorophenyl-2,4,5-trichlorophenyl sulfone; 2,4,4',5-Tetrachloor-difenyl-sulfon [Dutch]; 3,4,6,4'-Tetrachlor-diphenylsulfon [German]; 4-Chlorophenyl 2,4,5-trichlorophenyl sulphone; 2,4,4',5-Tetrachlor-diphenyl-sulfon [German]; 2,4,4',5-Tetracloro-difenil-solfone [Italian]; 2,4,4',5-Tetrachlorodiphenyl sulphone (british); Benzene, 1,2,4-trichloro-5-((4-chlorophenyl)sulfonyl)-; DSSTox_CID_1316; DSSTox_RID_76076; DSSTox_GSID_21316; CAS-116-29-0; Acarvin; Mitifon; Acaroil TD; Agrex T-7.5; SCHEMBL27902; Tetradifon, analytical standard; CHEMBL437926; DTXSID7021316; CTK8E8284; MLGCXEBRWGEOQX-UHFFFAOYSA-; MLGCXEBRWGEOQX-UHFFFAOYSA-N; Sulfone, p-chlorophenyl 2,4,5-trichlorophenyl (7CI)(8CI); ZINC2041031; Tox21_202396; Tox21_302766; AKOS015960875; LS-7716; Tetradifon 10 microg/mL in Cyclohexane; NCGC00163708-01; NCGC00163708-02; NCGC00163708-03; NCGC00256511-01; NCGC00259945-01; Tetradifon 10 microg/mL in Acetonitrile; Tetradifon 100 microg/mL in Cyclohexane; AC-12472; CC-34854; S354; AX8153331; DB-041307; TR-003006; FT-0603317; Tetradifon, PESTANAL(R), analytical standard; C18451; p-Chlorophenyl, 2,4,5-trichlorophenyl sulfone; 116T290; C-20770; Q413684; 1,2,4-trichloro-5-(4-chlorophenylsulfonyl)benzene; J-003419; Sulfone, p-chlorophenyl 2,4,5-trichlorophenyl (7CI); InChI=1/C12H6Cl4O2S/c13-7-1-3-8(4-2-7)19(17,18)12-6-10(15)9(14)5-11(12)16/h1-6H;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H6Cl4O2S",
"molecular_weight": "356",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "8305",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02146",
"RC02767",
"RC03388"
]
},
{
"compound_ID": "D1119",
"name": "tetraiodoethene",
"synonyms": "Tetraiodoethylene; Tetraiodoethene; Periodoethene; Ethene, tetraiodo-; 513-92-8; Ethylene periodide; Diiodoform; Ethylene tetraiodide; ETHYLENE, TETRAIODO-; Diodoform; Caswell No. 842; UNII-K9R00J32Z7; EINECS 208-176-2; NSC 66408; EPA Pesticide Chemical Code 046908; BRN 1741414; Ethene,1,1,2,2-tetraiodo-; Ethene, 1,1,2,2-tetraiodo-; K9R00J32Z7; C2I4; ACMC-20ajjk; Tetraiodoethylene, 97%; DSSTox_CID_22462; DSSTox_RID_80031; DSSTox_GSID_42462; 4-01-00-00724 (Beilstein Handbook Reference); 1,1,2,2-Tetraiodoethylene #; CHEMBL3182626; DTXSID4042462; CTK4J4169; ZGQURDGVBSSDNF-UHFFFAOYSA-N; NSC66408; ZINC6827597; Tox21_301628; 6898AF; NSC-66408; AKOS015913264; NCGC00255759-01; CAS-513-92-8; LS-68552; DS-002698; TC-164999; Q27282133;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C2I4",
"molecular_weight": "531.64",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "10568",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02147",
"RC02768",
"RC03389"
]
},
{
"compound_ID": "D1120",
"name": "tetra-n-octylammonium bromide",
"synonyms": "Tetraoctylammonium bromide; 14866-33-2; tetra-N-Octylammonium bromide; Tetraoctyl ammonium bromide; tetraoctylazanium bromide; tetra(n-octyl)ammonium bromide; UNII-52QW29OWOC; 1-OCTANAMINIUM, N,N,N-TRIOCTYL-, BROMIDE; EINECS 238-936-9; MFCD00011863; 52QW29OWOC; AK106154; W-108100; Tetra-n-octylammonium bromide, 98%; ACMC-1BVTH; tetra-octylammonium bromide; C32H68BrN; tetra octyl ammonium bromide; DSSTox_CID_14042; DSSTox_RID_79108; DSSTox_GSID_34042; SCHEMBL28062; KSC491C0J; CHEMBL1499545; DTXSID7034042; CTK3J1104; QBVXKDJEZKEASM-UHFFFAOYSA-M; ZX-AT021570; Tox21_201028; ANW-21158; AKOS015833042; CS-W019360; GS-3229; JC10010; N,N,N-trioctyloctan-1-aminium bromide; RTR-005983; TRA0171723; KS-00000H61; NCGC00091022-01; NCGC00258581-01; SC-80217; SY010775; AB0011245; CAS-14866-33-2; DB-050368; LS-195425; ST2407751; TR-005983; FT-0653960; K-4724; A808797; C-45664; Q7706628; 1-OCTANAMINIUM, N,N,N-TRIOCTYL-, BROMIDE;N,N,N-TRIOCTYL-1-OCTANAMINIUMBROMIDE;TETRA-N-OCTYLAMMONIUM BROMIDE;TETRAOCTYLAMMONIUM BROMIDE;Tetraoctyl ammonium bromide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C32H68BrN",
"molecular_weight": "546.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2734117",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02148",
"RC02769",
"RC03390"
]
},
{
"compound_ID": "D1121",
"name": "tetraoctylphosphonium bromide",
"synonyms": "Tetraoctylphosphonium bromide; 23906-97-0; Tetra-n-octylphosphonium Bromide; Phosphonium,tetraoctyl-, bromide (1:1); tetraoctylphosphanium bromide; Tetra-n-octylphosphoniumBromide; EINECS 245-935-7; ACMC-209g6x; tetraoctylphosphanium,bromide; DSSTox_CID_27876; DSSTox_RID_82629; DSSTox_GSID_47900; SCHEMBL125260; CHEMBL3182779; DTXSID5047900; CTK4F2536; QVBRLOSUBRKEJW-UHFFFAOYSA-M; KS-000015QV; Tox21_200576; ANW-25255; AKOS015833043; VZ33794; NCGC00258130-01; AS-59832; CAS-23906-97-0; TR-011068; J-015269;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C32H68BrP",
"molecular_weight": "563.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "3015167",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02149",
"RC02770",
"RC03391"
]
},
{
"compound_ID": "D1122",
"name": "tetrasul",
"synonyms": "TETRASUL; 2227-13-6; Tetradisul; Animert; Animert V-10; Animert V-10K; Animert V-101; Philips-duphar V-101; Caswell No. 213; Tetrasul [BSI:ISO]; UNII-BEO7JP5U0R; V-101; ENT 27,115; 2,4,4',5-Tetrachlorodiphenyl sulfide; 2,4,5,4'-Tetrachlorodiphenyl sulfide; 2,4,4',5-Tetrachlorodiphenyl sulphide; 1,2,4-trichloro-5-(4-chlorophenyl)sulfanylbenzene; V 101; 4-Chlorophenyl 2,4,5-trichlorophenyl sulfide; p-Chlorophenyl 2,4,5-trichlorophenyl sulfide; Sulfide, p-chlorophenyl 2,4,5-trichlorophenyl; EINECS 218-761-4; BEO7JP5U0R; 3,4,6,4'-Tetrachlor-diphenylsulfid; EPA Pesticide Chemical Code 079201; BRN 1884271; AI3-27115; 2-Chlorophenyl 2,4,5-trichlorophenyl sulfide; CHEBI:82162; 3,4,6,4'-Tetrachlor-diphenylsulfid [German]; 4-Chlorophenyl 2,4,5-trichlorophenyl sulphide; Benzene, 1,2,4-trichloro-5-((4-chlorophenyl)thio)-; Benzene, 1,2,4-trichloro-5-[(4-chlorophenyl)thio]-; 2,4,4',5-Tetrachlorodiphenylsulphide; DSSTox_CID_314; p-Chlorophenyl-2,4,5-trichlorophenyl sulfide; DSSTox_RID_75508; DSSTox_GSID_20314; 1,2,4-Trichloro-5-(4-(chlorophenyl)thio)benzene; 1,2,4-trichloro-5-[(4-chlorophenyl)thio]benzene; CAS-2227-13-6; SCHEMBL26508; CHEMBL1365576; DTXSID5020314; 1,2,4-Trichloro-5-(4-(chlorophenyl)thio)benzene (9CI); QUWSDLYBOVGOCW-UHFFFAOYSA-N; BENZENE,1,2,4-TRICHLORO-5-[(4-CHLOROPHENYL)THIO]-; ZINC2161992; Tox21_202392; Tox21_302984; AKOS024319292; ACM2227136; DB12838; LS-7270; MCULE-2053204562; NCGC00166163-01; NCGC00166163-02; NCGC00256524-01; NCGC00259941-01; DB-045861; FT-0634147; Tetrasul, PESTANAL(R), analytical standard; C19032; (4-chlorophenyl)(2,4,5-trichlorophenyl)sulfane; C-57950; J-014616; Q15632887; 1,2,4-Trichloro-5-[(4-chlorophenyl)sulfanyl]benzene #;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H6Cl4S",
"molecular_weight": "324",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16685",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02150",
"RC02771",
"RC03392"
]
},
{
"compound_ID": "D1123",
"name": "thidiazuron",
"synonyms": "THIDIAZURON; 51707-55-2; 1-Phenyl-3-(1,2,3-thiadiazol-5-yl)urea; Defolit; Dropp; Urea, N-phenyl-N'-1,2,3-thiadiazol-5-yl-; Caswell No. 659A; UNII-0091WH7STF; Thidiazuron [ANSI:BSI:ISO]; SN 49537; N-Phenyl-N'-1,2,3-thiadiazol-5-ylurea; EINECS 257-356-7; EPA Pesticide Chemical Code 120301; BRN 1078092; N-Phenyl-N'-1,2,3-thiazol-5-ylurea; (N-1,2,3-Thiadiazolyl-5)-N'-phenylurea; N-Phenyl-N'-1,2,3-thiadiazol-5-yl-urea; 0091WH7STF; CHEMBL505661; CHEBI:81977; AK116569; Urea, 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-; W-105872; (phenylamino)-N-(1,2,3-thiadiazol-5-yl)carboxamide; 1-phenyl-3-(thiadiazol-5-yl)urea; Thidiauron; Thidiazuran; HSDB 7734; CCG-24904; 5-Phenylcarbamoylamino-1,2,3-thiadiazole; Cambridge id 5282278; DSSTox_CID_12651; DSSTox_RID_79026; DSSTox_GSID_32651; SCHEMBL121077; Urea, N-phenyl-N'-1,2,3-thiadiazol-5-yl- (9CI); DTXSID0032651; SCHEMBL11467912; ZINC73715; BIT0888; HFCYZXMHUIHAQI-UHFFFAOYSA-N; ZX-AFC000685; 1-phenyl-3-(5-thiadiazolyl)urea; Tox21_300651; BDBM50274591; GY0412; MFCD00078723; STL298442; AKOS000505963; HF-0028; MCULE-8227703755; VA11865; ACM41118836; NCGC00160490-01; NCGC00160490-02; NCGC00160490-03; NCGC00160490-04; NCGC00254559-01; AC-14070; M955; ST023312; AB0015469; CAS-51707-55-2; DB-015552; LS-160656; TR-036946; CS-0012891; FT-0630649; N-phenyl-N'-1,2,3-thiadiazole-5-yl Urea; ST24038173; 1-phenyl-3-(1,2,3-thiadiazole-5-yl)-urea; KS-00000072; C18812; J10259; K-9492; Thidiazuron, PESTANAL(R), analytical standard; AB00079069-01; 118T836; A828736; Thidiazuron, plant cell culture tested, BioReagent; Q1968056; UREA,N-PHENYL-N'-1,3,4-THIADIAZOL-2-YL-; Pesticide2_Thidiazuron_C9H8N4OS_1-Phenyl-3-(1,2,3-thiadiazol-5-yl)urea; WA1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C9H8N4OS",
"molecular_weight": "220.25",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "40087",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02151",
"RC02772",
"RC03393"
]
},
{
"compound_ID": "D1124",
"name": "thiram",
"synonyms": "thiram; Tetramethylthiuram disulfide; 137-26-8; Thiuram; TMTD; Pomarsol; Thirame; Arasan; Fernasan; Nobecutan; Rezifilm; Thioscabin; Thirasan; Aapirol; Tersan; Tetrathiuram disulfide; Tetramethylthiuram; Falitiram; Formalsol; Hexathir; Kregasan; Mercuram; Normersan; Sadoplon; Spotrete; Tetrasipton; Thillate; Thiramad; Aatiram; Atiram; Fermide; Fernide; Hermal; Pomasol; Puralin; Thiosan; Thiotox; Thiulin; Thiulix; Heryl; Pomarsol forte; Methyl tuads; Polyram ultra; Accelerator T; Methyl Thiram; Fernasan A; Nocceler TT; Arasan-M; Bis(dimethylthiocarbamoyl) disulfide; Thiram B; Arasan-SF; Cyuram DS; Ekagom TB; Hermat TMT; Tetramethylenethiuram disulfide; Accel TMT; Accelerator thiuram; Aceto TETD; Radothiram; Royal TMTD; Tetramethyl-thiram disulfid; Fernacol; Sadoplon 75; Tetramethylthiuram bisulfide; Tetrapom; Thioknock; Thirampa; Thiramum; Anles; Arasan-SF-X; Aules; Thimer; Panoram 75; Tetramethylthiuram disulphide; Tetramethylthiurane disulfide; Arasan 70; Arasan 75; Tersan 75; Thiram 75; Thiram 80; Spotrete-F; TMTDS; Arasan 70-S Red; Tetramethylthioperoxydicarbonic diamide; Methylthiuram disulfide; Tetramethylthiouram disulfide; N,N-Tetramethylthiuram disulfide; Metiurac; Micropearls; Nomersan; Thianosan; Cunitex; Delsan; Metiur; Thimar; Teramethylthiuram disulfide; Tersantetramethyldiurane sulfide; Pol-Thiuram; Arasan 42-S; Tetramethylthiurum disulfide; Disulfure de tetramethylthiourame; Tetrathiuram disulphide; Sranan-sf-X; Bis(dimethylthiocarbamyl) disulfide; Hy-Vic; Chipco thiram 75; Bis(dimethyl-thiocarbamoyl)-disulfid; Orac TMTD; Tetramethylthioramdisulfide; Tetramethyldiurane sulphite; Thiotox (fungicide); Disulfide, bis(dimethylthiocarbamoyl); Bis((dimethylamino)carbonothioyl) disulfide; Fermide 850; Tetramethyl thiuramdisulfide; Tetramethylthiocarbamoyldisulphide; Thiuramyl; Thylate; Attack; Methyl thiuramdisulfide; Tetramethyl thiurane disulfide; Bis(dimethyl thiocarbamoyl)disulfide; Thirame [INN-French]; Thiramum [INN-Latin]; Thiuram D; Disolfuro di tetrametiltiourame; Tetramethyl thiurane disulphide; Tetramethylenethiuram disulphide; N,N'-(Dithiodicarbonothioyl)bis(N-methylmethanamine); SQ 1489; RCRA waste number U244; Flo Pro T Seed Protectant; Tetramethylthiuram bisulphide; Tetramethylthiuran disulphide; Tetramethylthiurum disulphide; Tetramethyl thiuram disulfide; Caswell No. 856; alpha,alpha'-Dithiobis(dimethylthio)formamide; Thiotex; Thiurad; Tirampa; Tiuramyl; Trametan; Tridipam; Tripomol; Tyradin; Tuads; Tutan; Vulkacit mtic; N,N,N',N'-Tetramethylthiuram disulfide; N,N-Tetramethylthiuram disulphide; Vulkacit thiuram; Thioperoxydicarbonic diamide, tetramethyl-; Thiuram M; Vulkacit TH; Tetramethylthioramdisulfide [Dutch]; Vulcafor TMT; Vulcafor TMTD; Bis((dimethylamino)carbonothioyl) disulphide; FMC 2070; NSC-1771; Bis(dimethylthiocarbamoyl) disulphide; Tetramethyl-thiram disulfid [German]; UNII-0D771IS0FH; Formamide, 1,1'-dithiobis(N,N-dimethylthio-; dimethylcarbamothioylsulfanyl N,N-dimethylcarbamodithioate; Zaprawa Nasienna T; [Me2NC(S)S]2; Vancida tm-95; Disulfuro di tetrametiltiourame; Arasan 42S; TUEX; CCRIS 1282; HSDB 863; Disolfuro di tetrametiltiourame [Italian]; Disulfuro di tetrametiltiourame [Italian]; Disulfure de tetramethylthiourame [French]; C6H12N2S4; ENT 987; NSC1771; KUAZQDVKQLNFPE-UHFFFAOYSA-N; Bis(dimethyl-thiocarbamoyl)-disulfid [German]; NSC 1771; VUAgT-I-4; EINECS 205-286-2; NSC 49512; NSC 59637; Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetramethyl-; RCRA waste no. U244; EPA Pesticide Chemical Code 079801; NSC 622696; [disulfanediylbis(carbonothioylnitrilo)]tetramethane; BRN 1725821; Thiuram M rubber accelerator; AI3-00987; MLS000069752; MLS002702972; 0D771IS0FH; CHEBI:9495; Thiuram disulfide, tetramethyl-; DTXSID5021332; Thiuram-M; Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetramethyl-; Tetramethylthiuram disulfide, 97%; NSC49512; CCG-35460; NSC622696; TNTD; NCGC00091563-01; SMR000059023; Thioperoxydicarbonic diamide ((H2N)C(S))2S2, tetramethyl-; [dithiobis(carbonothioylnitrilo)]tetramethane; DSSTox_CID_1332; DSSTox_RID_76087; .alpha.,.alpha.'-Dithiobis(dimethylthio)formamide; DSSTox_GSID_21332; Granuflo; Thiuramin; N,N',N'-Tetramethylthiuram disulfide; TMT Disulfide; (dimethylamino){[(dimethylamino)thioxomethyl]disulfanyl}methane-1-thione; Thioperoxydicarbonic diamide (((H2N)C(S))2S2), N,N,N',N'-tetramethyl-; Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), N,N,N',N'-tetramethyl-; CAS-137-26-8; Formamide,1'-dithiobis(N,N-dimethylthio-; Bis[(dimethylamino)carbonothioyl] disulfide; Attack [Antifungal]; NSC59637; Thiram [USAN:INN]; WLN: 1N1 & YUS & SSYUS & N1 & 1; tiramo; Basultra; Betoxin; Tiradin; Accelerant T; Arasan m; Vulkazam S; Vanguard GF; Vancide TM; Akrochem TMTD; Perkacit TMTD; Vulkacit DTMT; Robac TMT; Thiram (Tmtd); Rezifilm (TN); Arasan 50 red; Spotrete WP 75; MFCD00008325; Vancide TM-95; Naftocit thiuram 16; Thiram [BSI:ISO]; Spectrum_001687; Thiram (USAN/INN); Agrichem flowable thiram; Spectrum2_001554; Spectrum3_001592; Spectrum4_000860; Spectrum5_001653; bmse000928; EC 205-286-2; NCIMech_000272; cid_5455; NCIOpen2_007854; SCHEMBL21144; BSPBio_003184; KBioGR_001499; KBioSS_002167; 4-04-00-00242 (Beilstein Handbook Reference); KSC491C8F; BIDD:ER0359; DivK1c_000741; SPECTRUM1503322; SPBio_001428; CHEMBL120563; Thiram [USAN:INN:BSI:ISO]; BDBM43362; CTK3J1182; HMS502F03; KBio1_000741; KBio2_002167; KBio2_004735; KBio2_007303; KBio3_002684; KUAZQDVKQLNFPE-UHFFFAOYSA-; ENT-987; NINDS_000741; HMS1922A12; HMS2093E03; HMS2234B08; HMS3374C05; Pharmakon1600-01503322; KS-00000Z7X; ZINC1532176; Thiram 10 microg/mL in Cyclohexane; Tox21_111150; Tox21_201569; Tox21_301102; LS-803; NSC-49512; NSC758454; SBB000804; STL264104; AKOS000120200; bis (dimethyl thiocarbamoyl) disulfide; Bis(dimethylaminothiocarbonyl)disulfide; Tox21_111150_1; DB13245; KS-5354; MCULE-4171536161; NSC-622696; NSC-758454; RTR-004967; SQ-1489; IDI1_000741; QTL1_000082; TRA-0180716; NCGC00091563-02; NCGC00091563-03; NCGC00091563-04; NCGC00091563-05; NCGC00091563-06; NCGC00091563-07; NCGC00091563-08; NCGC00091563-09; NCGC00091563-10; NCGC00091563-12; NCGC00255002-01; NCGC00259118-01; CC-34914; NCI60_001477; NCI60_006736; SC-18941; ST044501; SBI-0051813.P002; Thiram, PESTANAL(R), analytical standard; AB1002114; DB-042384; TR-004967; B0486; CS-0012858; FT-0083178; FT-0631799; 37T268; C11160; D06114; 26833-EP2280009A1; 26833-EP2305658A1; 26833-EP2314583A1; AB00052345_10; C-31381; Q416572; SR-01000736911; J-006992; J-524968; SR-01000736911-2; Thiram, certified reference material, TraceCERT(R); BRD-K29254801-001-06-3; F0001-0468; TETRAMETHYLTHIOPEROXYDICARBONIC ACID [(H2N)C(S)]2S2; N,N-dimethyl[(dimethylcarbamothioyl)disulfanyl]carbothioamide; 1-(dimethylthiocarbamoyldisulfanyl)-N,N-dimethyl-methanethioamide; N,N-dimethylcarbamodithioic acid (dimethylthiocarbamoylthio) ester; InChI=1/C6H12N2S4/c1-7(2)5(9)11-12-6(10)8(3)4/h1-4H3; 1-(3-{[hydroxy(methoxy)methylidene]amino}phenoxy)-N-(3-methylphenyl)methanimidic acid; Bis(dimethylthiocarbamoyl) disulfide; Bis(dimethylthiocarbamyl) disulfide; Thiram; N(1),N(1),N(3),N(3)-tetramethyl-2-dithioperoxy-1,3-dithiodicarbonic diamide; N,N-dimethylcarbamodithioic acid [[dimethylamino(sulfanylidene)methyl]thio] ester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C6H12N2S4",
"molecular_weight": "240.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5455",
"classification": "P",
"indications": "",
"side_effects": "",
"atc_codes": "P03AA05",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02152",
"RC02773",
"RC03394"
]
},
{
"compound_ID": "D1125",
"name": "tibrofan",
"synonyms": "TIBROFAN; UNII-2K1U70U1M5; 15686-72-3; 4,5-dibromo-N-(4-bromophenyl)thiophene-2-carboxamide; 2K1U70U1M5; NCGC00160448-01; Tibrofan [USAN:INN]; Tibrofan (USAN/INN); DSSTox_CID_26156; DSSTox_RID_81387; DSSTox_GSID_46156; SCHEMBL2110124; 2-Thiophenecarboxamide, 4,5-dibromo-N-(4-bromophenyl)-; CHEMBL1315136; DTXSID9046156; ZINC538456; Tox21_111818; AKOS001354723; MCULE-6350568360; NCGC00160448-02; 4,4',5-Tribromo-2-thiophenecarboxyanilide; CAS-15686-72-3; D06134; SR-01000944960; SR-01000944960-1; Q27254847;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H6Br3NOS",
"molecular_weight": "439.95",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "27448",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02153",
"RC02774",
"RC03395"
]
},
{
"compound_ID": "D1126",
"name": "tioxidazole",
"synonyms": "Tioxidazole; 61570-90-9; Methyl (6-propoxybenzo[d]thiazol-2-yl)carbamate; UNII-NZW046NI85; Sch-21480; NZW046NI85; NCGC00160481-01; Carbamic acid, (6-propoxy-2-benzothiazolyl)-, methyl ester; (6-Propoxy-benzothiazol-2-yl)-carbamic acid methyl ester; Tioxidazol; Tioxidazolum; Tiox; Tiox (Veterinary); SMR001353140; Tioxidazol [INN-Spanish]; Tioxidazole [USAN:INN]; Tioxidazolum [INN-Latin]; EINECS 262-854-2; Tiox (TN); Methyl 6-propoxy-2-benzothiazolecarbamate; ChemDivAM_000281; Tioxidazole (USAN/INN); ChemDiv1_000106; DSSTox_CID_26178; DSSTox_RID_81409; DSSTox_GSID_46178; Oprea1_503682; Oprea1_841146; SCHEMBL23382; MLS004754522; MLS006011641; CHEMBL1371412; DTXSID7046178; CTK5B3437; HMS587E18; HLLICFJUWSZHRJ-UHFFFAOYSA-N; ZINC1842639; Tox21_111843; SCH 21480; STK832929; AKOS000539060; CCG-103442; DB11472; MCULE-6592029073; NCGC00160481-02; AX8154207; CAS-61570-90-9; methyl-6-n-propoxybenzothiazole-2-carbamate; ST50223266; methyl-6-n-propyloxybenzothiazole-2-carbamate; D06158; methoxy-N-(6-propoxybenzothiazol-2-yl)carboxamide; SR-01000884010; methyl (6-propoxy-1,3-benzothiazol-2-yl)carbamate; SR-01000884010-1; BRD-K08404405-001-01-0; Q27285133; Carbamic acid,N-(6-propoxy-2-benzothiazolyl)-, methyl ester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H14N2O3S",
"molecular_weight": "266.32",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "72157",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02154",
"RC02775",
"RC03396"
]
},
{
"compound_ID": "D1127",
"name": "tolclofos-methyl",
"synonyms": "Tolclofos-methyl; 57018-04-9; Risolex; Rizolex; Toclofos-methyl; Basilex; UNII-G42OQL6F5B; Tolclofos-methyl [BSI:ISO]; S-3349; Phosphorothioic acid, O-(2,6-dichloro-4-methylphenyl) O,O-dimethyl ester; EINECS 260-515-3; o-(2,6-Dichloro-4-methylphenyl) o,o-dimethyl phosphorothioate; BRN 2136521; G42OQL6F5B; O-(2,6-Dichloro-p-tolyl) O,O-dimethyl thiophosphate; O-2,6-Dichloro-p-tolyl O,O-dimethyl phosphorothioate; CHEBI:81731; O,O-Dimethyl O-(2,6-dichloro-4-methylphenyl)phosphorothioate; O-(2,6-Dichloro-p-tolyl) O,O-dimethyl ester of phosphorothioic acid; W-111130; Phosphorothioic acid, O-(2,6-dichloro-p-tolyl) O,O-dimethyl ester; PHOSPHOROTHIOIC ACID O-(2,6-DICHLORO-PARA-TOLYL) O,O-DIMETHYL ESTER; Phosphorothioic acid,O-(2,6-dichloro-4-methylphenyl) O,O-dimethyl ester; C9H11Cl2O3PS; Grancer; tolclofos-Me; Tolclophos-methyl; (2,6-dichloro-4-methylphenoxy)-dimethoxy-sulfanylidene-?^{5}-phosphane; TOLCOFOS-METHYL; DSSTox_CID_14776; DSSTox_RID_79202; DSSTox_GSID_34776; SCHEMBL30367; BIDD:ER0164; CHEMBL2141416; DTXSID0034776; CTK5A6161; KS-00001FCN; OBZIQQJJIKNWNO-UHFFFAOYSA-N; HY-B2053; Tox21_301347; O-(2,6-Dichloro-4-methylphenyl) O,O-dimethyl phosphorothioate (9CI); AKOS015961111; O-(2,6-dichloro-4-methylphenyl)phosphorothioic acid O,O-dimethyl ester; AC01012; CS-5201; RTR-019946; NCGC00164279-01; NCGC00255519-01; AC-12691; CC-35090; O803; CAS-57018-04-9; DB-053000; LS-108553; TR-019946; FT-0630695; Tolclofos-methyl 10 microg/mL in Cyclohexane; C18407; 018T049; C-18799; Q1651656; Tolclofos-methyl, PESTANAL(R), analytical standard; Dimethyl O-(2,6-dichloro-4-methylphenyl) phosphorothioate; o-2,6-dichloro-4-methylphenyl o,o-dimethyl phosphorothioate; O,O-Dimethyl O-(2,6-dichloro-4-methylphenyl) phosphorothioate; O-(2,6-Dichloro-4-methylphenyl) O,O-dimethyl thiophosphate #; Phosphorothioic acid, O-(2,6-dichloro-4-methylphenyl) O,O-dimethylester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C9H11Cl2O3PS",
"molecular_weight": "301.13",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "91664",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02156",
"RC02777",
"RC03398"
]
}
]
}
